A role for AMPK in the regulation of mitosis and cytokinesis by Bremner, Shaun Kennedy
 
 
 
 
 
 
 
 
Bremner, Shaun Kennedy (2020) A role for AMPK in the regulation of 
mitosis and cytokinesis. PhD thesis. 
 
 
 
 
https://theses.gla.ac.uk/80254/ 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
 
 
1 
 
 
A role for AMPK in the regulation of 
mitosis and cytokinesis 
 
 
 
 
Shaun Kennedy Bremner MRes, BSc (Hons) 
Submitted in fulfilment of the requirements for 
the Degree of Doctor of Philosophy 
March 2020 
 
 
 
 
School of Medical, Veterinary and Life Science 
Institute of Cardiovascular and Medical Science 
University of Glasgow 
  
2 
 
Abstract 
AMP-activated protein kinase (AMPK) has a central role in maintaining cellular 
energy homeostasis. AMPK is activated allosterically by AMP and signals to inhibit 
ATP consuming pathways while simultaneously promoting ATP producing 
pathways. As such AMPK exerts an anti-proliferative effect to induce cell cycle 
arrest when nutrient resources are limited. Although many of the anti-
proliferative effects of AMPK have been well documented during interphase, less 
is known about how AMPK signalling may influence mitosis. A few publications 
have reported that levels of active phospho-T172 AMPK increase as mitosis 
progresses and a link has also been reported between AMPK and myosin 
regulatory light chain (MRLC) in mitosis. In this Thesis, a combination of cellular, 
genetic and biochemical techniques were used to further characterise the role 
of AMPK in mitosis.  
A novel localisation of the AMPKα1 subunit was described, where AMPKα1 was 
detected at the microtubule organising centres (MTOCs) during mitosis in both 
primary human cells and in HeLa cells. AMPKα2 localisation to the midbody was 
also demonstrated in primary cells and in cell lines. Modulation of AMPK activity 
by either pharmacological or genetic means caused cell cycle arrest and 
influenced polyploidy in a number of cell lines.  
A yeast genetic approach was utilised to investigate the link between the AMPK 
pathway and a number of key mitotic regulates. Genetic interactions were 
detected between the AMPK pathway and S. pombe aurora kinase (ark1), polo-
like kinase (plo1), anillin (mid1) and components of the endosomal sorting 
complex required for transport (ESCRT) machinery. Furthermore, a network of 
cross phosphorylation events were described in vitro between the mammalian 
protein orthologues. This included the phosphorylation of aurora A, aurora B and 
PLK1 by AMPK and the phosphorylation of aurora A and aurora B by 
Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ).  
Considering the localisation of AMPK to mitotic structures and the numerous 
interactions documented with mitotic proteins, a role for AMPK in the regulation 
of mitosis is clear although the precise cellular effects remain difficult to 
discern.  
3 
 
Table of Contents  
A role for AMPK in the regulation of mitosis and cytokinesis ........................ 1 
Shaun Kennedy Bremner MRes, BSc (Hons) ............................................. 1 
Submitted in fulfilment of the requirements for the Degree of Doctor of 
Philosophy ................................................................................... 1 
September 2019 ......................................... Error! Bookmark not defined. 
Abstract ...................................................................................... 2 
Table of Contents .......................................................................... 3 
List of Figures ............................................................................... 8 
List of Tables ............................................................................... 12 
Acknowledgement ......................................................................... 13 
Author’s Declaration ...................................................................... 14 
Abbreviations .............................................................................. 15 
1 Chapter 1-Introduction .............................................................. 19 
1.1 The cell cycle and cytokinesis ................................................. 19 
1.1.1 Overview of the cell cycle ................................................ 19 
1.1.2 Centrosomes in mitosis .................................................... 20 
1.1.3 Cytokinesis ................................................................... 20 
1.1.4 Important regulators of cytokinesis ...................................... 22 
1.2 AMPK .............................................................................. 27 
1.2.1 Structure of AMPK subunits ............................................... 27 
1.2.2 Control of AMPK activity ................................................... 29 
1.2.3 Pharmacological activators and inhibitors of AMPK ................... 31 
1.2.4 Function and downstream targets of AMPK ............................. 33 
1.3 AMPK in mitosis and cytokinesis ............................................... 35 
1.3.1 AMPK orthologues ........................................................... 37 
1.4 S. pombe and the cell cycle ................................................... 38 
1.4.1 S. pombe overview ......................................................... 38 
1.4.2 S. pombe as a model organism ........................................... 38 
1.4.3 Cell cycle of S. pombe ..................................................... 39 
1.4.4 The AMPK orthologue in S. pombe ....................................... 42 
1.5 Aims ............................................................................... 44 
2 Chapter 2-Materials and methods ................................................. 45 
2.1 Materials .......................................................................... 45 
2.1.1 List of materials and suppliers ............................................ 45 
2.1.2 Standard solutions .......................................................... 47 
2.1.3 List of antibodies and condition of use .................................. 50 
2.1.4 PCR primers ................................................................. 55 
4 
 
2.1.5 Plasmids ...................................................................... 56 
2.1.6 S. pombe media ............................................................. 57 
2.1.7 Bacteria medium............................................................ 58 
2.2 Mammalian cell culture procedure ........................................... 58 
2.2.1 Mammalian cell suppliers .................................................. 58 
2.2.2 Cell culture plastic ware .................................................. 58 
2.2.3 Cell culture growth media ................................................ 59 
2.2.4 Passaging of cells ........................................................... 59 
2.2.5 Cryopreservation of cell stocks ........................................... 59 
2.2.6 Resurrection of frozen cell stocks ........................................ 60 
2.3 Preparation of cell lysates ..................................................... 60 
2.4 Protein concentration determination ........................................ 60 
2.5 SDS-PAGE ......................................................................... 60 
2.6 Western blotting of proteins ................................................... 61 
2.6.1 Electrophoretic transfer of proteins onto nitrocellulose membranes
 61 
2.6.2 Blocking of membranes and incubation with primary antibodies ... 61 
2.6.3 Secondary antibodies and immunodetection of proteins using the LI-
COR detection system ............................................................... 61 
2.6.4 Stripping of nitrocellulose membranes .................................. 61 
2.6.5 Densitometric quantification of protein bands ......................... 62 
2.7 Immunofluorescence ............................................................ 62 
2.7.1 Preparation of coverslips .................................................. 62 
2.7.2 Immunofluorescence staining ............................................. 62 
2.7.3 Incubation of coverslips with primary and secondary antibodies.... 62 
2.7.4 Staining of DNA ............................................................. 63 
2.7.5 Mounting coverslips on slides ............................................. 63 
2.7.6 Preparation of samples in ibidi® μ slides ............................... 63 
2.7.7 Confocal microscopy and image acquisition ............................ 63 
2.8 Recombinant adenoviruses ..................................................... 64 
2.8.1 Adenoviruses used .......................................................... 64 
2.8.2 Adenovirus propagation and purification ............................... 64 
2.8.3 Adenovirus infection of mammalian cells ............................... 65 
2.9 siRNA-mediated knockdown of gene expression ............................ 65 
2.10 Transfection of plasmid DNA ................................................ 66 
2.11 Cell synchronisation .......................................................... 66 
2.11.1 Thymidine and nocodazole block ...................................... 66 
2.11.2 Double thymidine block ................................................. 67 
2.12 Flow cytometry ................................................................ 67 
5 
 
2.13 Cell viability assay (MTS assay) ............................................. 67 
2.14 Cell proliferation assay (BrdU assay) ....................................... 67 
2.15 Immunoprecipitation ......................................................... 68 
2.15.1 FLAG-tag immunoprecipitation ........................................ 68 
2.15.2 Immunoprecipitation using conjugated nanobodies ................ 68 
2.16 In vitro Phosphorylation assays ............................................. 68 
2.16.1 Substrate generation .................................................... 68 
2.16.2 Lambda phosphatase treatment ....................................... 69 
2.16.3 Phosphorylation reaction ............................................... 69 
2.16.4 SDS-PAGE and visualisation ............................................. 70 
2.17 Transformation of competent E. coli ...................................... 70 
2.18 Preparation of plasmid DNA ................................................. 70 
2.19 PCR .............................................................................. 70 
2.20 Agarose gel electrophoresis and visualisation of PCR products ........ 71 
2.21 General S.pombe methods ................................................... 71 
2.22 Generating mutants by homologous recombination ..................... 71 
2.22.1 Generating transforming DNA .......................................... 71 
2.22.2 Transformation of S. pombe ............................................ 73 
2.22.3 Confirmation of homologous recombination ......................... 73 
2.23 Generation of double mutants .............................................. 74 
2.23.1 Mating of S. pombe strains ............................................. 74 
2.23.2 Tetrad analysis ........................................................... 74 
2.23.3 Random spore analysis .................................................. 75 
2.23.4 Genotype analysis/replica plating ..................................... 75 
2.24 Serial dilution analysis of S. pombe ........................................ 75 
2.25 Analysis of septation phenotypes ........................................... 76 
2.26 Statistical analysis ............................................................ 76 
3 Chapter 3-AMPK may have a role in mammalian mitosis ....................... 77 
3.1 Introduction ...................................................................... 77 
3.2 Results ............................................................................ 78 
3.2.1 AMPK subcellular localisation during mitosis ........................... 78 
3.2.2 AMPK activity may influence mitosis in mammalian cells ............ 88 
3.3 Discussion ........................................................................ 108 
3.3.1 Principal findings .......................................................... 108 
3.3.2 Localisation of AMPK mitosis ............................................. 108 
3.3.3 AMPK activity and the cell cycle ........................................ 110 
3.3.4 Summary .................................................................... 117 
4 Chapter 4-Using fission yeast to investigate the role of AMPK in mitosis ... 119 
4.1 Introduction ..................................................................... 119 
6 
 
Results ................................................................................... 121 
4.1.1 AMPK has a role in cytokinesis in S. pombe ............................ 121 
4.1.2 Generation of double mutant strains ................................... 123 
4.1.3 Attempted generation of ssp2::KanMX6 strain ........................ 127 
4.1.4 ark1 interacts genetically with ssp1, ssp2 and amk2 ................. 129 
4.1.5 plo1 interacts genetically with ssp1, amk2 and cbs2 ................ 133 
4.1.6 mid1 interacts genetically with ssp1, ssp2, amk2 and cbs2 ......... 139 
4.1.7 ssp1 interacts genetically with components of the ESCRT pathway
 140 
4.2 Discussion ........................................................................ 146 
4.2.1 Principal findings .......................................................... 146 
4.2.2 AMPK has a role in controlling S. pombe cytokinesis ................. 146 
4.2.3 The AMPK pathway genetically interacts with a number of mitotic 
regulators in S. pombe ............................................................. 147 
4.2.4 Summary .................................................................... 152 
5 Chapter 5–Phosphorylation of mammalian mitotic proteins by AMPK and 
CaMKKβ .................................................................................... 153 
5.1 Introduction ..................................................................... 153 
5.2 Results ........................................................................... 155 
5.2.1 LKB1 function does not influence mitosis in HeLa cells .............. 155 
5.2.2 Development of in vitro phosphorylation assays ...................... 165 
5.2.3 Analysis of In vitro phosphorylation .................................... 171 
5.3 Discussion ........................................................................ 185 
5.3.1 Principal findings .......................................................... 185 
5.3.2 LKB1 activity may influence HeLa cell mitosis ........................ 185 
5.3.3 A network of phosphorylation exists between AMPK, CaMKKβ, LKB1 
and mitotic proteins ................................................................ 187 
5.3.4 Future work ................................................................ 191 
5.3.5 Summary .................................................................... 193 
6 Chapter 6–Discussion................................................................ 194 
6.1 Background ...................................................................... 194 
6.2 Final discussion ................................................................. 194 
6.2.1 AMPK localisation in mitosis ............................................. 194 
6.2.2 AMPK activity during mitosis ............................................. 195 
6.2.3 Signalling pathways AMPK may regulate in mitosis ................... 197 
6.3 Proposed model for AMPK in mitosis ......................................... 198 
6.4 Summary ......................................................................... 199 
6.5 Limitations of the present study ............................................. 199 
6.6 Future work ..................................................................... 200 
7 Appendix 1-S. pombe strain list ................................................... 203 
7 
 
8 Appendix 2-Negative genetic interactions between AMPK and ESCRT 
components in S. pombe ................................................................ 214 
8.1 Negative interactions between ssp2 and ESCRT components ............ 214 
8.2 Negative interactions between amk2 and ESCRT components ........... 215 
8.3 Negative interactions between cbs2 and ESCRT components ............ 220 
8.4 Negative interactions between ssp1 and ESCRT components ............ 224 
9 References ........................................................................... 227 
 
  
8 
 
List of Figures 
Figure 1-1. Representation of mammalian cell mitosis .............................. 19 
Figure 1-2. Schematic representation of ESCRT-mediated cytokinesis ............ 22 
Figure 1-3.Comparison of the ESCRT pathways for MVB biogenesis, virus budding 
and cytokinesis............................................................................. 25 
Figure 1-4. Schematic representation of the domain organisation of AMPK 
subunits ..................................................................................... 28 
Figure 1-5. Schematic representation of AMPK activation .......................... 30 
Figure 1-6. S. pombe mitotic and meiotic cell cycles ................................ 40 
Figure 1-7. Representation of S. pombe mitosis and cytokinesis ................... 41 
Figure 2-1: Schematic diagram showing the chromosomal deletion of ssp2 based 
on homologous recombination. .......................................................... 72 
Figure 2-2: Schematic representation of tetrad analysis used to identify double 
mutants in fission yeast. ................................................................. 74 
Figure 3-1. Subcellular localisation of AMPKα subunits during mitosis in HeLa 
cells ......................................................................................... 79 
Figure 3-2. Subcellular localisation of AMPKα subunits during mitosis in HUVECs80 
Figure 3-3. Subcellular localisation of AMPKα-GFP in HeLa cells ................... 81 
Figure 3-4. Subcellular localisation of phospho-T172 AMPK during mitosis in HeLa 
cells ......................................................................................... 83 
Figure 3-5. Subcellular localisation of phospho-T172 AMPK during mitosis in 
HUVECs ...................................................................................... 84 
Figure 3-6 Subcellular localisation of phospho-T172 AMPK during mitosis in wild 
type and AMPK -/- MEFs .................................................................. 85 
Figure 3-7. Subcellular localisation of Phospho-S79 ACC during mitosis in HUVECs
 ............................................................................................... 87 
Figure 3-8. The effect of modulating AMPK activity on binucleation in HeLa cells
 ............................................................................................... 89 
Figure 3-9. The effect of modulating AMPK activity on the DNA content of HeLa 
cells ......................................................................................... 90 
Figure 3-10. The effect of modulating AMPK activity on HeLa cell viability and 
proliferation ................................................................................ 91 
Figure 3-11. The effect of modulating AMPK activity on the DNA content of 
HUVECs ...................................................................................... 94 
Figure 3-12. The effect of modulating AMPK activity on binucleation in HUVECs 95 
Figure 3-13. The effect of SBI-0206965 on the DNA content of HUVECs .......... 97 
Figure 3-14. The effect of modulating AMPK activity on HUVEC viability and 
proliferation ................................................................................ 98 
Figure 3-15. The effect of modulating AMPK activity on the DNA content of wild 
type and AMPK -/- MEFs ................................................................. 101 
Figure 3-16. The effect of modulating AMPK activity on wild type and AMPK -/- 
MEF viability and proliferation ......................................................... 102 
Figure 3-17. The effect of adenovirus infection on binucleation in HUVECs .... 104 
Figure 3-18. The effect of AMPKα knockdown on the DNA content of HUVECs.. 105 
9 
 
Figure 3-19. The effect of compound C on the timing of mitosis ................. 107 
Figure 4-1. Chromosomal deletions of genes encoding AMPK subunits or ssp1 alter 
septation in S. pombe.................................................................... 122 
Figure 4-2. Representative examples of S. pombe double mutant isolation by 
tetrad analysis ............................................................................ 124 
Figure 4-3. Representative example S. pombe double mutant isolation by random 
spore analysis ............................................................................. 125 
Figure 4-4. Attempted generation of ssp2::KanMX6 S. pombe strain based on the 
homologous recombination method ................................................... 128 
Figure 4-5. Growth defects in ssp1Δ ark1-T8 double mutant cells. ............... 129 
Figure 4-6. Septation defects in ssp1Δ ark1T8 double mutant cells. ............. 130 
Figure 4-7. Growth defects in ssp2Δ ark1-T8, amk2Δ ark1-T8, and cbs2Δ ark1-T8 
double mutant cells. ..................................................................... 132 
Figure 4-8. Synthetic growth defects in ssp1Δ plo1-ts double mutant cells. .... 134 
Figure 4-9. Growth defects in ssp1Δ plo1-ts35 cells grown in liquid YE media. 134 
Figure 4-10. Synthetic septation defects in ssp1Δ plo1-ts double mutant cells. 135 
Figure 4-11. Analysis of synthetic growth defects in ssp2Δ plo1-ts18, amk2Δ-plo1-
ts18 and cbs2Δ-plo1-ts18 mutant strains. ............................................ 136 
Figure 4-12. Synthetic septation defects in amk2Δ plo1-ts18 and cbs2Δ plo1-ts18 
double mutant cells. ..................................................................... 137 
Figure 4-13. Plo1-GFP cells did not express GFP fusion protein. .................. 138 
Figure 4-14. Growth defects in mid1Δ and ssp1Δ/ssp2Δ/amk2Δ/cbs2Δ double 
mutant cells. .............................................................................. 139 
Figure 4-15. Analysis of synthetic growth defects in ssp1Δ vps2Δ double mutant 
ells. ......................................................................................... 141 
Figure 4-16. Analysis of synthetic septation defects in ssp1Δ vps2Δ double mutant 
cells. ....................................................................................... 142 
Figure 4-17. Analysis of synthetic growth defects in ssp1 vps4 double mutant 
cells. ....................................................................................... 144 
Figure 4-18. Analysis of synthetic septation defects in ssp1Δ vps4Δ double mutant 
cells. ....................................................................................... 145 
Figure 4-19. Ssp1p may regulate Mid1p in a number of ways ...................... 151 
Figure 5-1. Subcellular localisation of LKB1 during telophase ..................... 156 
Figure 5-2. Subcellular localisation of aurora A during telophase ................ 158 
Figure 5-3. Subcellular localisation of aurora B during telophase ................. 159 
Figure 5-4. Subcellular localisation of PLK1 during telophase ..................... 160 
Figure 5-5. The effect of modulating AMPK activity on the DNA content of WT- 
and KD-LKB1 expressing HeLa cells .................................................... 164 
Figure 5-6. Expression of substrates for in vitro phosphorylation assays in HEK 
293 cells ................................................................................... 166 
Figure 5-7. Immunoprecipitation of KD-AMPKα1-myc from adenovirus infected 
HEK 293 cells .............................................................................. 167 
Figure 5-8. Immunoprecipitation of KD-LKB1-FLAG from transgenic HeLa cells 168 
Figure 5-9. Dephosphorylation of rat liver AMPK by lambda phosphatase ....... 169 
Figure 5-10. In vitro phosphorylation of MBP by recombinant proteins .......... 170 
10 
 
Figure 5-11. Analysis of in vitro phosphorylation of KD-LKB1 and DN-AMPK-myc by 
aurora A .................................................................................... 172 
Figure 5-12. Analysis of in vitro phosphorylation of CaMKKβ-GST by aurora A .. 173 
Figure 5-13. Analysis of in vitro phosphorylation of KD-LKB1 and DN-AMPK-myc by 
aurora B .................................................................................... 175 
Figure 5-14. Analysis of in vitro phosphorylation of CaMKKβ-GST by aurora B .. 176 
Figure 5-15. Analysis of in vitro phosphorylation of KD-LKB1 and DN-AMPK-myc by 
PLK1 ........................................................................................ 177 
Figure 5-16. Analysis of in vitro phosphorylation of CaMKKβ-GST by PLK1 ...... 178 
Figure 5-17. Analysis of in vitro phosphorylation of DN-Aurora A-mCherry, DN-
Aurora B-GFP, DN-PLK1-YFP and CHMP2A-GFP by CaMKKβ ......................... 180 
Figure 5-18. Analysis of in vitro phosphorylation of DN-Aurora A-mCherry, DN-
Aurora B-GFP, DN-PLK1-YFP and CHMP2A-GFP by AMPKα1β1γ1 ................... 182 
Figure 5-19. Analysis of AMP-dependence of the in vitro phosphorylation of DN-
Aurora A-mCherry, DN-Aurora B-GFP or DN-PLK1-YFP by AMPKα2β2γ1 .......... 183 
Figure 5-20. Analysis of in vitro phosphorylation of DN-Aurora A-mCherry, DN-
Aurora B-GFP, DN-PLK1-YFP and CHMP2A-GFP by AMPKα2β2γ1 ................... 184 
Figure 5-21. A number of phosphorylation events link the AMPK pathway to 
aurora A, aurora B and PLK1 ............................................................ 187 
Figure 5-22. Sequence analysis of aurora A and PLK1 indicated the presence of 
an AMPK phosphorylation motif ........................................................ 189 
Figure 5-23. Sequence analysis of CHMP2A and CHMP2B indicated the presence of 
an AMPK phosphorylation motif ........................................................ 192 
Figure 6-1. Proposed role for AMPK in mitosis and cytokinesis. ................... 199 
Figure 8-1. No growth rate defects were observed in ssp2Δ vps25Δ double mutant 
cells ........................................................................................ 214 
Figure 8-2. No growth rate defects were observed in amk2Δ sst4Δ double mutant 
cells ........................................................................................ 215 
Figure 8-3. No growth rate defects were observed in amk2Δ sst6Δ double mutant 
cells ........................................................................................ 215 
Figure 8-4. No growth rate defects were observed in amk2Δ vps28Δ double 
mutant cells ............................................................................... 216 
Figure 8-5. No growth rate defects were observed in amk2Δ vps36Δ double 
mutant cells ............................................................................... 216 
Figure 8-6. No growth rate defects were observed in amk2Δ vps25Δ double 
mutant cells ............................................................................... 217 
Figure 8-7. No growth rate defects were observed in amk2Δ vps20Δ double 
mutant cells ............................................................................... 217 
Figure 8-8. No growth rate defects were observed in amk2Δ vps32Δ double 
mutant cells ............................................................................... 218 
Figure 8-9. No growth rate defects were observed in amk2Δ vps2Δ double mutant 
cells ........................................................................................ 218 
Figure 8-10. No growth rate defects were observed in amk2Δ vps4Δ double 
mutant cells ............................................................................... 219 
Figure 8-11. No growth rate defects were observed in cbs2Δ sst4Δ double mutant 
cells ........................................................................................ 220 
11 
 
Figure 8-12. No growth rate defects were observed in cbs2Δ sst6Δ double mutant 
cells ........................................................................................ 220 
Figure 8-13. No growth rate defects were observed in cbs2Δ vps28Δ double 
mutant cells ............................................................................... 221 
Figure 8-14. No growth rate defects were observed in cbs2Δ vps36Δ double 
mutant cells ............................................................................... 221 
Figure 8-15. No growth rate defects were observed in cbs2Δ vps25Δ double 
mutant cells ............................................................................... 222 
Figure 8-16. No growth rate defects were observed in cbs2Δ vps20Δ double 
mutant cells ............................................................................... 222 
Figure 8-17. No growth rate defects were observed in cbs2Δ vps2Δ double 
mutant cells ............................................................................... 223 
Figure 8-18. No growth rate defects were observed in cbs2Δ vps4Δ double 
mutant ..................................................................................... 223 
Figure 8-19. No growth rate defects were observed in ssp1Δ sst4Δ double mutant
 .............................................................................................. 224 
Figure 8-20. No growth rate defects were observed in ssp1Δ sst6Δ double mutant 
cells ........................................................................................ 224 
Figure 8-21. No growth rate defects were observed in ssp1Δ vps28Δ double 
mutant cells ............................................................................... 225 
Figure 8-22. No growth rate defects were observed in ssp1Δ vps36Δ double 
mutant cells ............................................................................... 225 
Figure 8-23. No growth rate defects were observed in ssp1Δ vps20Δ double 
mutant ..................................................................................... 226 
Figure 8-24. No growth rate defects were observed in ssp1Δ vps32Δ double 
mutant cells ............................................................................... 226 
 
  
12 
 
List of Tables 
Table 2-1: Primary antibodies used for immunoblotting ............................ 51 
Table 2-2: Secondary antibodies used for immunoblotting ......................... 52 
Table 2-3: Primary antibodies used for immunofluorescence ...................... 53 
Table 2-4: Secondary antibodies used for immunofluorescence ................... 54 
Table 2-5: Primers used for PCR ........................................................ 55 
Table 2-6: Plasmids used during this investigation ................................... 57 
Table 2-7: Mammalian cell culture media and supplements ........................ 59 
Table 2-8: Adenoviruses used ............................................................ 64 
Table 2-9. Volumes and quantities of Lipofectamine® 2000 and plasmid DNA used 
for the transfection of mammalian cells. .............................................. 66 
Table 4-1. Comparison of mammalian and S. pombe orthologues.................119 
Table 4-2. Double mutant S. pombe strains generated in this study. .......... 1266 
Table 4-3. Summary of ESCRT deletion strains used in the present study. ... 14040 
Table 4-3. Summary of the genetic interactions detected in S. pombe ........ 1477 
Table 7-1. S. pombe strain list..........................................................202 
  
13 
 
Acknowledgement 
First and foremost I would like to thank my supervisor Dr. Ian Salt for his endless 
support and encouragement. I would also like to thank my second supervisor 
Prof. Gwyn Gould for his continued help and support. The upmost thanks go to 
Dr. Chris McInerny who tirelessly helped me with the yeast genetic studies.  
I am grateful to members of Lab 241 past and present for their help and moral 
support. In particular Dr. Sarah Mancini, Dr. Kamilla Laidlaw and Dr. Anastasiya 
Strembitska who’s friendship and advice has helped immensely during my time in 
the lab.  
Finally I would like to acknowledge everyone who contributed to the MVLS 
Doctoral Training Program which funded my work.  
  
14 
 
Author’s Declaration 
I declare that the work presented in this Thesis has been carried out by me, 
unless otherwise stated. It is entirely of my own composition and has not, in 
whole or in part, been submitted for any other degree. 
Shaun Kennedy Bremner 
March 2020 
  
15 
 
Abbreviations 
4E-BP1 eukaryotic initiation factor 4E binding protein  
ACC Acetyl-CoA carboxylase 
ADaM Allosteric drug and metabolite 
Ad.AMPK-CA constitutively active AMPK adenovirus  
Ad.AMPK-DN Dominant negative AMPK adenovirus  
Ad.GFP GFP recombinant adenovirus 
Ad.Null Null adenovirus 
ADP Adenosine diphosphate 
AICAR 5-aminoimidazole-4-carboxamide riboside 
AID Auto-inhibitory sequence 
ALIX Apoptosis-linked gene 2-interacting protein 
AMP Adenosine monophosphate 
AMPK AMP-activated protein kinase 
ANOVA Analysis of variance 
APS Ammonium persulphate 
ARK AMPK related kinase 
ATP Adenosine triphosphate 
BRSK1/2 brain-specific kinase 1/2 
BSA Bovine serum albumin 
CaM Calmodulin 
CaMKK Calcium calmodulin dependent protein kinase kinase 
CBS Cystathionine β synthase 
CBD Carbohydrate binding domain 
cdc Cell division cycle 
CDK Cyclin-dependant kinase 
CDKI CDK inhibitor 
C. elegans Caenorhabditis elegans  
16 
 
CEP55 Centrosomal protein of 55 kDa 
CHMP Charged multivesicular body protein 
DMEM Dulbecco’s modified Eagle's medium 
DMSO Dimethyl sulphoxide 
DN Dominant negative 
DTT Dithiothreitol  
E. coli Escherichia coli 
FBS Foetal bovine serum 
EMM Edinburgh minimal media 
ESCRT Endosomal sorting complex required for transport 
FS-A Forward scatter by area 
G1-phase Gap 1-phase 
G2-phase Gap 2-phase 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GFP Green fluorescent protein 
GG “Glasgow” lab collection number 
GLUT4 Glucose transporter 4 
HAEC Human aortic endothelial cells 
HEK 293 Human embryonic kidney 293 cell 
HIV Human immunodeficiency virus 
HUVEC Human umbilical vein endothelial cells 
ID Immunodeplete 
IF Immunofluorescence  
IgG Immunoglobulin G 
IP Immunoprecipitation 
Ipl1 increase-in-polyploidy 1  
KD Kinase dead 
LKB1 Liver kinase B1 
LSB Laemmli sample buffer 
17 
 
MBP Myelin basic protein 
mCherry Monomeric cherry 
ME Malt extract 
MEF Mouse embryonic fibroblast 
MEM Minimal essential media 
MetSal Metformin and salicylate 
M-phase Mitosis-phase 
MO25 Mouse protein-25 
MRLC Myosin regulatory light chain 
MTOC Microtubule organising centre 
mTOR Mammalian target of rapamycin 
mTORC1 mTOR complex 1 
mTORC2 mTOR complex 2 
MVB Multivesicular bodies 
MYPT1 myosin phosphatase targeting-1 
NSCLC Non-small cell lung carcinoma  
p70S6K p70 ribosomal protein S6 kinase 1 
PBD Polo-box domain 
PBS Phosphate buffered saline 
PBST PBS with Tween-20 
PCM Pericentriolar material 
PE-A Phycoerythrin by area 
pfu Plaque forming units 
PI Propidium iodide 
PJS Peutz-Jeghers syndrome 
PLK Polo-like kinase 
PP1β protein phosphatase 1β  
Sc Scrambled 
S. cerevisiae Saccharomyces cerevisiae 
18 
 
SDS-PAGE Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
SEM Standard error of the mean 
SGLT2 Sodium/glucose cotransporter 2 
siRNA Small interfering RNA 
Snf1 Sucrose non-fermenting1 
SnRK1 Snf1-related protein kinase 
SPB Spindle pole body 
SSC Squamous cell carcinoma 
STRAD STE20-related kinase adapter protein 
S-phase Synthesis-phase 
S. pombe Schizosaccharomyces pombe 
TBS Tris buffered saline 
TBST TBS with Tween-20 
TE Tris-EDTA 
TEMED N,N,N′,N′-tetramethylethylenediamine 
TSG101 Tumour susceptibility gene 101 
ULK1 Unc-51 like kinase 1 
UTR Untranslated region  
Vps Vacuolar protein sorting 
YE Yeast extract 
YFP Yellow fluorescent protein 
YGRC Yeast genetic resource centre 
WT Wild type 
ZMP 5’-aminoimidazole-4-carboxamide ribonucleotide 
monophosphate 
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1 Chapter 1-Introduction 
1.1 The cell cycle and cytokinesis 
1.1.1 Overview of the cell cycle 
During the cell cycle, eukaryotic cells sequentially pass through several phases 
culminating in the formation of two daughter cells. The cell cycle can be divided 
into four distinct stages; G1 (gap 1) where cells grow; S (synthesis) phase where 
DNA replication occurs; G2 (gap 2) an intermediate phase allowing cells to 
perform check points and grow before finally M (mitosis) phase, where 
chromosomes segregate and the cell divides (Figure 1-1) (Alberts et al., 2012). 
Collectively G1-, S- and G2- phase are referred to as interphase.  
 
Figure 1-1. Representation of mammalian cell mitosis 
During prophase, the nuclear envelope breaks down as chromosomes condense. In metaphase, 
the chromosomes align at the cell equator as the spindles attach to the centromeres. As mitosis 
progresses to anaphase, the chromatids are separated as a cleavage furrow forms. Plasma 
membrane ingression continues into telophase until daughter cells are connected by a thin 
intracellular bridge. Cytokinesis resolves the intracellular bridge, separating the daughter cells.  
Mitosis can also be subdivided into a number of phases; prophase, metaphase, 
anaphase and telophase (Figure 1-1). During prophase chromosomes condense 
and spindles begin to form. In metaphase spindle fibres align the chromosomes 
in the centre of the cell. In anaphase chromatids are separated and begin to 
move to the poles of the cell. Finally in telophase, chromatids arrive at the 
poles of the cells and the nuclear envelope reforms. For daughter cells to 
separate, a cleavage furrow is formed by the ingression of the plasma 
membrane. Membrane furrowing continues until the daughter cells are 
connected by a thin intracellular bridge with an array of microtubules at is core, 
called the central spindle. At the centre of the intracellular bridge, the 
midbody, a series of signalling pathways culminate in membrane abscission, this 
will be discussed in more detail in the following Sections (Alberts et al., 2012).  
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1.1.2 Centrosomes in mitosis 
From early investigations, it was apparent that microtubules originate from a 
distinct subcellular site which was termed the microtubule organising centre 
(MTOC) (Pickett-Heaps, 1969). MTOCs act as a site for the minus (non-dynamic) 
end of microtubules to anchor to and nucleate from. The most well defined 
MTOC is the centrosome which is crucial for karyokinesis. The centrosome is 
composed of two centrioles and pericentriolar material (PCM). Generally, most 
mammalian cells contain one MTOC which is replicated in S-phase in dividing 
cells (Robbins et al., 1968).  
Early in mitosis a number of proteins localise to the centrosomes such as cyclin-
dependant kinase 1 (CDK1)/cyclin B, aurora A and polo-like kinase 1 (PLK1) 
(Jackman et al., 2003). Therefore it has been suggested that the centrosomes 
may act as a platform to integrate mitotic signalling pathways. PLK1 and aurora 
A play an important role in the maturation of centrioles, which will be discussed 
further in Section 1.1.4.  
1.1.3 Cytokinesis 
In mammalian cells the division plane is defined by the microtubules following 
karyokinesis (Cao and Wang, 1996; Eckley et al., 1997). During the early stages 
of cytokinesis, the primary ingression occurs to form the intracellular bridge. 
This process is controlled by the formation of an actomyosin ring beneath the 
cell membrane at the cell equator. Contraction of the actomyosin ring begins in 
anaphase and causes invagination of the cell membrane to form the cleavage 
furrow (Eggert et al., 2006). After chromosome separation, the spindles in the 
midzone are reorganised to form an array of antiparallel bundles (central 
spindle) which become the backbone for the intracellular bridge (Guertin et al., 
2002). To enable daughter cell separation, the endosomal sorting complex 
required for transport (ESCRT) machinery is recruited to the midbody to mediate 
abscission (Eggert et al,. 2006). The role of the ESCRT machinery in cytokinesis 
will be discussed in this Section and other facets of the ESCRT proteins will be 
discussed further in Section 1.1.4.3.  
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Briefly, the ESCRT machinery have been described in a number of processes 
including multivesicular body (MVB) formation, HIV budding and cytokinesis. The 
ESCRT proteins were originally described in S. cerevisiae where mutations in the 
ESCRT genes caused the missorting of cargo destined for the vacuole causing an 
abnormal endocytic structure to form (Raymond et al., 1992). Many of these 
mutated genes were denotes as “vacuolar protein sorting mutants (vps)” 
(Raymond et al., 1992). The ESCRT proteins can be organised into member of 
four heteromeric complexes, denoted, ESCRT-0, ESCRT-I, ESCRT-II and ESCRT-III, 
or form a group of accessory proteins which includes Vps4 an AAA-ATPase 
(Saksena et al., 2009).  
For membrane abscission, centrosomal protein of 55 kDa (CEP55), is recruited to 
the midbody by the endosomal membrane protein syntaxin 16 (Lee et al., 2008; 
Neto et al., 2013). The ESCRT-I tumour susceptibility gene 101 (TSG101) is then 
recruited to the midbody which forms two cortical rings on either side of CEP55 
(Figure 1-2) (Lee et al., 2008). ESCRT-III subunits (charged multivesicular body 
protein 4b (CHMP4B), CHMP2A, CHMP2B and CHMP6) polymerises to form a 
ringed structure on either side of the midbody (Elia et al., 2011; Guizetti et al., 
2011). The initial ESCRT-III polymer structure forms with a diameter greater than 
1 µm (Elia et al., 2012). However, ESCRT-III polymer rings favour a diameter of 
50 nm, thus the greater diameter puts mechanical stress on the complex. As 
ESCRT-III assembles, Vps4 remodels the emerging polymer and eventually splits 
the complex into two distinct structures. The initial structure remains in place 
at the midbody, whereas the second structure (referred to as the fission 
complex) constricts to 50 nm as it travels along the intracellular bridge while 
remaining bound to the membrane (Figure 1-2). As the fission complex relaxes to 
its more energetically favourable structure, the membrane is deformed to drive 
membrane fusion (Elia et al., 2012). ESCRT proteins are vital for efficient 
cytokinesis; disruption of the Cep55/ESCRT-III interaction causes failure of 
cytokinesis and binucleation (Carlton et al., 2008). Furthermore, depletion of 
TSG101 or Vps4 overexpression prevents abscission in HeLa cells (Morita et al., 
2007).  
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Figure 1-2. Schematic representation of ESCRT-mediated cytokinesis 
Following membrane furrowing, newly formed daughter cells are connected by a thin intracellular 
bridge. At the centre of the intracellular bridge is the midbody where the ESCRT machinery 
catalyse membrane fusion to separate daughter cells. CEP55 is recruited to the midbody which in 
turn recruits ESCRT-I components which links to the ESCRT-III machinery. ESCRT-III polymerise 
to forms cortical rings with a diameter of >1 µm on either side of the midbody. Following 
remodelling by Vps4, some of the ESCRT-III polymer separates and constricts to a diameter of 50 
nm. The deformation forces of this remodelling causes membrane fusion to separate daughter 
cells. Red lines are microtubules.  
1.1.4 Important regulators of cytokinesis 
1.1.4.1 Aurora kinases 
Aurora was identified as an orthologue of increase-in-polyploidy 1 (Ipl1) in S. 
cerevisiae during a screen for mitotic mutants that failed to segregate 
chromosomes normally (Chan and Botstein, 1993). The Drosophila orthologue is 
crucial for mitosis to occur efficiently and mutations cause pupal lethality, 
mitotic arrest and chromosome mis-segregation (Glover et al., 1995). 
Mammalian cells encode three aurora kinases; aurora A, aurora B and aurora C.  
The mammalian aurora paralogues have similar sequences in the C-terminal 
kinase domain but have differing N-terminal domains (Bischoff et al., 1998; Giet 
and Prigent, 1999). The three kinases show overlapping yet distinct localisations 
and functions. Aurora-A associates with the centrosomes, with regions on 
microtubules proximal to centrosomes and the spindle midzone (Sugimoto et al., 
2002). During prophase, aurora A and other mitotic regulators such as PLK1 are 
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recruited to the MTOC (Petretti et al., 2006). Aurora A then facilitates 
centrosomal maturation and γ-tubulin recruitment (Hannak et al., 2001). 
Depletion of aurora A leads to monopolar spindles and delays mitosis (Liu and 
Ruderman, 2006; Bertolin et al., 2016). As mitosis progresses, aurora A is 
important for formation of the central spindle (Lioutas and Vernos, 2013; 
Reboutier et al., 2013).  
Aurora-B interacts with centromeric heterochromatin in early mitosis to regulate 
the interaction between chromosomes and microtubules to ensure proper 
segregation (Shimada et al., 2016). In anaphase, aurora B accumulates at the 
cleavage furrow and remains there as the midbody forms (Fuller et al., 2008). 
Additionally aurora B signalling also coordinates the contraction of the 
actomyosin ring. (Minoshima et al., 2003). Aurora-C is the least well 
characterised of the aurora paralogues. The kinase localises to the centrosome, 
and in late mitosis and is thought to regulate centrosome function (Kimura et 
al., 1999). Aurora-A has attracted the most attention, due to its overexpression 
in numerous tumours (Bischoff et al., 1998; Tanner et al., 2000; Goepfert et al., 
2002). Overexpression of aurora A also causes polyploidy and centrosome 
overgrowth (Meraldi, Honda and Nigg, 2002).  
1.1.4.2 Polo-like kinase 
Polo-like kinase (PLK) was initially identified in S. cerevisiae during the 
screening of a number of cell division cycle (cdc) mutants. Temperature 
sensitive cdc5 mutant cells have defective cytokinesis with increased instances 
of binucleation and cell cycle arrest (Hartwell et al., 1973). Later it was 
discovered that mutations in the Drosophila gene polo inhibited embryonic 
development by causing cells to arrest in metaphase (Sunkel and Glover, 1988). 
Cells presented with multipolar spindles, polyploidy and altered centrosome 
structure (Sunkel and Glover, 1988). S. cerevisiae cdc5 was later shown to be the 
orthologue of Drosophila polo and the mammalian PLK1 (Hartwell et al., 1973). 
In mammalian cells, PLK1 has diverged into five paralogues, denoted PLK1-5. 
The PLK family are defined by the presence of a polo-box domain (PBD) (Kothe 
et al., 2007). The five PLK paralogues vary in a number of ways; the number of 
PBDs, expression in different cells and temporal expression/activity during the 
cell cycle.  
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PLK1 has a dynamic subcellular localisation during mitosis; initially localising to 
the centrosomes, followed by the spindle midzone, the kinetochore of mitotic 
chromosomes and finally to the midbody (Arnaud et al., 1998). Reflecting the 
dynamic mitotic localisation, PLK1 regulates a number of processes including 
centrosome maturation and bipolar spindle formation in late G2 or prophase 
(Lane, 1996). PLK1 signalling is also important for mitotic progression past the 
G2/M boundary (Abrieu et al., 1998). Depletion of PLK1 delays mitotic entrance, 
and cells accumulate in a pre-anaphase state which often causes apoptosis 
(Sumara et al., 2004). Injection of a constitutively active form of Plx1 (Xenopus 
orthologue of PLK1) into Xenopus oocytes causes arrest prior to cytokinesis 
resulting in polyploidy. This suggests that PLK1 must be inactivated for 
cytokinesis to occur efficiently (Qian et al., 1999). Conversely, PLK1 inhibition 
during anaphase suppresses cleavage furrow formation and cell division (Burkard 
et al., 2007).  
The other mammalian PLK paralogues can be organised into two families; PLK2, 
PLK3 and PLK5 belong to the PLK2 subfamily whereas PLK4 is distinct. PLK4 is 
the most structurally divergent of the PLK family and functions as a regulator of 
centriole duplication (Habedanck et al., 2005). PLK2 expression peaks in S-phase 
and is not essential for growth (Ma et al., 2003). PLK3 is important at the G1/S 
phase transition and has a role in responding to DNA damage and mitotic spindle 
disruption (Bahassi et al., 2002). The human gene for PLK5 contains a stop codon 
within the kinase domain, immediately after this stop codon is a second open 
reading frame which encodes the rest of PLK5 (Andrysik et al., 2010). PLK5 is 
downregulated in proliferating cells and ectopic expression caused causes cell 
cycle arrest in G1 (Andrysik et al., 2010; de Carcer et al., 2011).  
1.1.4.3 ESCRT proteins 
As described in Section 1.1.3 the ESCRT machinery plays a central role in 
cytokinesis. In this Section the ESCRT proteins will be described more broadly. 
The ESCRT machinery can be divided into four complexes which function with an 
array of accessory proteins such as Vps4 and apoptosis-linked gene 2-interacting 
protein (ALIX) an “early acting ESCRT-factor”. Vps4 oligomerizes to form a 
hexameric ring crucial for recycling and remodelling the ESCRT-III polymer 
(Carlton and Martin-Serrano, 2007; Su et al., 2017).  
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Figure 1-3.Comparison of the ESCRT pathways for MVB biogenesis, virus budding and 
cytokinesis  
Representation of the three main pathways of membranes scission catalysed by the ESCRT 
machinery. Multivesicular body (MVB) biogenesis occurs by the “canonical” ESCRT pathway in 
which the ESCRT-0 recognises cargo and sequentially recruits the other complexes culminating in 
scission being catalysed by ESCRT-III and Vps4. In HIV budding, Gag is the adaptor utilised 
whereas in cytokinesis, CEP55 is the adaptor for ALIX. Following binding to ALIX, the canonical 
ESCRT pathway is followed to mediate membrane fusion 
Other than cytokinesis, the ESCRT machinery regulates a number of other 
membrane fusion events including MVB formation, repair of ruptured membranes 
and by being co-opted during budding of enveloped retroviruses such as HIV. In 
the canonical ESCRT pathway for MVB biogenesis, HRS/STAM of ESCRT-0 binds to 
cargo and links to ESCRT-I enabling the sequential recruitment of the ESCRT 
machinery before membrane abscission is catalysed by ESCRT-III (Katzmann et 
al., 2001) (Figure 1-3). The retroviral structural protein Gag co-opts the ESCRT 
machinery by interacting with ALIX to mediate viral budding (Garoff et al., 1998) 
(Figure 1-3).  
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ESCRT-III proteins CHMP2A and CHMP4B have been implicated in the reformation 
of the nuclear envelope following karyokinesis (Olmos et al., 2015). 
Furthermore, the ESCRT proteins have also been linked to the repair of the 
nuclear envelope in interphase cells. As mammalian cells migrate, the nuclear 
envelope can deform causing the exchange of nuclear and cytoplasmic material, 
these deformations are repaired by the ESCRT machinery (Raab et al., 2016). 
Finally the ESCRT machinery has also been suggested to have a role in the repair 
of the plasma membrane following damage (Jimenez et al., 2014; Scheffer et 
al., 2014). 
1.1.4.4 Anillin  
Anillin was first described in Drosophila as a protein that binds to F-actin (Miller 
et al.,1989). In mammalian cells, anillin localises to the nucleus during 
interphase and upon the onset of mitosis localises to the cell cortex followed by 
enrichment at the cleavage furrow in anaphase and telophase (Field and Alberts, 
1995; Oegema et al., 2000). Anillin acts as a scaffold protein at the division 
plane and is involved in the formation of the actomyosin ring (Piekny and 
Glotzer, 2008). Anillin is necessary to maintain active myosin at the cleavage 
furrow (Straight et al., 2005; Piekny and Glotzer, 2008). Interestingly, anillin is 
not required for the initial furrowing but is necessary for myosin accumulation 
and to maintain furrowing position during ingression (Straight et al., 2005). 
Downregulation of anillin in HeLa cells causes mislocalization of the contractile 
ring and binucleation (Straight et al., 2005). Overexpression of anillin has been 
described in a number of tumours, interestingly anillin expression increases as 
the pathology progresses (Hall et al., 2005). The S. pombe orthologue of anillin 
(mid1) has a critical role in fission yeast cytokinesis and will be discussed in 
Section 1.4.3.  
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1.2 AMPK 
1.2.1 Structure of AMPK subunits 
AMP-activated protein kinase (AMPK) is a heterotrimeric serine/ threonine 
protein kinase composed of a catalytic α subunit and regulatory β and γ 
subunits. AMPK is activated allosterically by AMP binding to the γ subunit but for 
maximal activation, T172 on the α subunit is phosphorylated by liver kinase B1 
(LKB1) or Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ) (Hawley 
et al., 2003b, 2005; Townley and Shapiro, 2007).  
In humans, multiple of isoforms the AMPK subunits exist; α1, α2, β1, β2, γ1, γ2 
and γ3 each encoded by a separate gene. Therefore 12 different AMPK 
heterotrimer are theoretically possible (Kahn et al., 2005). The expression of 
the different subunits varies dramatically; the β1 isoform is highly expressed in 
the liver with very low expression in skeletal muscles, conversely the β2 subunit 
is the predominant subunit in skeletal muscles (Thornton et al., 1998). The 
subunit composition can influence AMPK activity and localisation. AMPKα2 
containing heterotrimers have a much greater dependence on AMP and shows a 
nuclear localisation (Salt et al., 1998). The γ1 isoform is the predominant 
subunit and is thought to represent 80-90% of total AMPK activity in many 
tissues.(Cheung et al., 2000). The γ2 subunit is the most AMP-dependent isoform 
whereas the γ3 subunit has the lowest AMP dependence (Cheung et al., 2000). 
The N terminus of the α subunit contains the kinase domain (Figure 1-4). On the 
activation loop there is a critical threonine residue, T172 in AMPKα1 or T174 in 
AMPKα2 (by convention referred to as T172) important for activation of AMPK 
(Figure 1-4). The C terminus contains a domain for complex assembly. AMPKα 
also contains regulatory elements including an autoinhibitory domain (AID) and 
motifs involved in the allosteric regulation by adenine nucleotides (α linker) 
(Figure 1-4) (Xiao et al., 2011; Chen et al., 2012, 2013).  
The β subunits act as a scaffold for heterotrimer formation and contains a 
domain for glycogen binding (Figure 1-4) (Hardie et al., 2003; Polekhina et al., 
2003). The N-terminus of the β subunits can be myristoylated which may be 
important for the subcellular localisation of AMPK (Mitchelhill et al., 1997).  
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Figure 1-4. Schematic representation of the domain organisation of AMPK subunits 
The α subunit contains the kinase domain and a critical threonine (T172) in the activation loop. The 
α subunit also contains regulatory elements including an autoinhibitory domain (AID) and the α-
linker region. At the C-terminus, there is a domain needed for interaction with the β subunit. The β 
subunit contains a glycogen binding domain and a domain important for heterotrimer formation. 
The γ subunit contains an N-terminal domain which interacts with the β subunit and contains four 
cystathionine β-synthase repeats (CBS) which form two Bateman domains.  
The γ subunit contain four cystathionine β-synthase repeats (CBS) which interact 
to form two Bateman domains (Figure 1-4) (Kemp, 2004). The CBS domains are 
responsible for nucleotide binding and thus control the allosteric activation of 
AMPK by AMP. Modelling studies have suggested that CBS1 and CBS3 can 
exchange adenine nucleotides competitively whereas CBS4 has a much high 
affinity for AMP which may not be exchangeable (Xiao et al., 2011; Chen et al., 
2012; Calabrese et al., 2014). CBS2 in non-functional and cannot bind adenine 
nucleotides as it lacks a critical aspartate. (Xiao et al., 2011).   
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1.2.2 Control of AMPK activity 
1.2.2.1 Binding of adenine nucleotides 
AMP activates AMPK by three mechanisms; allosteric activation by binding to the 
γ domain, promoting phosphorylation of T172 by upstream kinases while 
inhibiting its dephosphorylation by protein phosphatases (Figure 1-5) (Davies et 
al., 1995). Binding of AMP to CBS3 causes a conformational change where the α-
hook region of the α subunit interacts with CBS3. This interaction displaces the 
AID from the kinase domain enabling catalytic activity (Chen et al., 2012; 
Calabrese et al., 2014; Li et al., 2015). The movement of the α-hook lowers the 
flexibility of the α-linker region, which in turn promotes an interaction between 
the activation loop with the C terminus of the β domain. This is believed to 
physically protect T172 from phosphatases (Sanders et al., 2007; Xiao et al., 
2011).  
While ADP does not allosterically activate AMPK, binding of ADP can prevent 
T172 dephosphorylation (Xiao et al., 2011; Gowans et al., 2013). However, AMP 
is a 10-fold more potent inhibitor of T172 dephosphorylation than ADP (Gowans 
et al., 2013). ATP binding causes the AID to remain in the inhibitory position 
where T172 remains exposed to phosphatases (Xiao et al., 2011).  
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Figure 1-5. Schematic representation of AMPK activation 
AMPK is activated allosterically by the binding of AMP or ADP. For maximal activation T172 in the 
α subunit is phosphorylated by liver kinase B1 (LKB1) which is in a complex with accessory 
proteins STRAD and MO25. Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ) can 
also phosphorylate T172 in response to increased intracellular calcium. AMP binding also 
promotes phosphorylation of T172 while preventing dephosphorylation by protein phosphatases 
(PPase). AMPK activity can be modulated by a number of compounds; STO-609 inhibits CaMKKβ 
and AMPK; compound C inhibits AMPK; A769662 and salicylate allosterically activate AMPK; 
AICAR is metabolised by cells to ZMP, an AMP mimetic; metformin and canagliflozin increase AMP 
levels by inhibiting mitochondrial respiration.  
1.2.2.2 Phosphorylation of T172  
As described, activation of AMPK involves the phosphorylation of T172 by either 
LKB1 or CaMKKβ (Figure 1-5) (Hawley et al., 2003b; Woods et al., 2005). 
Allosteric activation by AMP increases AMPK activity by approximately 5-fold, 
whereas phosphorylation of T172 increases activity over 100-fold (Davies et al., 
1994; Suter et al., 2006).  
LKB1 was identified as a cause in the development of Peutz-Jeghers syndrome 
(PJS), a hereditary condition where individuals have a predisposition to tumours 
(Hemminki et al., 1998). Loss of function LKB1 mutations are often detected in 
patients with PJS (Hemminki et al., 1998). LKB1 interacts with two accessory 
proteins; STE20-related adaptor (STRAD) and MO25 (Hawley et al., 2003a). LKB1 
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is necessary for full AMPK activation in response to increased intracellular AMP 
or AMP mimetics (Hawley et al., 2003b). However, LKB1 is not itself stimulated 
by AMP or AMP mimetics, thus LKB1 is considered to be constitutively active 
(Lizcano et al., 2004; Sakamoto et al., 2004).  
The second AMPK kinase to be described in vivo was CaMKKβ (Figure 1-5). 
CaMKKβ is activated by an increase in intracellular calcium and is not dependent 
on the energy state of the cell (Hawley et al., 2005). Calcium mediated CaMKKβ 
activation of AMPK is believed to be how many hormones can activate AMPK 
(Hawley et al., 2005).  
1.2.3 Pharmacological activators and inhibitors of AMPK 
1.2.3.1 A769662 
A769662 is a commonly used allosteric activator of AMPK (Figure 1-5) (Cool et 
al., 2006). AMPK activation by A769662 is independent of T172 phosphorylation 
but requires phosphorylation of S108 in the β1 subunit (Scott et al., 2014). 
A769662 binds to an allosteric site formed between the glycogen binding motif 
of the β subunit and the N-terminal lobe of the kinase domain (Cool et al., 2006; 
Calabrese et al., 2014; Li et al., 2015). This binding site is referred to as the 
allosteric drug and metabolite (ADaM) site. A769662 stabilizes the active 
conformations of the α subunit and displaces the AID from the kinase domain 
(Calabrese et al., 2014). Binding also induces the formation of an α helix in the β 
subunit which interacts with the kinase domain protecting phospho-T172 from 
dephosphorylation and increases substrate affinity (Göransson et al., 2007; 
Sanders et al., 2007; Calabrese et al., 2014). A799662 shows considerably higher 
selectivity for AMPK heterotrimers containing the β1 subunit over the β2 isoform 
(Scott et al., 2008). 
1.2.3.2 AICAR 
Aminoimidazole-4-carboxamide ribonucleotide (AICAR) is an indirect activator of 
AMPK. AICAR is transported into cells and phosphorylated by adenylate kinase to 
generate ZMP, an AMP mimetic (Sullivan et al., 1994; Corton et al., 1995). ZMP 
has a lower potency than AMP for the γ subunit but stimulates AMPK activity in a 
similar manner (Figure 1-5) (Day et al., 2007). AICAR/ZMP has also been 
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reported to stimulate a number of AMP-dependent enzymes other than AMPK 
such as fructose-1,6-bisphosphatase and 6-phosphofructo-2-kinase (Vincent et 
al., 1991; Vincent et al., 1992).  
1.2.3.3 Canagliflozin  
Canagliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor used 
clinically for the treatment of type 2 diabetes. SGLT2 is located in the proximal 
convoluted tubule and is responsible for glucose reabsorption from the urine. 
Thus, by inhibiting SGLT2, canagliflozin increases glucose excretion in urine to 
effectively lower blood glucose (Rosenwasser et al., 2013). Canagliflozin 
stimulates AMPK activity whereas other SGLT2 inhibitors such as dapagliflozin 
and empagliflozin do not activate AMPK to the same extent (Hawley et al., 
2016). Activation of AMPK is achieved though inhibition of complex I of the 
electron transport chain which increases intracellular AMP and ADP levels (Figure 
1-5) (Hawley et al., 2016).  
1.2.3.4 Compound C 
Compound C is a potent ATP-competitive inhibitor of AMPK (Figure 1-5) (Zhou et 
al., 2001). However, compound C has a number of well documented AMPK-
independent effects. In vitro compound C inhibits a number of kinases to a 
greater extent than AMPK (Bain et al., 2007; Emerling et al., 2007; Nam et al., 
2008). 
1.2.3.5 Metformin 
Metformin has been used clinically in the treatment of diabetes for a number of 
years. Metformin acts as a mild mitochondrial toxin by inhibiting complex I of 
the electron transport chain, thereby increasing AMP and ADP levels (figure 1-5) 
(Owen et al., 2000). In doing so hepatic gluconeogenesis is reduced and glucose 
utilization of peripheral tissues is increased (Owen et al., 2000).  
1.2.3.6 Salicylate 
Salicylate is a naturally occurring compound found in willow bark and is 
produced as a metabolite of aspirin (Higgs et al., 1987). Salicylate directly binds 
to AMPK causing allosteric activation and preventing T172 dephosphorylation 
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(Figure 1-5) (Hawley et al., 2012). Similarly to A7629662, salicylate binds to the 
ADaM site, is dependent on S108 phosphorylation in the β subunit and shows a 
selectivity for β1 containing complexes (Hawley et al., 2012). AMPK activation 
by salicylate is independent of adenine nucleotide ratio (Hawley et al., 2012).  
Salicylate and metformin are often used in combination (MetSal) to activate 
AMPK due to the different mechanisms of stimulating AMPK activity. This 
synergistic effect can be seen in human and mouse hepatocytes where MetSal 
causes a large increase in AMPK activity whereas incubation with either 
compound alone resulted in limited AMPK activation (Hawley et al., 2012).  
1.2.3.7 STO-609 
STO-609 is an ATP-competitive inhibitor of CaMKK (Figure 1-5) (Tokumitsu et al., 
2002). Inhibition of CaMKKβ is approximately 5-fold higher than the inhibition of 
CaMKKα (Tokumitsu et al., 2002). STO-609 therefore represents a mechanism to 
downregulate AMPK activity by inhibiting one of the upstream kinase. However, 
as with compound C, STO-609 can inhibit a number of kinases including AMPK 
directly (Bain et al., 2007).  
1.2.4 Function and downstream targets of AMPK 
1.2.4.1 Energy homeostasis 
As AMPK is activated by increased levels of AMP, AMPK acts as a key sensor of 
cellular energy levels. AMPK signals to restore energy homeostasis by inhibiting 
ATP consuming processes such as fatty acid synthesis, gluconeogenesis and 
protein synthesis. Simultaneously, AMPK promotes ATP producing pathways; 
fatty acid oxidation, glucose uptake and mitochondrial biogenesis.  
One of the principal downstream targets of AMPK is acetyl-CoA carboxylase 
(ACC) which is phosphorylated on S79 to inhibit its activity. S79 is 
phosphorylated exclusively by AMPK and as such phospho-S79 ACC has been 
accepted as a marker of AMPK activity (Ha et al., 1994; Gowans et al., 2013). 
ACC catalyses the conversion of acetyl-CoA to malonyl-CoA in the lipid synthesis 
pathway, thus the inhibitory phosphorylation of S79 inhibits lipid synthesis 
(McGarry, 2002; Munday, 2002). Furthermore, inhibition of ACC reduces the 
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levels of malonyl-CoA, an inhibitor of fatty acid oxidation. Therefore 
phosphorylation of ACC inhibits lipid synthesis while promoting fatty acid 
oxidation to re-establish energy homeostasis (McGarry, 2002; Fediuc et al., 
2006).  
AMPK increases glucose import into striated muscle by increasing insulin 
stimulated trafficking of glucose transporter 4 (GLUT4) to the plasma membrane 
as well as increasing its transcription (Kurth-Kraczek et al., 1999; McGee et al., 
2008; Lee et al., 2012). GLUT4 translocation to the plasma membrane increases 
glucose import and thus ATP synthesis, conversely in adipocytes AMPK inhibits 
insulin stimulated GLUT4 trafficking which is believed to inhibit fatty acid 
synthesis, thereby conserving ATP (Salt et al., 2000).  
Consistent with the actions of AMPK to increase cellular ATP, a role has been 
described in mitochondrial biogenesis. One of the key transcription factors which 
regulate mitochondrial biogenesis is PGC-1α (Wu et al., 1999). A769662 increases 
PGC-1α expression, whereas in AMPKα knockout cells expression of PGC-1α is 
impaired (Zhao et al., 2014). Furthermore, pharmacological activation of AMPK 
in human umbilical vein endothelial cells (HUVECs) upregulates the expression of 
a number of proteins involved in mitochondrial biogenesis (Kukidome et al., 
2006). 
1.2.4.2 Cell growth and proliferation 
AMPK coordinates a metabolic checkpoint at the G1/S-phase transition. During 
glucose limitation, AMPK induces cell cycle arrest by phosphorylating the tumour 
suppressor p53 at S15 (Jones et al., 2005). Phosphorylation prevents p53 
degradation allowing protein levels to accumulate (Shieh et al., 1997). 
Furthermore, AMPK phosphorylates MDMX at S342, enhancing binding to 14-3-3 
(He et al., 2014). MDMX is a negative regulator of p53 which mediates p53 
proteasomal degradation. Thus AMPK-induced sequestration of MDMX enables 
p53 levels to accumulate (He et al., 2014). p53 regulates a number of genes 
including the cyclin-dependent kinase inhibitor (CDKI) p21CIP to cause cell cycle 
arrest. A metabolic checkpoint at the G1/S-phase transition ensures cells have 
sufficient energy to undergo DNA replication and mitosis. 
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Additionally, AMPK regulates protein synthesis through mammalian target of 
rapamycin complex 1 (mTORC1). mTORC1 is pro-proliferative and promotes cell 
growth, lipid biogenesis and protein synthesis. AMPK phosphorylates raptor, one 
of the components of mTORC1, to inhibit mTORC1 kinase activity to cause cell 
cycle arrest following energy stress (Gwinn et al., 2008). Furthermore, AMPK 
also phosphorylates the upstream regulator of mTOR, TSC2 to enhance its Rheb-
GAP activity thereby inhibiting mTORC1 (Inoki et al., 2003). Inhibition of 
mTORC1 causes inhibition of p70 ribosomal protein S6 kinase 1 (p70S6K) thereby 
inhibiting translation. mTORC1 inhibition also caused activation of eukaryotic 
initiation factor 4E binding protein (4E-BP1) to inhibits translation (Inoki et al., 
2002). Thus, AMPK activation inhibits protein synthesis and limits cell growth.  
1.3 AMPK in mitosis and cytokinesis 
Phospho-T172 AMPK has been described to localise to the MTOC during mitosis 
(Vazquez-Martin et al., 2009; Thaiparambil et al., 2012). AMPK has also been 
reported to be important for the correct positioning of the spindle apparatus, as 
downregulation of AMPK causes spindle misorientation and mitotic delay 
(Thaiparambil et al., 2012). In later stages of mitosis, the AMPKα2 subunit and 
phospho-T172 AMPK has been reported to localise to the midbody (Vazquez-
Martin et al., 2009; Pinter et al., 2012). Interestingly, glucose deprivation does 
not alter phospho-T172 AMPK mitotic localisation (Vazquez-Martin et al., 2012).  
Phospho-S79-ACC has been reported to have an identical localisation pattern as 
phospho-T172 AMPK during mitosis (Vazquez-Martin et al., 2009; Vazquez-Martin 
et al., 2013). Additionally, levels of S79-phospho-ACC have been shown to be 
increased during mitosis in an AMPK-dependent manner demonstrating AMPK 
activity in mitosis (Mao et al., 2013). Fission yeast which have a disrupted ACC 
gene have impaired nuclear division causing the formation of large polyploid 
nuclei which arrest at the G2/M transition (Saitoh et al., 1996). Furthermore, 
inhibition of fatty acid synthesis in HeLa cells causes cell cycle arrest at the 
G2/M-phase boundary despite fatty acids being present in the media. Together 
this may suggest a role for ACC in mitosis either through the coupling of 
lipogenesis to cell cycle progression or in a yet to be defined role (Scaglia et al., 
2014).  
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A chemical genetic screen identified protein phosphatase 1 regulatory subunit 
12C (PPP1R12C) and p21-activated protein kinase (PAK2) as substrates for 
AMPKα2 phosphorylation on S452 and S20 respectively (Banko et al., 2011). 
PPP1R12C inhibits myosin regulatory light chain (MRLC), a regulator of mitosis 
and cytokinesis whereas PAK2 promotes MRLC phosphorylation (Tuazon and 
Traugh, 1984; Komatsu et al., 2000; Banko et al., 2011). Thus, AMPK may 
regulate two antagonizing pathways in mitosis (Banko et al., 2011). Both AMPK 
T172 and PPP1R12C S452 phosphorylation are elevated in prometaphase. 
Phosphorylation levels of both decrease as mitosis progresses but PPP1R12C 
phosphorylation increases at the end of mitosis (Banko et al., 2011). Cells which 
express a phospho-null PPP1R12C (S452A) mutant have an increase in polyploidy 
(Banko et al., 2011). Phosphorylation of PPP1R12C promotes interaction with 14-
3-3 which may inactivate the complex, thus AMPK activity would promote the 
activation of MRLC (Banko et al., 2011). 
PAK2 mediates the phosphorylation of myosin light chain kinase (MLCK) and is 
involved in cytoskeletal reorganisation (Goeckeler et al., 2000). The inhibitory 
phosphorylation of MLCK causes stress fibre dissolution (Sanders et al., 1999). 
PAK2 localises with the centrosomes until metaphase where it activates aurora A 
and PLK1 facilitating mitotic entry, although a role for AMPK remains elusive at 
this time (Zhao et al., 2005; Ando et al., 2007; Maroto et al., 2008; May et al., 
2014). 
Metformin has been shown to alter the transcriptome of the epidermoid cancer 
cell line A431 cells by causing down regulation of a number of proteins including; 
auroras kinases, PLKs; kinesin and tubulin (Oliveras-Ferraros et al., 2009). 
Strikingly, chronic metformin treatment has also been reported cause a 
reorganisation of nuclei structure forming crescent, ring or lobular shapes 
(Vazquez-Martin et al., 2009).  
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1.3.1 AMPK orthologues 
AMPK or its orthologues appear to be a fundamental feature of eukaryotic cell 
life. AMPK orthologues have been described in a range of organisms including 
fungi and plants, an AMPK orthologue has even been described in the primitive 
protozoan Giardia lamblia (Adam, 2000; Hardie et al., 2003).  
In budding yeast, the AMPKα orthologue sucrose non-fermenting 1 (Snf1) is 
important in the cellular response to low glucose (Hardie et al., 1998). S. 
cerevisiae encode three β subunits (Gal183, Sip1 and Sip2) and one γ orthologue 
Snf4 (Celenza and Carlson, 1989; Yang et al., 1994). Similar to mammalian 
AMPK, Snf4 relieves the inhibition of Snf1 by interacting with the AID domain 
(Leech et al., 2003). The T172 of AMPKα1 is orthologous to T210 in Snf1 which is 
phosphorylated by three kinases; Sak1, Tos3 and Elm1 (Hong et al., 2003; 
Sutherland et al., 2003). Interestingly, Snf1 is not allosterically activated by AMP 
(Wilson et al., 1996). SNF1 is important for a number of cellular processes such 
as autophagy and the response to a number of environmental stresses including 
ionic and heat shock (Wang et al., 2001; Portillo et al., 2005; Platara et al., 
2006). 
AMPK also has an important role in plants, which encode two homologues of the 
AMPKα subunits, Snf1-related protein kinase (SnRK1) a/b. In the moss 
Physcomitella petens double AMPKα knockout inhibits growth unless kept under 
constant illumination (Thelander et al., 2004).  
AMPK is also well conserved in the fission yeast Schizosaccharomyces pombe (S. 
pombe) and will be discussed in detail in Section 1.4.4.   
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1.4 S. pombe and the cell cycle 
1.4.1 S. pombe overview 
S. pombe, or fission yeast, is a unicellular ascomycete fungus. The ascomycete 
phylum is defined by the production of their sexual spores in a specialised cell 
wall-like structure called an ascus (derived from the Greek askos for bag), this 
process is discussed further in Section 1.4.3.2 (Hoffman et al., 2015). S. pombe 
was originally isolated from an East African beer with “pombe” being the Swahili 
word for alcohol. S. pombe was first used as a model organism in the 1940s by 
Urs Leupold who researched mating and homothallism (Leupold, 1949). From 
these early studies, three distinct strains were isolated; 968 h90, 972 h- and 975 
h+, which became the founders for nearly all subsequent S. pombe strains used 
experimentally (Fantes and Hoffman, 2016). As the majority of S. pombe 
research is carried out on the ancestors of these three strains (which were 
originated from a single isolate), most laboratory strains of S. pombe are 
isogenic. Conversely, in S. cerevisiae, the other widely used experimental yeast 
species, there are differences between the ancestral “wild type” strains, so 
subsequent genetic alterations could produce different results (Elion et al., 
1991; Ralser et al., 2012; Hoffman et al., 2015).  
1.4.2 S. pombe as a model organism 
S. pombe was the sixth eukaryotic organism to have its genome sequenced, 
confirming fission yeast a popular model for genetic studies (Wood et al., 2002). 
S. pombe generally exist as haploid cells, which is important when assessing the 
impact of a mutation. Generally a mutation will produce a loss of function effect 
and be recessive to the wild type allele. Thus, in a diploid organism the effect of 
a recessive heterozygotic mutation would not readily be detectable, being 
masked by the wild type gene. Diploid fission yeast cells can however be formed 
and maintained under controlled certain conditions, important for other genetic 
analysis, especially with essential genes.  
A number of the key genes and proteins have been evolutionarily conserved 
between S. pombe and mammalian cells, emphasising the use of fission yeast as 
a model organism. In the context of this Thesis, proteins involved in mitosis and 
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cytokinesis appeared one billion years ago in the common ancestor for amoeba, 
fungi and animals (Pollard and Wu, 2010).  
1.4.3 Cell cycle of S. pombe 
S. pombe have two cell cycles: an asexual/mitotic cell cycle in which vegetative 
cells follow and a sexual/meiotic cell cycle that is induced upon nitrogen 
limitation (Figure 1-6). In the vegetative cell cycle, S. pombe cells pass through 
consecutive G1-, S-, G2- and M-phases similar to animal cells. The cells grow by 
linear extension followed by medial fission once they reach ~14 µm, producing 
two daughter cells of identical size (Mitchison and Nurse, 1985). During mitosis, 
a division septum is deposited on the division plane prior to abscission, with this 
process being analogous to mammalian cytokinesis. Following septation, but 
prior to separation, cells which have a volume above a critical level rapidly 
progress through G1 and S-phases (Nasmyth et al., 1979). Therefore, the short G1 
and S-phase occur between mitosis and separation, meaning that once cells 
separate at the end of the previous cell cycle they are already in G2 of the 
following cell cycle.  
After cytokinesis, the newly formed daughter cell grows from the “old end” until 
mid G2 when growth begins to occur at the “new end” that was created from the 
previous cell division. This alteration in growth polarity is termed “new end 
take-off” (NETO) and represents the switch from monopolar to bipolar growth 
(Mitchison and Nurse, 1985).  
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Figure 1-6. S. pombe mitotic and meiotic cell cycles 
In the mitotic cell cycle S. pombe progress through G1-, S-, G2- and M phase. During cytokinesis a 
division septa is deposited to enable separation of daughter cells. Under nitrogen limitation cells 
can undergo the meiotic cell cycle where cells of opposite mating types (h+ or h-) undergo sexual 
differentiation to enable cell conjugation followed by nuclear fusion forming a diploid zygote. 
Meiosis and sporulation then generates four haploid spores enclosed in an ascus. The ascus is 
lysed to release the spores.  
As cells enter mitosis, medial extension stops and actin redistributes from the 
growth tips to form a cortical ring at the equator (Marks et al., 1986). S. pombe 
undergo “closed mitosis”, in that the nuclear envelope does not breakdown for 
karyokinesis. Instead, from the cytoplasm, two spindle pole body’s (SPBs; 
analogous to mammalian centrosome) align at either side of the nucleus and 
produce an intra-nuclear spindle (Figure 1-7) (Ding et al., 1997). The condensed 
chromosomes adhere to the spindle, and as the spindle elongates the sister 
chromatids are separated (Bak et al., 1977; Umesono et al., 1983).  
In mammalian cells the division site is defined by the microtubules, whereas in 
S. pombe the site of cytokinesis is defined by the position of the nuclei through 
the signalling of Plo1p (orthologous to mammalian PLK1) and Mid1p (anillin) 
(Chang et al., 1996; Sohrmann et al., 1996; Bähler et al., 1998). During 
interphase, Mid1p transitions between the nucleus and the cell cortex (Paoletti 
and Chang, 2000). Once mitosis begins, Mid1p is phosphorylated by Plo1p and 
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exits the nucleus to the cortex forming a ring overlying the nucleus and recruits 
proteins for actomyosin ring formation (Sohrmann et al., 1996; J Bähler et al., 
1998). Mutations in mid1 results in abnormal septum positioning although cells 
can still divide (Sohrmann et al., 1996). 
 
Figure 1-7. Representation of S. pombe mitosis and cytokinesis 
During S. pombe mitosis the nucleus is located at the cell equator. Microtubules separate the 
nuclei to the cell poles and a contractile actomyosin ring is assembled at the cell equator. As the 
ring contracts there is deposition of septum material behind the division plane. Enzymatic digestion 
of the septum material separates the cells. Occasionally, cells will not separate immediately, 
instead remaining attached with a “delayed separation following septation” phenotype. 
1.4.3.1 Septation and cytokinesis 
During fission yeast cytokinesis, an actomyosin ring forms on the division plane 
followed by the formation of the division septa behind the contractile ring 
(Figure 1-7). The septum is a three-layered structure composed of an inner 
primary layer with secondary septa on either side. The primary septum is 
composed of 1,3-β-glucan and binds strongly to the stain Calcofluor-White 
whereas the secondary septa consist of 1,3-α-glucan, 1,6-branched 1,3-β-glucan, 
1,6-β-glucan and galactomannans and is less calcofluor sensitive (Horisberger 
and Rouvet-Vauthey, 1985; Humbel et al., 2001; Sugawara et al., 2003). As the 
primary septa is degraded by digestive enzymes, there is increased turgor 
pressure on the secondary septa generating a physical force to the cells (Sipiczki 
and Bozsik, 2000; Dekker et al., 2004). Occasionally cells do not immediately 
separate following division and have a “delayed separation following septation” 
phenotype (Figure 1-7) (Mitchison and Nurse, 1985; Bhutta et al., 2014).  
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1.4.3.2 Meiotic cell cycle 
When under nutritional stress, calls rapidly progress though the cell cycle before 
arresting in G1 at a smaller cell size. Two haploid cells of opposite mating types 
can then undergo sexual differentiation and mating to form four dormant spores 
which can survive unfavourable conditions (Egel and Egel-Mitani, 1974) (Figure 1-
6). This process has been utilised in a number of genetic screens where two 
parental strains carrying mutations in separate genes were crossed to produce 
double mutant progeny. 
Mating type is determined by the expression of genes at the mat-cassette on 
chromosome two. The mating types are denoted as h+, h- and h90, with h+ and h-
being heterothallic and h90 homothallic. Conjugation of two cells requires the 
cells to be of opposite mating types. h90 is capable with mating with itself but h+ 
and h- cannot, necessitating both mating types to be present (Egel and Gutz, 
1981; Beach, 1983). In a population of h90 cells, there will be a mixture of both 
h+ and h- cells. mat-cassette gene expression is inhibited at G2, so the genes are 
only expressed upon nitrogen starvation when G1 is extended. The cassette 
control the expression of one of two pheromones and a receptor for the opposite 
pheromone. Binding of the pheromone to the appropriate receptors induces 
conjugation of the cells and nuclear fusion. In the now single cell, the 
pheromones form a heterodimer which triggers meiosis forming four haploid 
nuclei. A specialised cell walls forms around the spores called the ascus 
membrane which will eventually lyse enabling the spores to enter the mitotic 
cell cycle (Hoffman et al., 2015). 
1.4.4 The AMPK orthologue in S. pombe  
Similar to mammalian AMPK, the S. pombe orthologue is a heterotrimer 
composed of Ssp2p (AMPKα subunit orthologue), Amk2p (AMPKβ) and Cbs2p 
(AMPKγ) (Valbuena and Moreno, 2012). Cbs2p contains four CBS domains (Hanyu 
et al., 2009). Structural analysis of the S. pombe AMPK heterotrimer has 
indicated that adenine nucleotides can bind competitively to a single site in 
Cbs2p (Townley and Shapiro, 2007). Amk2p can bind ADP but the functional 
significance is not known (Jin et al., 2007). Ssp2p activity is regulated by a 
single upstream kinase Ssp1p. Sequence analysis of S. pombe identified ssp1 as 
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the orthologue of mammalian CaMKKα and CaMKKβ. Ssp1 was first identified as a 
protein kinase responsible for regulating cell polarity (Matsusaka et al., 1995; 
Hanyu et al., 2009). In ssp1 mutant cells, cortical actin was only detected at one 
end of the cell indicating that the cells failed to alter growth polarity for NETO. 
Overexpression of wild type ssp1 caused a random distribution of cortical actin 
(Matsusaka et al., 1995). Ssp1p phosphorylates T189 in Ssp2p in response to a 
number of environmental triggers including; glucose depletion, nitrogen 
limitation and osmotic stress (Hanyu et al., 2009; Valbuena and Moreno, 2012; 
Davie et al., 2015; Schutt and Moseley, 2017).  
Consistent with mammalian studies on AMPK regulation, all three subunits are 
required for the adaption to low-glucose media (Matsuzawa et al., 2012; Saitoh 
et al., 2015; Deng et al., 2017). Mutation of T289A in Ssp2p reduces the capacity 
for cells to grow on low glucose media, which mimics the phenotype of ssp1Δ 
and ssp2Δ. Furthermore, amk2Δ and cbs2Δ reduced cell proliferation and 
phospho-T189 Ssp2p levels (Deng et al., 2017). This indicates that all the 
subunits of the AMPK heterotrimer are necessary for the adaption to low glucose 
and, that T189 must be phosphorylated by Ssp1p. These observations are in line 
with the established role of S. cerevisiae Snf1p in the response to glucose 
deprivation. Snf1p is essential for growth on media lacking glucose (Carlson et 
al., 1981). Additionally, Snf1p is also involved in the adaption to low glucose 
conditions by regulating glucose uptake through the phosphorylation of Mig1p, a 
transcription factor for hexose transporters (Nicastro et al., 2015; Treitel et al., 
1998). 
Ssp1p mediated phosphorylation of Ssp2p is required for the adaptation to low 
nitrogen levels (Davie et al., 2015). Unusually, for the response to nitrogen 
stress, Amk2p and Cbs2p are not required, nor are alterations in cellular adenine 
nucleotide levels (Davie et al., 2015). Although each of the Ssp2p heterotrimer 
subunits and Ssp1p is important for sexual differentiation of S. pombe and 
deletion of each of the proteins dramatically reduced the number of zygotes 
(Valbuena and Moreno, 2012). Deletion of ssp2 reduces levels of Ste11p, a 
transcription factor important for sexual differentiation (Valbuena and Moreno, 
2012).  
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1.5 Aims  
A number of publications have suggested a role for AMPK in the regulation of 
mitosis, however, the signalling pathways in which AMPK regulates have not 
been fully characterised. As such, this body of work sought to further elucidate 
the role of AMPK in mitosis and cytokinesis.  
By using a combination of cellular, biochemical and genetic techniques the role 
of AMPK in the control of mitosis was assessed in both mammalian cells and 
fission yeast. Additionally, to examine the pathways in which AMPK may regulate 
during the cell cycle, a genetic screen was undertaken using the model organism 
S. pombe.  
Thus, the following research questions were investigated: 
 Can the reported subcellular localisation of AMPK be replicated in other 
cell types? 
 How does modulation of AMPK activity influence cytokinesis? 
 Does S. pombe AMPK genetically interact with any of the key regulators of 
the cell cycle? 
 Are the genetic interactions discovered in yeast conserved in a 
mammalian system? 
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2 Chapter 2-Materials and methods 
2.1 Materials 
2.1.1 List of materials and suppliers 
Abcam, Cambridge, UK 
A769662. 
Acros Organics, Thermo Fisher Scientific, Geel, Belgium 
Brij-35.  
BDH Laboratory supplies, Poole, UK 
Coomassie Brilliant Blue G-250, tetra-sodium pyrophosphate. 
Beckman Coulter™, High Wycombe, UK 
ISOTON, ultra-Clear™ ultracentrifuge tubes.  
Bio-rad Laboratories Ltd, Hertfordshire, UK 
SureBeads™ Protein A/G magnetic beads 
Biotium, Hayward, CA, USA 
RedDot2. 
Cambridge Biosciance Ltd, Cambridge, UK 
Quick Titre™ Adenovirus Titre Immunoassay kit. 
ChromoTek, Planegg-Martinsried, Germany 
Anti-GFP magnetic beads, anti-RFP magnetic beads, anti-Myc magnetic beads. 
Dharmacon Inc, Lafayette, Colorado, USA 
AMPKα1 and AMPKα2 siRNA. 
Fisher Scientific UK Lts, Loughborough, Leicestershire, UK 
Corning tissue culture T25/T75/T150 flasks, Corning 6-well and 12-well plates. 
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Ibidi, Martinsried, Germany 
Ibidi cell culture chambers.  
Thermo Fisher Scientific (including Life technologies, Applied Bio Systems, 
GIBCO and Invitrogen), Carlsbad, Ca, USA 
Blasticidin, DMEM, EMEM, FCS, Lipofectamine® 2000 reagent, non-essential 
amino acids (100x), One Shot chemically competent E. coli, Opti-MEM® reduced 
serum media, Penicillin-Streptomycin (10000 U/ml, 10000 μg/ml), Taq DNA 
Polymerase, Trypsin-EDTA, Immuno-Mount™, zeocin.  
Merck Chemicals Ltd, Nottingham, UK 
BrdU cell proliferation kit, Compound C, lithium acetate. 
New England Biolabs, Ipswich, MA, USA 
Prestained protein markers, Lambda protein phosphatase. 
Pall Life Science, Pensacola, FL, USA 
Nitrocellulose membrane, 0.25 μm pore size. 
Perkin Elmer, Beaconsfeild, Buckinghamshire, UK 
[γ-32P] ATP. 
Promega, Madison, Wisconsin, USA 
MTS reagent. 
PromoCell, Heidleberg, Germany 
MV2 endothelial cell growth media (with supplement). 
R&D Systems, Inc (Tocris Bioscience), Minneapolis, MN, USA 
STO-609. 
Severn Biotech Ltd, Kidderminster, Hereford, UK 
Acrylamide: bisacrylamide (37.5:1; 30 % (w/v) acrylamide).  
Sigma-Aldrich Ltd, Gillingham, Dorset, UK 
ATP, AMP, ampicillin, β-Glucuronidase from Helix pomatia, Calcofluor-White 
stain, benzamidine, propidium iodide, nocodazole, recombinant aurora A, 
 47 
 
recombinant aurora B, recombinant CaMKKβ, recombinant PLK1, Ribonuclease A, 
soybean trypsin inhibitor (SBTI), N,N,N’,N’-Tetramethylethylenediamine 
(TEMED), Triton X-100, Tween 20. 
Synvolux Products, Leiden, Netherlands 
SAINT-sRNA. 
Toronto Research Chemicals Inc, Ontario, Canada 
AICAR. 
VWR International Ltd, Lutterworth, Leicestershire, UK 
Falcon brand cell culture plastics. 
Qiagen, Venlo, Netherlands 
HiPerFect® Transfection reagent.  
2.1.2 Standard solutions 
Unless stated otherwise, all buffers and reagents were made up with distilled 
water. 
Bradford’s reagent 
30 mg/l Coomassie Brilliant Blue, 5.0% (v/v) ethanol, 5.1% (v/v) orthophosphoric 
acid 
Note: Bradford’s reagent was filtered and stored in the dark 
Coomassie Brilliant Blue solution 
1 g/l Coomassie Brilliant Blue, 50% (v/v) methanol, 10% (v/v) acetic acid 
Note: Coomassie Brilliant Blue solution was filtered prior to use 
Destain solution 
10% (v/v) acetic acid, 40% (v/v) methanol 
Genome extraction buffer 
2 % (v/v) Triton X-100, 1 % (w/v) SDS, 100 mM Tris-HCl (pH 8 at room 
temperature), 1 mM EDTA 
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HEPES-Brij-DTT 
50 mM HEPES (pH 7.4- NaOH), 0.02% (v/v) Brij-35, 1 mM DTT, 1 mM Na3VO4 
Immunofluorescence (IF) buffer 
0.2% (w/v) fish skin gelatin, 0.1% (v/v) goat or donkey serum 
Note: solution was made up in PBS. The serum chosen for the buffer was one 
that was different to the species of the secondary antibodies used in IF staining.  
Immunoprecipitation (IP) buffer 
50 mM Tris-HCl, pH 7.4 at 4oC, 150 mM NaCl, 50 mM NaF, 5 mM Na4P2O7, 1 mM 
EDTA, 1 mM EGTA, 1 % (v/v) Triton X-100, 1 % (v/v) glycerol, 1 mM DTT, 1 mM 
Na3VO4, 0.1 mM benzamidine, 0.1 mM PMSF, 5 μg/ml SBTI 
Kinase assay buffer 
5 mM MOPS (pH 7.2), 2.5 mM glycerol 2-phosphate, 250 μM DTT, 1 mM Na3VO4 
Laemmli sample buffer (LSB) 4x 
200 mM Tris-HCl (pH 6.8), 8 % (w/v) SDS, 40 % (v/v) glycerol, 0.4 % (w/v) 
bromophenol blue, 200 mM DTT 
Permeabilization buffer 
0.1% (v/v) Triton X-100 
Note: solution was made up in PBS. Solution was filtered prior to use. 
4% p-formaldehyde 
4% (w/v) p-formaldehyde, 1 mM CaCl2, 1 mM MgCl2 
Note: solution was made up in PBS 
Phosphate-buffered saline (PBS) (pH 7.2) 
85 mM NaCl, 1.7 mM KCl, 5 mM Na2HPO4, 0.9 mM KH2PO4 
Ponceau S stain 
0.2% (w/v) Ponceau S, 1% (v/v) acetic acid 
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Quenching buffer 
50 mM NH4Cl 
Note: solution was made up in PBS 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) running buffer 
190 mM glycine, 62 mM Tris base, 0.1% (w/v) SDS 
SDS-PAGE sample buffer (4X)  
200 mM Tris-HCl, pH 6.8, 8% (w/v) SDS, 40% (v/v) glycerol, 0.4% (w/v) 
bromophenol blue, 200 mM DTT 
Note: DTT was added on the day of use. 
TE buffer 
0.1 M Tris-HCl, pH 7.5, 0.1 M EDTA 
Transfer buffer 
190 mM glycine, 62 mM Tris base 
Tris-buffered saline (TBS)  
20 mM Tris-HCl, pH 7.5, 137 mM NaCl 
Tris-buffered saline + Tween 20 (TBST) 
20 mM Tris-HCl, pH7.5, 137 mM NaCl, 0.1% (v/v) Tween 20 
Triton X-100 lysis buffer 
50 mM Tris-HCl, pH 7.4 at 4oC, 50 mM NaF, 1 mM Na4P2O7, 1 mM EDTA, 1 mM 
EGTA, 1% (v/v) Triton X-100, 250 mM mannitol, 1 mM DTT, 1 mM Na3VO4, 0.1 mM 
benzamidine, 0.1 mM PMSF, 5 μg/ml SBTI 
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2.1.3 List of antibodies and condition of use 
2.1.3.1 Primary antibodies for immunoblotting 
Antibodies were diluted in 3% (w/v) Bovine serum albumin (BSA) in TBST. Blots 
were incubated with antibodies overnight at 4oC. 
Epitope Clonality 
Host 
species Dilution 
Source  
(product number) 
ACC Monoclonal Rabbit 1:1000 
New England Biolabs, 
Hertfordshire, UK. (#3676) 
Phospho-S79 
ACC 
Polyclonal Rabbit 1:1000 
New England Biolabs, 
Hertfordshire, UK. (#3661) 
AMPK Polyclonal Rabbit 1:1000 
New England Biolabs, 
Hertfordshire, UK. (#2532) 
AMPK α1 Polyclonal sheep 1 μg/ml 
A generous gift from Prof. 
D. G. Hardie, University of 
Dundee, UK (A Woods et 
al., 1996) 
AMPK α2 Polyclonal Sheep 1 μg/ml 
A generous gift from Prof. 
D. G. Hardie, University of 
Dundee, UK (A Woods et 
al., 1996) 
Phospho-
T172 AMPK 
Monoclonal Rabbit 1:1000 
New England Biolabs, 
Hertfordshire, UK. (#2535) 
Aurora A Polyclonal Rabbit 1:1000 
Abcam, Cambridgeshire, 
UK. (#1287) 
 51 
 
Aurora B Polyclonal  Rabbit  1:1000 
Abcam, Cambridgeshire, 
UK. (#2254) 
FLAG Monoclonal  Mouse 10 μg/ml 
Merc, Kenilworth, USA. (F-
3165) 
GAPDH Monoclonal  Mouse 1:80000 
Ambion, Cambridgeshire, 
UK. (#4300) 
GFP Monoclonal Mouse 1:4000 
Abcam, Cambridgeshire, 
UK. (#184519) 
LKB1 Monoclonal Rabbit 1:1000 
New England Biolabs, 
Hertfordshire, UK. (#3050) 
mCherry Polyclonal Rabbit 1:1000 
Badrilla, Leeds, UK. 
(A010-mCherry-5) 
PLK1 Polyclonal  Rabbit 
0.5 
μg/ml 
Novus Biologicals, 
Abingdon, UK. (NB100-
547) 
Table 2-1: Primary antibodies used for immunoblotting 
 
2.1.3.2 Secondary antibodies for immunoblotting 
Antibodies were diluted in 3% (w/v) BSA in TBST. Blots were incubated with 
secondary antibodies for 1 h at room temperature. 
Epitope 
Linked 
molecule Host species Dilution 
Source  
(product number) 
Mouse IgG IRDye ®680cw Donkey 1:10000 
Li-COR, Lincoln, 
USA. (#925-68072). 
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Rabbit IgG IRDye ®800cw Donkey 1:10000 
Li-COR, Lincoln, 
USA. (#926-32213). 
Sheep IgG IRDye ®680cw Donkey 1:10000 
Li-COR, Lincoln, 
USA. (#925-32214).  
Table 2-2: Secondary antibodies used for immunoblotting 
 
2.1.3.3 Primary antibodies for immunofluorescence 
Antibodies were diluted in immunofluorescence buffer containing 0.1% (v/v) 
donkey or goat serum. 
Epitope Clonality 
Host 
species Dilution 
Source  
(product number) 
Phospho-S79 
ACC 
Polyclonal Rabbit 1:250 
New England Biolabs, 
Hertfordshire, UK. 
(#11818) 
AMPK α1 
(amino acids 
344-358) 
Polyclonal Sheep 1 μg/ml 
A generous gift from 
Prof. D. G. Hardie, 
University of Dundee, 
UK (A Woods et al., 
1996) 
AMPK α1 
(amino acids 
351-366) 
Monoclonal Mouse  1:200 
Abcam, Cambridge UK. 
(ab110036).  
AMPK α2 
(amino acids 
351-366) 
Polyclonal Sheep 1 μg/ml 
A generous gift from 
Prof. D. G. Hardie, 
University of Dundee, 
UK (A Woods et al., 
1996) 
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AMPK α2 
(amino acids 
29-510) 
Polyclonal Rabbit 1:100 
Thermo Fisher 
Scientific, Waltham, 
USA. (PA5-21494)  
Phospho-T172 
AMPK 
Monoclonal Rabbit 1:100 
New England Biolabs, 
Hertfordshire, UK. 
(#2535) 
Phospho-T172 
AMPK 
Polyclonal Rabbit 1:50 
Santa Cruz 
Biotechnology, INC, 
Dallas, USA (sc-101630) 
Aurora A Polyclonal Rabbit 1:100 
Abcam, Cambridge UK. 
(ab1287) 
Aurora B Polyclonal  Rabbit 1 μg/ml 
Abcam, Cambridge UK. 
(ab2254) 
Myc Monoclonal Mouse 1:50 
Santa Cruz 
Biotechnology, INC, 
Dallas, USA (sc-40) 
PLK1 Polyclonal  Rabbit 
0.5 
μg/ml 
Novus Biologicals, 
Abingdon, UK. (NB100-
547) 
Tubulin Monoclonal  Rabbit 1:50 
New England Biolabs, 
Hertfordshire, UK. 
(#2125) 
Tubulin Monoclonal Rat 1:1000 
Abcam, Cambridge UK. 
(ab6160) 
Table 2-3: Primary antibodies used for immunofluorescence 
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2.1.3.4 Secondary antibodies for immunofluorescence  
Antibodies were diluted in immunofluorescence buffer containing 0.1% (v/v) 
donkey or goat serum. 
Epitope 
Linked 
molecule 
Host 
species Dilution 
Source  
(product number) 
Mouse IgG 
Alexa Flour ® 
488 
Donkey 1:500 
Invitrogen, 
Carlsbad, USA. 
(A21202) 
Rabbit IgG 
Alexa Flour 
®568 
Donkey 1:500 
Invitrogen, 
Carlsbad, USA. 
(A11011) 
Rabbit IgG 
Alexa Flour 
®488 
Donkey 1:500 
Invitrogen, 
Carlsbad, USA. 
(A11008) 
Rat IgG 
Alexa Flour 
®568 
Goat 1:500 
Invitrogen, 
Carlsbad, USA. 
(A11077) 
Rat IgG 
Alexa Flour 
®488 
Donkey 1:500 
Invitrogen, 
Carlsbad, 
USA.(A21208) 
Sheep IgG 
Alexa Flour 
®568 
Donkey 1:500 
Invitrogen, 
Carlsbad, USA. 
(A21099) 
Table 2-4: Secondary antibodies used for immunofluorescence 
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2.1.4 PCR primers 
Target Sequence (5’ to 3’) Length 
fkh2 forward 
primer 
CAACGATAACAAAGACGCATT 21 
fkh2 reverse 
primer 
AGCAATTGTGCTGTTGGTGT 20 
ssp2 forward 
deletion primer 1 
AATTTAAGCCTTGCTATTAAGGAAAAAAAGATTT
TATCAATAAACTTTCAATATTGGATTTGCCAAGC
GAATAGCTGATACGGATCCCCGGGTTAATTAA 
100 
ssp2 forward 
deletion primer 2 
ATATTTATCTCACACTCTGAAATTTAAGCCTTGCT
ATTAAGGAAAAAAAGATTTTATCAATAAACTTTCA
ATATTGGATTCGGATCCCCGGGTTAATTAA 
100 
ssp2 forward 
deletion primer 3 
TTTGCCTTCTACCAAATTATATATTTATCTCACAC
TCTGAAATTTAAGCCTTGCTATTAAGGAAAAAAA
GATTTTATCAACGGATCCCCGGGTTAATTAA 
100 
ssp2 reverse 
deletion primer 1 
TGCTATTGAGTAGATTTGTTCAACAATGGGTAAT
TAAGGGATGCTTGAAAACAGCGTGTTAAATGGG
GAGTTACAATAAAGAATTCGAGCTCGTTTAAAC 
100 
ssp2 reverse 
deletion primer 2 
AAAAAAATAAAATGTGTCTTTGCTATTGAGTAGA
TTTGTTCAACAATGGGTAATTAAGGGATGCTTGA
AAACAGCGTGTTGAATTCGAGCTCGTTTAAAC 
100 
ssp2 forward 
checking primer 
TTGAGTAAAATTCCGCATTGTG 22 
KanMX6 primer GCTAGGATACAGTTCTCACATCACATCCG 29 
Table 2-5: Primers used for PCR 
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2.1.5 Plasmids 
Description Plasmid backbone Source 
KD-Aurora A 
mCherry tagged.  
Kinase dead, K126R 
mCherry-C1 
A gift from Michael Davidson, 
University of California, USA. 
(Addgene plasmid # 54998) 
KD-Aurora B 
GFP tagged. 
Kinase dead, K106R 
pEGFP-C2 
A gift from Susanne Lens, 
Department of Medical 
Oncology, Netherlands. 
(Addgene plasmid # 108493). 
(Hengeveld et al., 2012).  
AMPK α1-GFP hGFP-S65T 
A generous gift from Prof. D. 
G. Hardie, University of 
Dundee, UK.  
AMPK α2-GFP hGFP-S65T 
A generous gift from Prof. D. 
G. Hardie, University of 
Dundee, UK.  
CHMP2A-GFP P643_pmEGFP_N_dest 
A gift from Daniel Gerlich, 
Swiss Federal Institute of 
Technology, Switzerland. 
(Addgene plasmid # 31805). 
(Guizetti et al., 2011).  
CHMP2B-GFP pLNCX2 
A gift from Sanford Simon, 
Rockefeller University, USA. 
(Addgene plasmid # 115329). 
(Johnson, Bleck and Simon, 
2018) 
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GFP peGFT-C2 
A generous gift from Prof. D. 
G. Hardie, University of 
Dundee, UK.  
KanMX6 pFA6a 
A gift from Jurg Bahler & 
John Pringle, University 
College London, UK. 
(Addgene plasmid # 39296). 
(Jürg Bähler et al., 1998). 
mCherry pCDH 
System Biosciences, Palo 
Alto, California USA. Cat 
CD512B.  
KD-PLK1 
YFP tagged. 
Kinase dead, K82R.  
pEYFP-C3 
A generous gift from J. 
Pines, Welcome 
Trust/Cancer Research UK 
Gordon Institute, Cambridge, 
UK. (Lindon and Pines, 
2004).  
Table 2-6: Plasmids used during this investigation 
 
2.1.6 S. pombe media 
Media was autoclaved prior to use. Solid media was made by the addition of 5% 
(w/v) agar. S. pombe were cultured as previously described (Moreno et al., 
1991).  
Edinburgh minimal media (EMM)  
20 g/L glucose, 5 g/L NH4Cl, 0.1 g/L Na2SO4, 0.1 g/L MgCl2, 15 mg/L CaCl2, 3 g/L 
potassium hydrogen phthalate, 1.8 g/L Na2HPO4, 55 μM inositol, 81 μM nicotinic 
acid, 2 μM calcium pantothenate, 40 μM biotin, 8.2 μM H3BO3, 3.5 μM MnSO4, 2.5 
μM ZnSO4, 1.2 μM FeCl3, 900 nM MoO3, 250 nM CuSO4, 5.2 μM citric acid, 6 nM KI 
 58 
 
Malt extract (ME) media 
30 g/l malt extract 
Yeast extract (YE) media 
30 g/l glucose, 5 g/l yeast extract, 0.225 g/l adenine, 0.225 g/l uracil 
2.1.7 Bacteria medium 
Bacteria were cultured with solid or liquid 2YT media. Solid media was made by 
the addition of 5% (w/v) agar. Media was autoclaved prior to use.  
2YT 
1.6% (w/v) tryptone, 1% (w/v) yeast extract, 0.5% (w/v) NaCl 
For selection, ampicillin (50-100 μg/ml) or kanamycin (50 μg/ml) was added 
after autoclaving. 
2.2 Mammalian cell culture procedure 
2.2.1 Mammalian cell suppliers 
Human umbilical vein endothelial cells (HUVECs) were purchased from 
PromoCell, Heidelberg Germany. HUVECs were supplied as a pool from 6-8 
donors. Human embryonic kidney 293 (HEK 293) cells and HeLa CCl-2 cells were 
obtained from ATCC, Manassas, USA. HeLa cells expressing FLAG-tagged wild 
type (WT) or kinase dead (KD) LKB1 were a kind gift from Prof. Dario Alessi, 
University of Dundee, UK (Sapkota et al., 2002). AMPK α1/α2 (AMPK -/-) double 
knockout and wild type mouse embryonic fibroblasts (MEFs) were a kind gift 
from Dr. Benoit Viollet, Institute Cochin, Paris France (Laderoute et al., 2006).  
2.2.2 Cell culture plastic ware  
Cells were maintained in Corning T25, T175 or T150 cell culture flasks. MEFs, 
HeLa cells and HEK 293 cells were cultured in Corning plastic ware. HUVECs were 
cultured on Falcon plastic. Alternatively, cells were seeded on 8-well Ibidi 
chambers. 
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2.2.3 Cell culture growth media 
Cells were maintained at 37oC in a 5% (v/v) CO2 humidified atmosphere and in 
the following media; 
Cell type Media and Supplement(s) 
HEK 293 DMEM and 10% (v/v) FBS 
HeLa CCl2 DMEM and 10% (v/v) FBS 
WT/KD-LKB1 HeLa 
 
MEM,10% (v/v) FBS, 2 mM glutamine, 100 
U/ml penicillin, 100 μg/ml streptomycin, 2 
mM non-essential amino acids, 5 μg/ml 
blasticidin and 100 μg/ml zeocin 
HUVECs 
MV2 with supplied 5% (v/v) serum 
supplement 
Wild type and AMPK -/- MEFs DMEM and 10% (v/v) FBS 
Table 2-7: Mammalian cell culture media and supplements 
 
2.2.4 Passaging of cells 
When cells were approximately 70% confluent, growth media was aspirated and 
cells briefly washed with PBS. Cells were incubated with 0.05% (v/v) trypsin (3 
ml in T75 flask or 6 ml in T150 flask) until cells began to detach. Trypsin was 
quenched with growth medium and cells diluted to the desired concentration 
and seeded onto fresh flasks or plates. HUVECs were cultured up to passage 6. 
HeLa cells, HEKs and MEFs were cultured up to passage 30. 
2.2.5 Cryopreservation of cell stocks 
Cell culture media was removed from T75 flasks and cells washed with PBS prior 
to the addition of 3 ml 0.05% (v/v) trypsin and incubated at 37oC until cells 
detached. Trypsin was neutralized with 9 ml of the appropriate cell culture 
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growth media (as described in Section 2.2.3). The cell suspension was 
transferred to a 15 ml centrifuge tube and cells sedimented at 350 x g for 5 
mins. The supernatant was aspirated and cell pellet resuspended in 1 ml of the 
appropriate media containing 10% DMSO (v/v) and transferred to a 1.8 ml 
polypropylene cryogenic tube. Cells were stored overnight at -80oC in a Mr. 
Frosty™ freezing container before being transferred to liquid nitrogen storage. 
2.2.6 Resurrection of frozen cell stocks 
Cell cryogenic vials were removed from liquid nitrogen storage and thawed in a 
37oC water bath. Cells were transferred into a T75 flask containing 11 ml of the 
appropriate cell culture growth media (as described in Section 2.2.3) and 
incubated for 4 h. Once cells had attached to the flask, media was aspirated and 
replaced with fresh medium. 
2.3 Preparation of cell lysates 
Media was aspirated and cells washed with ice cold PBS. Cells were lysed with 
100 μl lysis buffer per well of a 6-well plate or 50 μl lysis buffer per well of a 12-
well plate. Wells were scraped using a cell lifter and incubated for 20 mins on 
ice. Lysate was transferred to cold 1.5 ml microcentrifuge tubes and centrifuged 
at 21,910 x g for 5 mins at 4oC. The supernatant was collected and stored at -
20oC.  
2.4 Protein concentration determination 
Protein concentration was calculated by spectrophotometric analysis according 
to the Bradford method (Bradford, 1976). In duplicate, 0.5-5 μl of cell lysate was 
made up to 100 µl with distilled water in a plastic cuvette, followed by the 
addition of 1 ml Bradford’s reagent. Absorbance was measured at 595 nm using a 
WPA S2000 spectrophotometer equipped with appropriate filters.  
2.5 SDS-PAGE 
SDS-PAGE was carried out using 1.5 mm thick acrylamide gels between 8% and 15 
% (v/v) with a 5% (v/v) stacking gel of approximately 2 cm. Samples were mixed 
with LSB and heated at 95oC for 5 min. Electrophoresis was carried out at 80 V 
 61 
 
for the stacking gel and 80-150 V through the resolving gel until the dye front 
had migrated off the gel. Prestained broad range protein markers were used as a 
reference.  
2.6 Western blotting of proteins 
2.6.1 Electrophoretic transfer of proteins onto nitrocellulose 
membranes 
Gels were placed on nitrocellulose membrane (0.25 μm pore size) and layered 
between two sheets of 3 mm filter paper. Sponges were placed outside the filter 
paper and the ensemble placed in a gel holder cassette. Electrophoretic transfer 
was carried out at 60 V for 2.25 h or 30 mA overnight. Nitrocellulose membrane 
was stained with Ponceau S to assess transfer efficiency and equal loading of 
protein.  
2.6.2 Blocking of membranes and incubation with primary 
antibodies 
To prevent non-specific binding of antibodies to the membrane, the 
nitrocellulose was incubated in 5 % (w/v) Marvel milk powder in TBS for 30 mins 
at room temperature. Membranes were washed briefly with TBS followed by 
incubation with primary antibodies overnight at 4oC with shaking.  
2.6.3 Secondary antibodies and immunodetection of proteins 
using the LI-COR detection system 
Membranes were washes (3 times, 5 min) with TBST and incubated with the 
appropriate secondary antibodies for 1 h at room temperature with shaking. 
Membranes were subsequently washed (3 times, 5 min) with TBST. Secondary 
antibody fluorescence was detected using the LI-COR Odyssey ® SA system.  
2.6.4 Stripping of nitrocellulose membranes 
When required, antibodies were stripped from the nitrocellulose membranes by 
incubation with 0.2 mM NaOH for 12 min. Membranes were then washed (3 
times, 5 min) in TBST until pH returned to ~7.5. Membranes were stained with 
Ponceau S to ensure that proteins were not inadvertently stripped from the 
 62 
 
membrane during the process. Following stripping, membranes were blocked as 
described in section 2.6.2 and incubated with primary antibodies.  
2.6.5 Densitometric quantification of protein bands 
Blots were cropped using Image Studio Lite Version 5.0. Images were imported 
into ImageJ and band intensity calculated. 
2.7 Immunofluorescence 
2.7.1 Preparation of coverslips 
Glass coverslips (13 mm diameter) were immersed in 100% ethanol and placed 
upright in the wells of a 12-well plate and air dried in a laminar flow hood. Once 
dry, plates were agitated allowing the coverslips to fall to the bottom of the 
wells. Coverslips were exposed to UV light for a minimum of 30 min. 
2.7.2 Immunofluorescence staining 
Media was aspirated from wells and coverslips washed three times with PBS 
followed by incubation with 1 ml 4 % (w/v) p-formaldehyde (PFA) for 20 min. 
Cells were washed three times with PBS and incubated with 1 ml quenching 
buffer for 10 mins followed by three washes with PBS. Cells were incubated with 
1 ml permeabilization buffer for 5 min. Permeabilization buffer was aspirated 
and cells incubated in 1 ml IF buffer for at least 20 min to block non-specific 
sites. 
2.7.3 Incubation of coverslips with primary and secondary 
antibodies 
Primary antibodies were prepared in IF buffer, 35 μl of antibody solution was 
pipetted onto Parafilm. Coverslips were removed from the wells, inverted and 
placed onto the antibody solution using fine pointed tweezers. Coverslips were 
incubated with the primary antibody for 1 h at room temperature. Coverslips 
were returned to the wells and washed three times with IF buffer. 
Secondary antibodies were prepared in the same manner as primary antibodies 
but coverslips were only incubated for 30 min. Following incubation with 
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antibodies, coverslips were returned to their wells and washed three times with 
IF buffer. During incubation with the primary and secondary antibodies, the 
Parafilm was covered to reduce evaporation and prevent photobleaching of 
secondary antibodies 
2.7.4 Staining of DNA 
DNA was stained with either 4’,6-diamidino-2-phenylindol (DAPI) or RedDot2. 
DAPI staining was carried out following incubation with the secondary antibody; 
cells were incubated with 1 μg/ml DAPI for 10 min. Alternatively RedDot2 was 
diluted 1:200 and co-incubated with secondary antibodies. 
2.7.5 Mounting coverslips on slides 
A drop of Immuno-Mount was applied to a glass microscope slide and using fine 
tweezers, coverslips were placed cell-side down onto the Immuno-Mount. Slides 
were left to dry overnight in the dark. 
2.7.6 Preparation of samples in ibidi® μ slides 
For staining carried out in 8-well ibidi® μ slides, the protocol described in 
Section 2.7.2 can be followed but volumes adjusted to 300 μl. Antibody solutions 
(150 μl) were added directly to the chamber wells. Finally, three drops of ibidi® 
mounting medium was added to each chamber to preserve samples. 
2.7.7 Confocal microscopy and image acquisition  
Images were acquired using a Zeiss LSM Exciter laser scanning microscope with a 
63X/1.4 NA oil DIC objective lens. Images were processed using ImageJ. 
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2.8 Recombinant adenoviruses 
2.8.1 Adenoviruses used 
Adenoviruses used during the course of this project are outlined in Table 2-8. 
Virus Tag Details Reference 
Ad.AMPKα1-
dominant negative 
(DN) 
Myc 
Encodes full length 
AMPKα1 containing a 
D157A mutation 
A generous gift from 
Dr. F. Foufelle, 
Centre Biomedical des 
Cordelier, Paris 
(Woods et al., 2000).  
Ad.AMPKα1-
consitutively active 
(CA) 
GFP 
Encodes for amino 
acids 1-312 of AMPKα1 
containing a T172D 
mutation 
A generous gift from 
Dr. F. Foufelle, 
Centre Biomedical des 
Cordelier, Paris 
(Woods et al., 2000). 
Ad.GFP N/A Encodes for GFP 
A generous gift from 
Dr. F. Foufelle, 
Centre Biomedical des 
Cordelier, Paris 
(Woods et al., 2000). 
Ad.Null N/A Empty capsid virus 
A generous gift from 
Dr. F. Foufelle, 
Centre Biomedical des 
Cordelier, Paris 
(Woods et al., 2000). 
Table 2-8: Adenoviruses used during this investigation 
 
2.8.2 Adenovirus propagation and purification 
Two T150 flasks of HEK 293 cells were infected with 2 μl of virus and incubated 
for 48 h. Cells were detached by pipetting and collected in 50 ml Falcon tubes. 
Cells were sedimented at 340 x g for 15 min and the supernatant discarded. 
Pellets were pooled and resuspended in 10 ml PBS before being mixed with 10 ml 
Arklone P (1,1,1-trichloro-1,2,2-trifluroethane) and gently inverted for 10 sec. 
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The cell-Arklone P mixture was centrifuged at 340 x g for 15 min and the upper 
layer containing the virus isolated. The virus layer was diluted in 600 ml DMEM 
containing 10% (v/v) FBS and distributed between 25 T150 flasks of HEK 293 cells 
and incubated for 48 h. Cells were detached by pipetting and collected in 50 ml 
Falcon tubes. Cells were sedimented at 340 x g for 15 min and the supernatant 
discarded. Cell pellets were pooled and resuspended in 20 ml PBS. Cells were 
lysed with 10 ml of Arklone P and centrifuged at 340 x g for 15 min. The upper 
layer containing the virus was layered onto a CsCl gradient consisting of 2.5 ml 
of CsCl in TE buffer with a density of 1.33 g/ml layered on top of 1.5 ml CsCl in 
TE buffer with a density of 1.45 g/ml in a centrifuge tube. This was centrifuged 
at 100,000 x g in a SW40 rotor using an Optima™ XL-80K ultra centrifuge for 90 
min at 20oC. The centrifuge tube was punctured with a 19-gauge needle just 
below the virus layer and collected into a 1 ml syringe. Viruses were transferred 
to a float-a-lyzer to dialyse against TE buffer overnight at 4oC. The following 
morning, the float-a-lyzer was transferred to 10% (v/v) glycerol in TE buffer to 
dialyse for 2 h. Purified virus was stored at -80oC. Virus concentration was 
calculated using an adenovirus titration kit from Clontech according to the 
manufacturer’s guidelines.  
2.8.3 Adenovirus infection of mammalian cells 
Adenoviruses were diluted to the required concentration in the appropriate cell 
culture media (Section 2.2.3) and added directly wells. Cells were incubated 
with viruses for 24-48 h before experiments were conducted 
2.9 siRNA-mediated knockdown of gene expression 
HUVECs were seeded in 6-well plates 24 h prior to transfection. siRNA (40 μl of 
200 nM) was diluted in 500 μl Opti-MEM® with 40 μl SAINT-sRNA transfection 
reagent. The mixture was briefly vortexed and incubated at room temperature 
for 5 min. Cells were washed with 1 ml Opti-MEM® and siRNA solution added 
dropwise to cells. Cells were incubated for 3 h at 37oC. Following incubation, 1.5 
ml MV2 media was added to each well and cells cultured for 48 h.  
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2.10 Transfection of plasmid DNA 
HeLa cells or HEK 293 cells were plated 24 h prior to transfection. Plasmid DNA 
and Lipofectamine® 2000 was diluted in Opti-MEM® media, the volumes and 
quantities are described in Table 2-9. Media was vortex mixed briefly and 
incubated at room temperature for 20 min. Cells were washed once with Opti-
MEM® and DNA-lipid complexes added dropwise. Cells were incubated for 4 h at 
37oC. Opti-MEM® was aspirated and cells incubated in the appropriate media 
(Section 2.2.3) for 24-48 h. 
 Lipofectamine® 2000 Plasmid DNA Opti-MEM® 
1 well of a 12-well plate 4 μl 1.6 μg 200 μl 
1 well of a 6-well plate 10 μl 2.5 μg 500 μl 
10 cm dish 60 μl 24 μg 3 ml 
Table 2-9. Volumes and quantities of Lipofectamine® 2000 and plasmid DNA used for the 
transfection of mammalian cells. 
 
2.11 Cell synchronisation 
2.11.1 Thymidine and nocodazole block 
Cells were seeded in 20 T150 flasks and grown to 40% confluency, then 
incubated with 5 mM thymidine overnight. Flasks were washed three times with 
PBS and once with the appropriate growth media (Section 2.2.3). Flasks were 
incubated with the appropriate media for 8 h. Cells were then incubated with 10 
ng/ml nocodazole overnight. The following day, media was aspirated and cells 
detached by agitation. Flasks were washed with PBS and cells collected in 50 ml 
tubes. Cells were washed three times with PBS and once with the appropriate 
cell culture growth media. Cells were plated as required and incubated until 
cells reached the desired point of the cell cycle.  
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2.11.2 Double thymidine block 
HUVECs were plated in either 6-well or 12-well plates and grown to 30% 
confluency. Thymidine (2 mM) was added to media and cells incubated for 18 h. 
Cells were washed twice with PBS and once with MV2 media, followed by 
incubation in media for 9 h. Thymidine (2 mM) was added to media and cells 
incubated for 15 h. Cells were washed twice with PBS and once with MV2 media. 
Cells were then cultured at 37oC until they reached the desired point of the cell 
cycle.  
2.12 Flow cytometry 
Cells were detached from wells by mechanical agitation using a cell scraper and 
collected into 15 ml centrifuge tubes. Cells were sedimented at 350 x g for 5 
min and fixed by the addition of 5 ml ice cold 70% (v/v) ethanol while vortex 
mixing and incubated at 4oC for a minimum of 20 min. Cells were sedimented at 
350 x g for 5 min and resuspended in 1 ml PBS containing 50 μg/ml RNase A and 
50 μg/ml propidium iodide (PI). PI fluorescence was measures using a BD 
Biosciences FACSCanto II System with Fluidics Cart (6-color, blue/red) flow 
cytometer.  
2.13 Cell viability assay (MTS assay) 
Cells were seeded into a 96-well plate and incubated for 4-6 h to allow cells to 
adhere to plastic, followed by the addition of the required small molecule 
activator/inhibitors. After 18-24 h, 20 μl MTS reagent was added to each well 
(100 μl media/well). Cells were incubated with MTS reagent as follows; HUVECs 
for 2 h, HeLa cells 3 h and MEFs 4 h. Absorbance was measured at 489 nm using a 
BMG Labtech FLUOstar Optima spectrophotometer microplate reader.  
2.14 Cell proliferation assay (BrdU assay) 
Cell proliferation was assayed using a BrdU Assay Kit as directed by the 
manufacturer’s protocol. Briefly, cells were seeded into a 96-well plate and 
incubated for 4-6 h, to allow cells to adhere to plastic. BrdU reagent was diluted 
1:500 in the appropriate cell culture media (Section 2.2.3) and 20 μl added per 
well of a 96-well containing 100 µl media. Cells were cultured at 37oC for 18-24 
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h. Cells were fixed with the supplied fixing solution for 30 min. Plates were 
washed three times and incubated with supplied anti-BrdU antibody for 1 h. 
Plated were washed three times and incubated with supplied HRP-conjugated 
antibody for 30 min. Following washing, plates were incubated with a peroxidase 
substrate for 30 min in the dark. Reaction was terminated using supplied acidic 
stop solution. Detection was performed using a PHERAstar FS spectrophotometer 
microplate reader. Absorbance was measured at 450 nm and corrected by 
subtracting absorbance at 550 nm.  
2.15 Immunoprecipitation 
2.15.1 FLAG-tag immunoprecipitation 
HeLa cells expressing FLAG-tagged KD-LKB1 were cultured in 10 cm dishes until 
confluent. Cells were lysed with 500 μl lysis buffer as described in Section 2.3. 
Lysates were incubated with 10 μg anti-FLAG antibody (Merc, Kenilworth, USA. 
Catalogue number F-3165) and 20 μl magnetic protein G beads overnight on a 
rotating mixer at 4oC. Beads were washed three times with PBS and protein 
complexes were either eluted from the beads by the addition of 2X LSB or 
resuspended in either HEPES-Brij DTT or kinase assays buffer. 
2.15.2 Immunoprecipitation using conjugated nanobodies 
Fusion proteins tagged with either GFP/YFP, Myc or RFP (mCherry) were 
immunoprecipitated using ChromoTek nanobodies conjugated to magnetic 
beads. Beads (20 μl of packed volume) were washed twice with 1 ml PBS and 
added to 500 μl of cell lysate. Lysates were incubated for 1 h at 4oC with mixing 
by rotation. Beads were washed three times with 1 ml PBS. Protein complexes 
were either eluted from the beads by the addition of 2X LSB or resuspended in 
either HEPES-Brij DTT or kinase assays buffer. 
2.16 In vitro Phosphorylation assays 
2.16.1 Substrate generation 
HEK-293 cells were transfected with plasmids encoding tagged proteins (KD-
aurora A-mCherry, KD-aurora B-GFP, KD-PLK1-GFP, CHMP2A) or infected with 
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Ad.AMPK-DN adenoviruses and lysates prepared (Section 2.3). Fusion proteins 
were immunoprecipitated as described in Section 2.15.2 using ChromoTek anti-
myc, anti-GFP or anti-RFP conjugated beads. Alternatively, FLAG-tagged LKB1 
was immunoprecipitated from HeLa cells expressing WT or KD-LKB1 (Section 
2.15.1). Myelin basic protein (MBP) (200 µg/ml) or GST (2.5 µg) were also used as 
substrates in in vitro phosphorylation assays. Finally, commercially available 
recombinant proteins were denatured by heating at 95oC for 5 min and 2.5 µg 
used as a substrate for assays.  
2.16.2 Lambda phosphatase treatment 
Immunoprecipitated substrates were incubated with commercial lambda 
phosphatase (New England Biolabs cat. 0735) to limit endogenous 
phosphorylation. Briefly, magnetic beads were washed with water and volumes 
adjusted to 40 μl using water, 5 μl 10X NEB protein metalloPhosphatases buffer 
was added with 5 μl 10 mM MnCl2 and 1 μl (400 U) lambda protein phosphatase. 
Reactions were incubated at 30oC for 1 h on a vibrating hot block. Beads were 
then separated and washed twice with PBS. Beads were either resuspended in 
2xLSB, HEPES-Brij DTT or kinase assay buffer.  
2.16.3 Phosphorylation reaction 
In vitro phosphorylation reactions were set up as follows; 5 μl substrate (from 
2.14.1); 5 μl kinase assay buffer (or HEPES-Brij DTT for assays using AMPK); 5 μl 1 
mM ATP and 25 mM MgCl2 containing 0.2 μCi/μl [γ32P] ATP; 5 μl the appropriate 
active kinase; 5 μl the appropriate cofactors; 1 mM AMP for reactions using AMPK 
or 1 mM CaCl2 and 10 μM calmodulin for reactions using CaMKKβ. Reactions using 
aurora A, aurora B or PLK1 did not require cofactors so an additional 5 μl buffer 
was added. 
Reactions were incubated for 30 min at 30oC on a vibrating platform. Reactions 
were terminated by either separating reaction mixture from magnetic beads 
followed by the addition of 15 μl 2X LSB or the addition of 8 μl 4X LSB directly to 
reaction. Samples were incubated at 70oC for 5 min. 
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2.16.4 SDS-PAGE and visualisation  
Phosphorylation products were resolved by SDS-PAGE as described in Section 2.5. 
Gels were stained using Coomassie blue solution for 20 min. Gels were washed 
using destain solution until background staining cleared and dried onto 3 mm 
filter paper by heating at 85oC for 2 h under a vacuum. Radioactive 32P 
incorporation was detected using a Fuji FLA 7000 Phosphor Imager. 
2.17 Transformation of competent E. coli  
Chemically competent E. coli (XL-1 blue or STBL3 depending on the required 
plasmid) were mixed with 1 μl plasmid DNA and incubated on ice for 20 min. E. 
coli were heat shocked at 42oC for 45 sec followed by incubation on ice for 2 min 
and the addition of 300 μl 2YT media. Cells were then incubated at 37oC for 1 h 
with shaking. Cells (200 μl) were spread onto solid 2YT media with the 
appropriate antibiotic and incubated overnight at 37oC.  
2.18 Preparation of plasmid DNA 
Plasmid DNA was purified using QIAGEN® plasmid Maxi kit. Briefly, E. coli 
cultures were grown overnight in 100 ml 2YT containing the appropriate 
antibiotic at 37oC with vigorous shaking. E. coli were harvested by sedimentation 
at 6000 x g for 1 h and resuspended in the supplied lysis buffer and incubated for 
5 mins. Neutralisation solution was added and cell debris pelleted by 
centrifugation at 20000 x g for 1 h. Lysate was loaded onto a QIAGEN-tip and 
allowed to flow through. Columns were washed twice with supplied wash 
solution. Plasmid was eluted and resuspended in 500 μl water. DNA 
concentration was quantified using a nanodrop spectrophotometer. 
2.19 PCR 
PCR reactions were assembled in thin-walled PCR tubes as follows: 1X PCR 
master mix, 0.2 mM ATP, 0.2 mM CTP, 0.2 mM GTP, 0.2 mM TTP,1.5 mM MgCl2, 
0.5 μM primers, 2.5 U Taq DNA polymerase and template DNA. Reactions were 
carried out in a Biometra T-gradient thermocycler. Reactions were heated to 
95oC for 3 min followed by 35 cycles of: 95oC 1 min, 55oC 1 min, 72oC 45 sec-2 
mins and finally 10 min at 72oC.  
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2.20 Agarose gel electrophoresis and visualisation of 
PCR products 
PCR products were separated on a 0.8-2 % (w/v) agarose gels containing 0.2 
μg/ml ethidium bromide. DNA was combined 5:1 NEB 6X DNA loading dye and gel 
electrophoresed at 70 V. Gels were visualised on an AlphaImager™ 3400 UV-
trans-illuminator  
2.21 General S.pombe methods 
The methods used were based on Rezig et al., 2019 and Moreno et al., 1991. S. 
pombe were allocated a “Glasgow” (GG) number and were Stored in 30% (v/v) 
glycerol at -70oC. Strains were resurrected from glycerol stocks by spreading 
onto solid YE medium and incubated at 25-30oC for 2-3 days prior to 
experimentation. Appendix 1 outlines the full genotypes for the S. pombe strains 
used in this Thesis.  
2.22 Generating mutants by homologous recombination 
2.22.1 Generating transforming DNA 
The method used was adapted from Bähler et al., (1998). Transforming DNA was 
generated by PCR using primers composed of an 80 base pair sections 
homologous to the untranslated region (UTR) regions 5’ (forward primer) or 3’ 
(reverse primer) of the gene to be deleted (ssp2 in this case), and a 20 base pair 
section homologous to the kanMX6 sequence present on the pFA6a-kanMX6 
plasmid (Table 2-6). This PCR generated the transforming DNA; a linear fragment 
containing the sequence of the kanMX6 cassette flanked by sequences 
homologous to sequences 5’ and 3’ of ssp2 (Figure 2-1A).  
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Figure 2-1: Schematic diagram showing the chromosomal deletion of ssp2 based on 
homologous recombination. 
(A and B) Transforming DNA was generated by PCR using a forward primer containing a region 
homologous to the 5’ UTR of the gene of interest (here ssp2+) and a region homologous to the first 
20 bases of the kanMX6 located on a plasmid. Similarly the reverse primer is composed of a region 
homologous to the 3’ UTR of the ssp2 and a region homologous to the kanMX6 sequence. (C and 
D) The linear DNA is transformed into S. pombe cells. Homologous recombination occurs between 
the transforming DNA and the yeast chromosome around the ssp2 gene. This resulting in the 
replacement of ssp2 gene with the kanMX6 sequence. The position of the “checking primers” is 
shown.  
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2.22.2 Transformation of S. pombe 
S. pombe strains were grown in liquid YE medium to approximately 107 cells/ml. 
Cells were washed once with sterile water and resuspended in 1 ml of water in a 
microcentrifuge tube. Cells were sedimented at 350 x g for 3 mins and 
resuspended in 1 ml TE buffer containing 0.1 M lithium acetate (LiAc/TE buffer). 
Cells were washed once with LiAc/TE buffer and resuspended at 2x109 cells/ml. 
Cells (100 μl) were mixed with 2 μl of 10 mg/ml sheared salmon sperm DNA and 
15 μl transforming DNA. Reactions were incubated at room temperature for 10 
mins followed by the addition of 260 μl 40% (w/v) polyethylene glycol in LiAc/TE 
and transferred to a shaking incubator at 30oC for 60 mins. DMSO (43 μl) was 
added and cells heat shocked at 42oC for 5 mins. Cells were washed once with 
water and resuspended in 500 μl water. The transformation reaction (250 μl) was 
spread onto solid YE medium and incubated overnight at 30oC. Cells were replica 
plated onto solid YE medium containing G418 (final concentration 100 mg/l) and 
incubated at 30oC until colonies formed. 
2.22.3 Confirmation of homologous recombination 
G418-resistant yeast colonies were grown to stationary phase in 5 ml liquid YE 
medium. Cells were washed twice with water and resuspended in 0.5 ml water 
in 1.5 ml microcentrifuge tubes. Cells were sedimented at 350 g for 3 mins and 
resuspended in 200 μl genome extraction buffer. Acid washed beads (0.3 g) were 
added with 200 μl phenol: chloroform: isoamyl alcohol (25:24:1) and vortex 
mixed for 5 mins. The aqueous layer was isolated by centrifugation at 21,910 x g 
for 5 mins and transferred to a fresh microcentrifuge tube. DNA was precipitated 
by the addition of 1 ml ethanol and pelleted (21,910 x g for 5 mins). DNA was air 
dried and resuspended in 50 μl TE buffer. 
PCR reactions were preformed using 5 μl genomic DNA. The forward primer was 
homologous to a section 5’ of the recombination event and the reverse primer 
was homologous to a sequence at the beginning of the KanMX6 cassette (Figure 
2-1D). PCR products were resolved using a 2% agarose gel. 
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2.23 Generation of double mutants 
2.23.1 Mating of S. pombe strains 
Equal sized colonies of actively growing yeast strains were mixed with 100 μl 
sterile water on solid ME medium. Cultures were incubated at 25oC for 2-3 days.  
2.23.2 Tetrad analysis 
The methods used to generate fission yeast double mutants by tetrad analysis is 
described in detail in Rezig et al., 2019, on which this section is based. The 
mating mixture from Section 2.23.1 was spread onto thinly poured (~1 mm thick) 
solid YE medium along one side of the Petri dish (Figure 2-2). The mating 
mixture was examined using a Singer MSM Ascus Dissector with a micro-
manipulator needle. Tetrad asci containing four ascospores were isolated and 
moved to form a vertical line along the centre of the Petri dish (Figure 2-2). 
Plates were incubated at 37oC for 3-5 h to induce the breakdown of the ascus 
membrane releasing the four ascospores. Ascospores were then separated to 
form a horizontal line (Figure 2-2) and plates incubated between 25-30oC until 
colonies formed. 
 
Figure 2-2: Schematic representation of tetrad analysis used to identify double mutants in 
fission yeast. 
(A) Yeast mating mixture was spread onto solid YE medium along one side of a Petri dish, termed 
the inoculum. Tetrad ascospores were isolated and placed in a vertical line along the centre of the 
dish (black circles). Plates were incubated at 37oC until the ascus membrane degraded. The four 
ascospores were then separated to form a horizontal line (grey circles) (B) Representative picture 
of S. pombe tetrads (indicated by white arrows).  
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2.23.3 Random spore analysis 
S. pombe strains were crossed as described in Section 2.23.1. Mating mixture 
was suspended in 1 ml sterile water containing 5% (v/v) β-glucuronidase from 
Helix pomatia (MERCK, cat G7017). Cell suspension was incubated at 25oC 
overnight on a shaking hot block. The following morning, a small amount of the 
mating mixture was placed on a glass slide and assessed using a light microscope 
to ensure that vegetative cells and asci membranes had been digested. Cell 
suspension was sedimented at 350 x g for 1 min and supernatant removed. Cell 
pellet was resuspended in 1 ml water. 3-10 μl was spread onto solid YE media 
and incubated between 25-30oC until colonies formed. 
2.23.4 Genotype analysis/replica plating 
To determine the genotype of the colonies generated by tetrad analysis or 
random spore analysis, replica plating onto selective media was carried out. 
Sterile velvet material mounted on a circular metal block was used to transfer 
yeast from the original plate onto selective media. To examine for the presence 
of auxotrophic markers, growth was tested on solid EMM where the appropriate 
nutrient was omitted which included; adenine (400 µl 375 mg/l), uracil (375 
mg/l), leucine (187.5 mg/l leucine) and histidine (187.5 mg/l). For each case, 
400 µl stock solutions was spread onto solid EMM media and allowed to dry. To 
select for the presence of the antibiotic resistance cassettes, 40 μl of 50 mg/ml 
G418 or 20 μl of100 mg/ml nourseothricin (clonNat) was spread onto solid YE 
media. Alternatively plates were incubated at different temperatures to 
examine temperature sensitivity. 
2.24 Serial dilution analysis of S. pombe 
Cells were suspended in sterile water and 100 μl of cell suspension mixed with 
10 ml ISOTON® in plastic cuvettes and cell number counted using a Z2 Coulter 
counter. Cell suspensions were diluted to 1.5x106 cells/ml, 1.5x105 cells/ml, 
1.5x104 cells/ml and 1.5x103 cells/ml and 10 μl of each dilution was pipetted 
onto solid YE media. Plates were incubated for 2-3 days at different 
temperatures. A wild type strain was diluted on each plate as a reference for 
cell growth.  
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2.25 Analysis of septation phenotypes 
Analysis of septation phenotypes was undertaken as previously described (Bhutta 
et al., 2014; Rezig et al., 2019). Yeast strains were grown overnight in liquid YE 
media at 30oC in a shacking incubator. Culture (1 ml) was transferred to 1.5 ml 
microcentrifuge tubes and mixed with 30 μl 1 mM Calcofluor-White and 
incubated for 1 min in the dark. Cells were sedimented by centrifugation at 
17,530 x g for 30 sec. Supernatant was removed and cells resuspended in 100 μl 
water. Cells (8 μl) were transferred onto a glass microscope slide, covered with 
a 22 X 22 mm cover slip and sealed using clear nail polish. Slides were visualised 
with a Zeiss Axiovert 135 fluorescent microscope with a Zeiss 63X Plan-
APOCHROMAT oil-immersion objective lenses. Calcofluor-White excitation was 
examined at 370 nm and emission at 440 nm. Septation phenotype of 100 cells 
was analysed across the three technical replicates and repeated three times. 
Septation phenotype were classified based on the descriptions from Bhutta et 
al., 2014.  
2.26 Statistical analysis 
Results are shown as mean ± standard error of the mean (SEM). Statistical 
significance was assessed by either two-tailed Students t-test, one-way or two-
way analysis of variance (ANOVA) with p<0.05 being deemed significant.  
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3 Chapter 3-AMPK may have a role in mammalian 
mitosis 
3.1 Introduction 
Emerging evidence has suggested a role for AMPK in controlling the cell cycle 
and mitosis. Active phospho-T172 AMPK has been reported to localize to specific 
areas during mitosis; as cells enter mitosis phospho-T172 AMPK is located at the 
MTOC, and during telophase phospho-T172 AMPK localises to the midbody 
(Vazquez-Martin et al.,2009). One of the principal downstream targets of AMPK, 
phospho-S79 ACC, has also been reported to follow the same spatio-temporal 
localisation as phospho-T172 AMPK, indicating a functional effect of AMPK at 
these locations (Vazquez-Martin et al., 2013). Furthermore, levels of phospho-
Ser79 ACC increase during mitosis and treatment of cells with the poorly-
selective AMPK inhibitor, compound C reduces mitotic accumulation 
(Thaiparambil et al., 2012).  
In the present study AMPK localisation during mitosis was assessed in primary 
human cells and in cell lines. Additionally, the effect of modulating AMPK 
activity by pharmacological or genetic means on the cell cycle was assessed. 
Initially HeLa cells were chosen for investigation as they have been widely used 
in the study of the cell cycle. However, as HeLa cells lack the AMPK kinase LKB1, 
experiments were also carried out on primary HUVECs as a more biologically 
relevant model.  
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3.2 Results 
3.2.1  AMPK subcellular localisation during mitosis 
3.2.1.1 Subcellular localisation of AMPKα subunits during mitosis 
It has been reported that the AMPKα2 subunit localises to the midbody in 
HUVECs and that phospho-T172 AMPKα similarly localises to the midbody and 
MTOC in HeLa cells and the A431 cancer cell line (Vazquez-Martin et al., 2009; 
Pinter et al., 2012;). The localisation of AMPKα subunits during mitosis was 
therefore investigated in primary human cells (HUVECs) and HeLa cells. Using 
antibodies raised to amino acids 344-358 of AMPKα1, immunoreactivity was 
observed at the MTOCs in HeLa cells (Figure 3-1) and HUVECs (Figure 3-2), 
whereas no staining was observed at the midbody. Conversely, when stained 
with an antibodies raised to amino acids 351-356 of AMPKα2, immunoreactivity 
was observed at the midbody with no immunoreactivity at the MTOCs in HeLa 
cells (Figure 3-1) and HUVECs (Figure 3-2). In both cell lines, AMPKα2 localised 
to two discreet areas on either side of the midbody (highlighted in Figure 3-2D). 
AMPKα1 and AMPKα2 immunoreactivity was also observed in the cytoplasm of 
mitotic cells. Further immunofluorescence experiments were undertaken using 
antibodies raised to distinct epitopes (amino acids 357-524 of AMPKα1 or amino 
acids 29-510 of AMPKα2), however no immunoreactivity was observed in HUVECS 
(data not shown).  
To avoid specificity issues of antibodies, HeLa cells were transfected with 
plasmids encoding genes for either AMPKα1-GFP, AMPKα2-GFP or GFP alone. 
Cells were fixed with PFA and GFP localisation assessed by fluorescence confocal 
microscopy. Despite successful induction of AMPKα1/2-GFP expression (Figure 3-
3D), the majority of GFP-positive cells were senescent. Only three GFP positive 
cells were observed which were connected by an intracellular bridge, and in all 
three cases GFP was apparent at the midbody (Figure 3-3).  
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Figure 3-1. Subcellular localisation of AMPKα subunits during mitosis in HeLa cells 
HeLa cells were fixed with 4% (w/v) PFA and stained with anti-tubulin (Abcam, ab6160), anti-
AMPKα1 (epitope raised against amino acids 344-358 of AMPKα1) (A and B) or anti-AMPKα2 
(epitope raised against 351-356 of AMPKα2) antibodies (C and D). DNA was stained with 
RedDot2. Cells undergoing metaphase are shown in A and C, cells undergoing telophase are 
shown in B and D. Scale bar 10 μm. Representative images are shown from three independent 
experiments in each case.  
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Figure 3-2. Subcellular localisation of AMPKα subunits during mitosis in HUVECs 
HUVECs were fixed with 4% (w/v) PFA and stained with anti-tubulin (Abcam, ab6160), anti-
AMPKα1 (epitope raised against amino acids 344-358 of AMPKα1) (A and B) or anti-AMPKα2 
(epitope raised against 351-356 of AMPKα2) antibodies (C and D). DNA was stained with 
RedDot2. Cells undergoing metaphase are shown in A and C, cells undergoing telophase are 
shown in B and D. Scale bar 10 μm. Representative images are shown from three independent 
experiments in each case.   
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Figure 3-3. Subcellular localisation of AMPKα-GFP in HeLa cells 
HeLa cells were transfected with plasmids containing the genes for GFP, AMPKα1-GFP or 
AMPKα2-GFP. (A-C) Representative images of transfected cells stained with anti-tubulin (Abcam, 
ab6160) antibodies and for DNA with RedDot2 from two independent experiments. Scale bar 10 
μm. (D) HeLa cells were transfected with the plasmids described. Lysates were prepared 24 h 
following transfection and resolved by SDS-PAGE followed by immunoblotting using anti-GFP 
antibodies. N=1.  
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3.2.1.2 Subcellular localisation of phospho-T172 AMPK during mitosis 
Using two different anti-phospho-T172 AMPK antibodies, immunoreactivity was 
observed at the MTOCs when cells were in metaphase and at the midbody during 
telophase in both HeLa cells (Figure 3-4) and HUVECs (Figure 3-5). 
Immunoreactivity of phospho-T172 AMPK was also observed in the cytoplasm of 
mitotic cells using both antibodies. Anti-phospho-T172 AMPK immunoreactivity 
was also detected at the spindle midzone of metaphase cells (Figure 3-4 and 
Figure 3-5).  
To determine if the observed anti-phospho-T172 AMPK immunoreactivity was 
specific, immunoreactivity of the antibodies was examined in AMPK α1/α2 
double knockout (AMPK -/-) MEFs. The wild type and AMPK -/- MEFs rapidly 
progress through the cell cycle, as a result M-phase cells were rarely observed 
when examined by microscopy (data not shown). To examine mitotic cells, MEFs 
were synchronised using a thymidine block followed by nocodazole arrest. Anti-
phospho-T172 AMPK (sc-101630) immunoreactivity was observed at the midbody 
in both wild type and surprisingly in AMPK -/- MEFs (Figure 3-6). Comparative 
levels of cytosolic and nuclear immunoreactivity was observed between the cell 
types (Figure 3-6).  
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Figure 3-4. Subcellular localisation of phospho-T172 AMPK during mitosis in HeLa cells 
HeLa cells were grown on glass cover slips, fixed with 4% (w/v) PFA and stained with anti-tubulin 
(Abcam ab6160), and either anti-phospho-T172 AMPK from Cell Signalling Technologies (CST) 
#2535 (A and B) or Santa Cruz Inc. sc-101630 (C and D). DNA was stained with RedDot2. Cells 
undergoing metaphase are shown in A and C. Cells undergoing telophase are shown in B and D. 
Scale bar 10 μm. Representative images from three independent experiments are shown.  
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Figure 3-5. Subcellular localisation of phospho-T172 AMPK during mitosis in HUVECs 
HUVECs were grown on glass cover slips, fixed with 4% (w/v) PFA and stained with anti-tubulin 
(Abcam ab6160) and either anti-phospho-T172 AMPK from Cell Signalling Technologies (CST) 
#2535 (A and B) or Santa Cruz Inc. sc-101630 (C and D). DNA was stained with RedDot2. Cells 
undergoing metaphase are shown in A and C. Cells undergoing telophase are shown in B and D. 
Scale bar 10 μm. Representative images from three independent experiments are shown.  
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Figure 3-6 Subcellular localisation of phospho-T172 AMPK during mitosis in wild type and 
AMPK -/- MEFs 
(A) Wild type and AMPK -/- MEFs were synchronised using a thymidine and nocodazole block. 
Synchronised MEFs were seeded onto 8-well Ibidi chambers and incubated until cells entered 
telophase. Cells were fixed using 4% (w/v) PFA and stained with anti-tubulin (Abcam, ab6160) and 
anti-phospho-T172 AMPK (Santa Cruz Inc. sc-101630) antibodies. Scale bar represents 10 μm. 
Representative images from two independent experiments are shown. (B) Unsynchronised wild 
type and AMPK -/- MEFs were incubated with 100 μM A769662 for 30 min before lysates were 
prepared. Lysates were resolved by SDS-PAGE followed by immunoblotting with the antibodies 
indicated. Arrow indicates a non-specific band of a higher molecular mass than AMPK. 
Representative immunoblots from three separate experiments.  
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3.2.1.3 Subcellular localisation of phospho-S79 ACC 
It has been reported that phospho-S79 ACC, a site phosphorylated exclusively by 
AMPK, exhibits a subcellular localisation which mirrors that of phospho-T172 
AMPK during mitosis in A431 cells. (Ha et al., 1994; Vazquez-Martin et al., 2013). 
However, during the course of this investigation, phospho-S79 ACC was not found 
to localise to the MTOC or the midbody in HUVECs (Figure 3-7). Immunoreactivity 
was observed in the cytoplasm of HUVECs. Additionally, phospho-S79 ACC 
immunoreactivity did not increase in response to A769662 (100 μM, 30 min) when 
examined by immunofluorescence microscopy, although A769662 stimulation 
caused a clear increase in phospho-S79 ACC signal intensity when assessed by 
immunoblotting (Figure 3-7). 
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Figure 3-7. Subcellular localisation of Phospho-S79 ACC during mitosis in HUVECs 
(A) HUVECs were seeded onto glass coverslips and stained with anti-tubulin (Abcam, ab6160) and 
anti-phospho-S79 ACC (Cell Signalling technology ®, #11818) antibodies and for DNA with 
RedDot2. Scale bar 10 μm. Representative images from three independent experiments are 
shown. (B-E) HUVECs were incubated with DMSO vehicle control or A769662 (100 μM, 30 min). 
(B/C) Cells were stained for anti-tubulin, anti-phospho-S79 ACC antibodies and DNA. (D) Cells 
were lysed and resolved by SDS-PAGE followed by immunoblotting with the antibodies indicated. 
(E) Mean fluorescence intensity of phospho-S79 ACC staining was measured in 20 cells using 
image J software. N=1.  
  
 88 
 
3.2.2 AMPK activity may influence mitosis in mammalian cells 
3.2.2.1 Pharmacological modulation of AMPK activity affects the fidelity of 
mitosis 
Next the functional consequences of AMPK activity during the cell cycle was 
investigated. HeLa cells were treated with pharmacological compounds known to 
alter AMPK activity namely; STO-609 (CaMKK/AMPK inhibitor), compound C (a 
poorly selective AMPK inhibitor) or A769662 (AMPK activator) (Tokumitsu et al., 
2002; Göransson et al., 2007; Isakovic et al., 2007). Cells were fixed with PFA, 
stained and examined by confocal microscopy where binucleation was assessed 
as a read out of failed cytokinesis. HeLa cells incubated with DMSO had a 
binucleation rate of approximately 2% (Figure 3-8). Compound C (10 μM) caused 
a modest but significant increase in the proportion of binucleated cells 
compared to DMSO treated cells (Figure 3-8). STO-609 (5 μM or 10 μM) did not 
significantly alter the proportion of binucleated cells, but a trend towards 
increased binucleation was apparent at higher concentrations (Figure 3-8). 
Stimulation with A769662 (10 μM) did not alter the proportion of binucleated 
cells (Figure 3-8).  
To assess binucleation/polyploidy in a greater number of cells, flow cytometry 
was undertaken using the DNA dye propidium iodide (PI). Quantification of PI 
incorporation into cells enabled the phase of the cell cycle to be identified; 2n 
DNA content represents cells in G0 or G1; 2-4n DNA content represents cells in S 
phase; 4n DNA content represents cells in G2/M phase or binucleated cells; >4n 
DNA content is polyploid cells. HeLa cells were treated with AMPK 
inhibitors/activators as described for 18 h prior to staining. Compound C caused 
a significant increase in the proportion of HeLa cells with 4n DNA and reduced 
the proportion of cells with 2n DNA content although this did not achieve 
statistical significance (p=0.1) (Figure 3-9). Incubation of HeLa cells with STO-
609 (5 μM or 10 μM) or A769662 (10 μM) did not alter DNA content (Figure 3-9).  
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Figure 3-8. The effect of modulating AMPK activity on binucleation in HeLa cells  
HeLa cells were treated with the indicated compound for 24 h. (A) Representative images of cells 
strained with anti-tubulin (Abcam, ab6160) antibodies and for DNA (DAPI). White arrows indicate 
binucleated cells, scale bar represents 10 μm. (B) Quantification of binucleated HeLa cells. (C) 
HeLa cells were treated as described prior to lysis. Cell lysates were resolved by SDS-PAGE and 
subjected to immunoblotting using the antibodies indicated. Representative images from three 
independent experiments are shown. * p<0.05 relative to DMSO alone (Students t-test).  
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Figure 3-9. The effect of modulating AMPK activity on the DNA content of HeLa cells 
HeLa cells were incubated with the compounds indicated for 24 h. Cells were harvested and fixed 
with ice cold 70% (v/v) ethanol. DNA was stained with PI and DNA content measured by flow 
cytometry. (A) Representative scatter plots showing the gating used. FSC-A (forward scatter by 
area), PE-A (Phycoerythrin by area, used as a pseudo measurement for PI staining). (B) 
Representative histograms, DMSO treated cells are shown in blue with the indicated treatment in 
pink. (C-F) Quantification of HeLa cell DNA content. Data shown as mean ± SEM. N=3-4. **** 
p<0.001 relative to DMSO (one-way ANOVA). 
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To assess how pharmacological modulation of AMPK activity may affect HeLa cell 
viability, MTS assays were undertaken in which the conversion of a tetrazolium 
salt to a coloured product was measured. This reaction is catalysed by succinate 
dehydrogenase, a component of the mitochondrial electron transport chain 
(Wang et al., 2010). Therefore, MTS assays measure mitochondrial activity as an 
indirect measure of cell viability. Compound C caused a dramatic reduction in 
HeLa cell viability (Figure 3-10A). Neither STO-609 nor A769662 altered HeLa cell 
viability (Figure 3-10A). 
Additionally, BrdU assays were undertaken to measure proliferation. BrdU is an 
analogue of thymidine and is incorporated into DNA during S phase and can be 
readily detected. STO-609, compound C and A769662 all caused a significant 
reduction in HeLa cell proliferation with compound C having the largest effect 
(Figure 3-10B).  
 
 
Figure 3-10. The effect of modulating AMPK activity on HeLa cell viability and proliferation  
HeLa cells were seeded in a 96-well plate and incubated for 4 h prior to incubation as indicated for 
18 h. (A) Cells were cultured in the presence of MTS reagent for 3 h to assess cell viability. (B) 
HeLa cells were cultured with BrdU reagent for 18 h to measure cell proliferation. Data shown as 
mean ± SEM % viability/proliferation relative to DMSO vehicle. N=3. * p<0.05, ** p<0.01 **** 
p<0.0001 relative to DMSO vehicle (one-way ANOVA).  
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As HeLa cells lack LKB1, HUVECs were utilised as a more biologically relevant 
model to establish how AMPK activity may influence mitosis (Sapkota et 
al.,2002). A greater number of AMPK pharmacological modulators were also 
examined; namely; AICAR (AMP-mimetic), canagliflozin and metformin (increase 
intracellular AMP) and salicylate (direct AMPK activator) (Corton et al., 1995; 
Zhou et al., 2001; Hawley et al., 2012, 2016). Metformin and salicylate (MetSal) 
were used in combination due to their synergistic mechanisms of AMPK 
activation (Hawley et al., 2012). HUVECs were incubated with the drugs 
indicated for 18 h and DNA content assessed by flow cytometry. Compound C (5 
µM and 10 μM) significantly increased the proportion of cells with 2n DNA 
content, dramatically reduced the proportion of cells with 2-4n DNA and 
increased the proportion of cells with >4n DNA (Figure 3-11). The 4n population 
was not affected by compound C (Figure 3-11). Activation of AMPK with MetSal 
caused a significant increase in the proportion of cells with 2n DNA content 
while reducing the proportion of cells with >4n DNA content (Figure 3-11). AICAR 
(0.1 mM and 1 mM) caused an increase in the proportion of cells with 2-4n DNA 
although there was considerable variation in the data set (p=.0.21 and p=0.18 
respectively) (Figure 3-11). STO-609 (10 μM), A769662 (10 μM or 50 μM), 
metformin (3 mM) or salicylate (5 mM) did not alter the DNA content of HUVECs 
(Figure 3-11).  
Selected pharmacological compounds were then investigated further, namely; 10 
μM compound C, 50 μM A769662, 1 mM AICAR, 10 μM canagliflozin and MetSal. 
Cells were incubated with the compounds for 18 h, fixed with PFA and stained 
for tubulin and DNA. Cells were examined by confocal microscopy and the 
proportion of binucleated cells assessed. No treatments significantly altered the 
proportion of binucleated cells (Figure 3-12).  
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Figure 3-11. The effect of modulating AMPK activity on the DNA content of HUVECs 
HUVECs were incubated with the indicated compounds for 18 h. Cells were harvested and fixed 
with ice cold 70% (v/v) ethanol. DNA was stained with PI and DNA content measured by flow 
cytometry. (A) Representative scatter plots showing the gating used. FSC-A (forward scatter by 
area), PE-A (Phycoerythrin by area, used as a pseudo measurement for PI staining). Gating was 
carried out individually for each treatment Representative histograms are shown below, DMSO 
treated cells are shown in blue with the indicated treatment in pink. (B-E) Quantification of HUVEC 
DNA content. (F) HUVECs were treated as described prior to lysis. Cell lysates were resolved by 
SDS-PAGE and subjected to immunoblotting using the antibodies indicated. Data shown as mean 
± SEM % cells. * p<0.05, ** p<0.01 relative to DMSO vehicle (one way ANOVA). N=3.  
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Figure 3-12. The effect of modulating AMPK activity on binucleation in HUVECs 
HUVECs were incubated with the described compounds for 18 h. Cells were fixed with PFA and 
strained with anti-tubulin (Abcam, ab6160) antibodies and for DNA using RedDot2. (A) The mean ± 
SEM percentage of binucleated cells are shown. (B) Representative images of stained cells. White 
arrows indicate binucleated cells, scale bar represents 10 μm. N=3.   
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During the course of the investigation, an inhibitor of Unc-51-like kinase 1 
(ULK1), SBI-0206965, was identified as a potent inhibitor of AMPK (Dite et al., 
2018). Concentrations of SBI-0206965 above 10 µM inhibited AICAR (1 mM, 1 h) 
stimulated phosphorylation of ACC S79 in HUVECs (Figure 3-13G). Therefore, SBI-
0206965 was used as another pharmacological tool to investigate how 
modulating AMPK activity may influence polyploidy. HUVECs were incubated with 
SBI-0206965 for 18 h and DNA content assessed by flow cytometry. SBI-0206965 
(10 μM) did not alter the DNA content of HUVECs, although 30 μM caused an 
apparent reduction in the proportion of cells with 2-4 DNA content (Figure 3-13).  
To assess how manipulation of AMPK activity influenced cell viability and 
proliferation in HUVECs, MTS and BrdU assays were carried out. All tested 
pharmacological modulators of AMPK activity significantly reduced HUVEC 
viability (Figure 3-14A). Compound C (5 μM and 10 μM), canagliflozin (10 μM), 
MetSal and SBI-0206965 (10 μM and 30 μM) significantly reduced proliferation 
when assessed by BrdU incorporation (Figure 3-15B). Neither A769662 (50 µM) or 
AICAR (1 mM) affected BrdU incorporation (Figure 3-15B).  
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Figure 3-13. The effect of SBI-0206965 on the DNA content of HUVECs 
HUVECs were treated as detailed for 18 h and DNA content measured by flow cytometry using PI 
staining. (A) Representative scatter plots showing the gating used. FSC-A (forward scatter by 
area), PE-A (Phycoerythrin by area, used as a pseudo measurement for PI staining). (B) 
Representative histograms from flow cytometry analysis comparing DMSO treated cells (pink 
histogram) and drug-treated (blue histogram). (C-F) Analysis of the proportion of cells with 2n, 2-
4n, 4n or >4n DNA content. (G) HUVECs were pre-treated with AICAR (1 mM, 1 h) followed by the 
detailed treatments with SBI-0206965 for 30 min. Cells were lysed and resolved by SDS-PAGE 
and interrogated by immunoblotting using the antibodies indicated. Data shown ± SEM. Data 
shown from two independent experiments.   
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Figure 3-14. The effect of modulating AMPK activity on HUVEC viability and proliferation 
HUVECs were seeded in a 96-well plates and incubated for 4 h. Cells were treated as indicated for 
18 h. (A) Cells were cultured in the presence of MTS reagent for 2 h to assess cell viability. (B) 
HUVECs were cultured with BrdU reagent for 18 h to measure cell proliferation. Data shown as 
mean ± SEM % viability/proliferation relative to DMSO vehicle N=3. * p<0.05, ** p<0.01, *** 
p<0.005 and **** p<0.0001 relative to DMSO (one-way ANOVA).  
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To determine if the observed alterations in binucleation/DNA content in 
response to pharmacological compounds were AMPK-dependent, experiments 
were undertaken using wild type and AMPK -/- MEFs. Compound C (5 μM and 10 
μM) markedly altered the DNA content of both MEF genotype. Scatter plots of 
compound C treated cells showed a broad spread of cell population that could 
not easily be separated. Comparing the histogram overlays of cells incubated 
with DMSO versus that of compound C treated cells indicated that in wild type 
MEFs compound C caused a dramatic reduction of cells with 4n DNA. AMPK -/- 
MEFs had cells correlating with 4n DNA but at a lower rate than DMSO treated 
cells (Figure 3-15). When the gating of DMSO treated cells was applied to 
compound C treated cells, the only statistically significant alteration was an 
increase in the proportion of 2-4n DNA in AMPK-/-MEFs (Figure 3-15). Neither 
A769662 (50 μM) nor canagliflozin (10 μM) significantly altered the DNA content 
of either wild type of AMPK -/- MEFs, although a substantial right shift was 
apparent for AMPK -/- MEFs incubated with A769662 (Figure 3-15). MetSal caused 
a left-shift in the AMPK -/- MEF histogram compared to both DMSO treated AMPK 
-/- cells and wild type MetSal treated MEFs (Figure 3-15).  
Compound C (5 μM) markedly reduced wild type MEF viability, whereas this 
effect was lessened in AMPK -/- MEFS (Figure 3-16A). Higher concentrations of 
compound C (10 μM) affected wild type and AMPK -/- MEFs equally (Figure 3-
17A). Low concentrations of SBI-0206965 (10 μM) reduced AMPK -/- MEF viability 
but did not affect wild type MEF viability (Figure 3-17A). At higher 
concentrations, SBI-0206965 (30 μM) reduced wild type and AMPK -/- MEF 
viability to a similar extent (Figure 3-16A). A769662 (50 μM), AICAR (1 mM), 
canagliflozin (10 μM) or MetSal did not significantly alter MEF viability (Figure 3-
176A).  
Compound C (5 μM and 10 μM), A769662 (50 μM), AICAR (1 mM), MetSal and SBI-
0206965 (10 μM and 30 μM) reduced MEF proliferation of both genotypes to a 
comparable extent (Figure 3-16B). Canagliflozin (10 μM) was the only compound 
not to alter MEF proliferation (Figure 3-17B).   
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Figure 3-15. The effect of modulating AMPK activity on the DNA content of wild type and 
AMPK -/- MEFs  
Wild type and AMPK -/- MEFs were incubated as indicated for 18 h and DNA content measured by 
flow cytometry using PI staining. (A) Representative scatter plots showing the gating used for wild 
type MEFs; FSC-A (forward scatter by area), PE-A (Phycoerythrin by area, used as a pseudo 
measurement for PI staining). Representative histogram overlays comparing DMSO treated cells 
blue) with drug treated cells (pink) of AMPK wild type MEFS. (B) Representative scatter plots and 
histogram overlays comparing DMSO treated cells (blue) with drug treated cells (pink) of AMPK -/- 
MEFS (C) Comparison of wild type (green) and AMPK -/- (blue) MEF DNA content histograms. (D-
G) Analysis of the proportion of cells with 2n, 2-4n, 4n or >4n DNA content. (H) MEFs were treated 
with the indicated compounds for 18 h. Cells were lysed and resolved by SDS-PAGE and 
immunoblotting using the antibodies detailed. Data shown are mean ± SEM % cells. ** p<0.01 
relative to DMSO (two-way ANOVA). N=3.   
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Figure 3-16. The effect of modulating AMPK activity on wild type and AMPK -/- MEF viability 
and proliferation  
Wild type and AMPK -/- MEFs were seeded in 96-well plates and incubated for 6 h. Cells were 
treated as indicated for 18 h. (A) Cells were cultured in the presence of MTS reagent for 4 h to 
assess viability. (B) MEFs were cultured with BrdU reagent for 18 h to measure proliferation. Data 
shown as mean ± SEM % viability/proliferation relative to DMSO. *p<0.05, *** p<0.005, **** 
p<0.0001 relative to DMSO treated cells (two-way ANOVA). # p<0.05, #’# p<0.001 relative to wild 
type MEFs (two-way ANOVA). N=3.   
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3.2.2.2 Genetic alteration of AMPK activity can alter polyploidy in HUVECs 
As many of the pharmacological modulators used during this investigation can 
have AMPK-independent effects, a genetic approach was employed to study 
polyploidy. HUVECs were infected with adenoviruses encoding either a dominant 
negative form of AMPK (Ad.AMPKα1-DN), constitutively active AMPK (Ad.AMPK-
CA) or GFP (Ad.GFP) and binucleation assessed. Infected cells were identified by 
confocal microscopy by either GFP fluorescence or myc immunoreactivity 
(Ad.AMPK-CA co-expressed GFP from a distinct promoter and Ad.AMPKα1-DN is 
myc-tagged). Expression of constitutively active AMPK caused a 20% reduction in 
the proportion of binucleated cells relative to Ad.GFP infected cells (Figure 3-
17). Expression of dominant negative AMPK appeared to reduce binucleation 
although this did not achieve statistical significance (p=0.11) (Figure 3-17).  
AMPKα expression was downregulated using targeted siRNA and DNA content 
assessed by flow cytometry. AMPKα1 and AMPKα2 expression was downregulated 
by 46.4 ± 12% and 65.3 ± 24.5% respectively, from two independent experiments 
(Figure 3-18). Transfection of cells with siRNA caused the appearance of so-
called “microcells” which contained 2n DNA but had a smaller size (Figure 3-18). 
AMPKα1 downregulation caused the greatest increase in microcells. Incubation of 
HUVECs with AMPKα1 siRNA caused a reduction in the proportion of cells with 4n 
DNA relative to scrambled (Sc) siRNA treated cells (Figure 3-18). Downregulation 
of AMPKα2 did not alter the DNA content of HUVECs (Figure 3-18).  
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Figure 3-17. The effect of adenovirus infection on binucleation in HUVECs 
HUVECs were infected with 30 PFU/cell adenoviruses expressing either constitutively active AMPK 
(Ad.AMPK-CA), dominant negative mutant AMPK (Ad.AMPK-DN) or GFP (Ad.GFP) for 24 h. (A) 
Representative images of infected HUVECs stained with anti-tubulin antibodies (Abcam, ab6160 
for Ad.AMPK-DN and Ad.GFP infected cells, New England Biolabs, #2125 for Ad.AMPK-CA 
infected cells). DNA was stained with RedDot2. Ad.AMPKα1-DN infected cells were stained with 
anti-myc antibodies (Santa Cruz sc-40). GFP fluorescence is shown for Ad.GFP and Ad.AMPK-CA 
(which co-expresses GFP). (B) The proportion of binucleated cells was assessed in adenovirus 
infected cells. Data shown are the mean ± SEM % binucleated cells, *** p<0.005 relative to 
Ad.GFP-infected cells (one-way ANOVA), N=4. (C) Lysates were prepared from infected HUVECs 
and analysed by immunoblotting using the antibodies indicated. N=1.   
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Figure 3-18. The effect of AMPKα knockdown on the DNA content of HUVECs 
HUVEC cells were incubated with scrambled (Sc) siRNA or siRNA targeting AMPKα1 or AMPKα2 
for 48 h. (A) HUVECs were lysed and resolved by SDS-PAGE followed by immunoblotting using 
the antibodies indicated. Representative Immunoblots are shown. (B) Quantification of AMPKα1 
knockdown relative to GAPDH as mean ± SEM, N=2. (C) Quantification of AMPKα2 knockdown 
relative to GAPDH as mean ± SEM, N=2. (D) Representative flow cytometry scatter plot and 
histogram of proliferating HUVECs. Scatter plot showing FSC-A (forward scatter by area), PE-A 
(Phycoerythrin by area, used as a pseudo measurement for PI staining). Gating used is indicated. 
(E) HUVECs incubated with siRNA were stained with PI and DNA content assessed by flow 
cytometry. Representative scatter plots are shown. (F) Representative histograms of siRNA treated 
HUVECs with Sc siRNA (blue) overlaid on AMPKα1/2 downregulation (pink) (G-K) Analysis of the 
mean ± SEM % cells. Data from two independent experiments are shown.   
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3.2.2.3 AMPK activity is important for the timing of mitosis 
To examine how AMPK function may regulate the timing of the cell cycle, 
HUVECs were synchronised using a double thymidine block to arrest in S phase. 
When cells were released from the block they were incubated with compound C 
(10 μM) and either lysed for immunoblotting or fixed with 4% (w/v) PFA for 
assessment by confocal microscopy. Cyclin B1 (a key mitotic regulator) (Pines 
and Hunter, 1989), expression peaked between 6-8 h post release (Figure 3-19. 
Compound C caused a delay in cyclin B1 expression until 13 h post-release 
(Figure 3-19). Examination of cells by confocal microscopy, revealed that cells 
which were incubated with DMSO were undergoing telophase 8 h post block, 
whereas compound C delayed mitotic entry, with cells undergoing metaphase 
after 12 h (Figure 3-19).  
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Figure 3-19. The effect of compound C on the timing of mitosis 
HUVECs were synchronised using a double thymidine block. Cells were released from S-phase 
block and treated with DMSO or 10 μM compound C. Cells were incubated as required and either 
lysed for immunoblotting or fixed with PFA and examined by confocal microscopy. (A) Lysates 
were resolved by SDS-PAGE and immunoblotted with the antibodies detailed. (B) Analysis of 
cyclin B1 expression relative to GAPDH expression. (C) Cells were stained with anti-tubulin 
antibodies (Abcam, ab6160) and for DNA (RedDot2). Representative images of cells 8 or 12 h 
following block. N=1. Scale bar represents 20 μm.  
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3.3 Discussion 
3.3.1 Principal findings 
 A novel subcellular localisation for AMPKα1 was described; the subunit 
isoform was detected at the MTOC of HeLa cells and HUVECs 
 AMPKα2 was confirmed to localise to the midbody in both primary cells 
(HUVECs) and shown to occur in HeLa cells for the first time 
 Compound C causes increased rates of binucleation in HeLa cells but not 
in HUVECs 
 Viral delivery of a constitutively active AMPK mutant reduced binucleation 
rates of HUVECs 
3.3.2 Localisation of AMPK mitosis 
A previously published study reported that during cytokinesis AMPKα2 localised 
to the midbody, cytoplasm, membrane and nucleus of HUVECs, whereas AMPKα1 
localised to the cytoskeletal fraction (Pinter et al., 2012). The midbody 
localisation of AMPKα2 was confirmed in this Chapter, and a novel localisation 
for AMPKα1 (but not AMPKα2) was described at the MTOC. Despite AMPKα1 
immunoreactivity being observed at the MTOC there was no obvious co-
localisation with other microtubules instead appearing diffuse in the cytoplasm. 
Anti-AMPKα2 immunoreactivity at the midbody (but not the MTOC or the spindle 
midzone) was also observed in HeLa cells. Furthermore, AMPKα2 
immunoreactivity was observed in the cytoplasm and the nuclei of telophase 
cells. The nuclear localisation of AMPKα2 is consistent with previous reports in 
HUVECs and the rat INS-1 cell line (Salt et al., 1998; Pinter et al., 2012).  
To circumvent potential non-specific binding of anti-AMPKα antibodies, HeLa 
cells were transfected with plasmids encoding GFP-AMPKα fusion proteins, which 
would also enable live cell imaging to examine the spatio-temporal dynamics of 
AMPK in the cell cycle. Unfortunately, following plasmid DNA transfection the 
majority of cells became senescent with few GFP positive cells undergoing 
mitosis. These issues were further complicated when GFP itself was found to 
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localise to the midbody, whereas other studies have not reported GFP 
localisation to the midbody in HeLa cells (Neto et al., 2013). In future the 
transfection protocol should be optimised and alternatives techniques such as 
electroporation examined.  
Phospho-T172 AMPK has previously been described at the midbody in human 
epidermoid carcinoma A431 cells and at the MTOC in a number of cell lines 
including A431 cells, HeLa cells, human lung carcinoma H1299 cell line and 
marsupial PtK1 cells (Vazquez-Martin et al., 2009; Thaiparambil et al., 2012). In 
agreement, this study found phospho-T172 AMPK localisation at the MTOC and 
midbody of HeLa cells and in primary human cells (HUVECs) with two different 
antibodies. The selectivity of one of the anti-phospho-T172 AMPK (sc-101630) 
antibodies was investigated utilising wild type and AMPK -/- MEFs. Cytosolic and 
midbody immunoreactivity was observed at comparable level in both wild type 
and AMPK -/- MEFs (Figure 3-7). This suggests that the anti-phospho-T172 AMPK 
antibodies lack specificity. This therefore casts doubt on the authenticity of 
phospho-T172 AMPK localisation to the midbody. Phospho-T172 AMPK MTOC 
localisation couldn’t be assessed in MEFs as cells in early phases of mitosis 
weakly adhered to the Ibidi chambers and were inadvertently washed off during 
staining. The immunoreactivity in AMPK -/- MEFs is therefore likely non-specific, 
although it may be possible that the anti-phospho-T172 AMPK antibodies could 
recognise the orthologous phosphorylated site on an AMPK-related kinase family 
member (Lizcano et al., 2004).  
The subcellular localisation of the AMPK substrate, phospho-S79 ACC has been 
reported to follow the same subcellular localisation as phospho-T172 AMPK 
(Vazquez-Martin et al.,2013; Vazquez-Martin et al.,2009). In the current study, 
anti-phospho-S79 ACC immunoreactivity was observed in the cytoplasm of 
HUVECs but no staining was observed at either the MTOC or midbody (Figure 3-
8). Consistent with the observation of ACC in the cytoplasm, ACC1 (the 
predominant isoform in HUVECs) has been reported to be predominantly 
cytosolic whereas ACC2 is associates with mitochondria in primary neonatal rat 
cardiomyocytes, mouse skeletal muscle cells and cancer cell lines (HepG2 and 
T47D cells) (Abu-Elheiga et al., 2000; Glatzel et al., 2018).  
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The differences in phospho-S79 ACC localisation between A431 cells and HUVECs 
may in part be due to the cells having different AMPK regulation/activity. A431 
cells have over activation of AMPK whereas HUVECs have a low basal AMPK 
activity, which might affect this localisation (Mizrachy-Schwartz et al., 2011). It 
is proposed that in A431 cells, AMPK is recruited to the MTOC/midbody where 
ACC is phosphorylated, in HUVECs however, AMPK localises to the MTOC and 
midbody but may not phosphorylate ACC. Potentially this could either be due to 
limited AMPK activity, AMPK having a higher affinity for alternative substrates 
during mitosis or that ACC may not be recruited/be excluded from these 
structures. At the midbody, diffusion from the cytoplasm is restricted (Schmidt 
and Nichols, 2004), thus if ACC was not actively transported to the midbody, 
phospho-S79 ACC would not be observed. When assessed by immunoblotting, 
A769662 induced an increase in phospho-S79 ACC, yet no increase in 
immunofluorescence intensity was observed by confocal microscopy, which may 
cast doubt on the specificity of the antibody.  
3.3.3 AMPK activity and the cell cycle 
3.3.3.1 Down regulation of AMPK activity 
Assessing binucleation as a readout of failed cytokinesis is an established way to 
discern how pharmacological and genetic manipulations influence mitosis 
(Vazquez-Martin et al., 2011; Högnäs et al., 2012; Neto et al., 2013). In line 
with the results presented in this study, HeLa cells have been shown to have a 
basal binucleation rate of approximately 3% (Neto et al., 2013). Incubation of 
HeLa cells with compound C caused a modest but significant increase in the 
proportion of binucleated cells. Furthermore, compound C caused an increase in 
the proportion of cells with 4n DNA content when assessed by flow cytometry. A 
4n DNA content could represents either cells in G2/M-phase or binucleated cells. 
Since flow cytometry cannot differentiate between cells in G2/M-phase or 
binucleated cells, it is important to interpret flow cytometry results in tandem 
with microscopic assessment of cells. Taken together it is clear that compound C 
increased binucleation in HeLa cells. Similarly, in U2OS cells, an osteosarcoma 
cell line, compound C caused a 3-fold increase in multinucleated cells (Banko et 
al., 2011).  
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However, in HUVECs compound C did not alter the proportion of cells with 4n 
DNA content or binucleation. Instead, compound C caused an increase in the 
proportion of HUVECS with 2n DNA content and a decrease in the proportion of 
2-4n and >4n cells. In HUVECs, compound C has a documented anti-proliferative 
role, however this may be AMPK-independent (Esfahanian et al., 2012; Liu et 
al., 2014). Therefore, the reduction in HUVECs with 2-4n DNA may represent cell 
cycle arrest prior to S-phase with cells accumulating with 2n DNA in G1 or G0 
phase. In both HeLa cells and HUVECs, compound C significantly reduced cell 
viability and proliferation when measured by MTS or BrdU assay respectively. In 
a different primary endothelial cell line, human aortic endothelial cells (HAECs), 
5 µM compound C did not alter the cell viability (Reihill et al., 2011), whereas in 
this Chapter 5 µM compound C caused a significant reduction in HUVEC viability. 
The sensitivity to compound C may reflect the different vascular origins of 
HUVECs and HAECs in addition to the juvenile/adult sources respectively.  
Unexpectedly, wild type and AMPK -/- MEFs responded differently to PI staining. 
Wild type MEFs incubated with DMSO showed two peaks of PI staining at 
approximately 90K (2n DNA content) and 150K (4n DNA content), whereas in 
AMPK -/- cells, peaks were apparent at 70K and 130K, indicating an overall 
reduction in PI staining. Potentially AMPK -/- MEF DNA may be less accessible to 
PI resulting in less PI intercalation and thus less fluorescence.  
Compound C drastically altered both wild type and AMPK -/- MEF DNA content 
which made the gating of distinct populations difficult. Rather than having two 
distinct peaks of PI staining, compound C caused a broad spread of cell staining. 
Furthermore, comparison of wild type and AMPK -/- MEFs treated with 5 μM 
compound C indicated that the cells responded differently. Wild type MEFs had a 
peak at approximately 130K for PI staining, a lower value than would be 
expected for a 4n population as discussed above. When the gating of DMSO 
control cells was applied to wild type cells it was apparent that there were 
almost no cells in the 4n DNA population. This may indicate that compound C 
caused cell cycle arrest during S-phase. Consistently, wild type cells had an 
increase in the proportion of cells with 2-4n DNA content after compound C 
incubation although this did not achieve statistical significance (p=0.12). 
Therefore wild type MEFs may initiate S-phase but arrest during the DNA 
replication process. In contrast, AMPK -/- MEFs treated with 5 µM compound C 
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had a broad spread of cell populations including cells with 4n DNA content, 
implying that the S-phase block induced by compound C was AMPK-dependent. 
As the individual populations could not be differentiated by gating following 
compound C treatment this may have introduced artefacts.  
A higher concentration of compound C (10 μM) reduced both wild type and AMPK 
-/- MEF viability and proliferation (Figure 3-17). Interestingly, 5 μM compound C 
did not reduce AMPK -/- cell viability but significantly reduce wild type MEF 
viability (Figure 3-17). This indicated that the reduction in cell viability (or 
mitochondrial activity) induced by 5 µM compound C was AMPK-dependent. Both 
genotypes were effected equally with higher concentrations of compound C. In 
contrast, 5 µM and 10 µM compound C reduced proliferation in both genotypes 
indicating it was an AMPK-independent effect (Figure 3-17). Compound C is at 
best a poorly-selective AMPK inhibitor, having been reported to inhibit a number 
of kinases in vitro to a greater extent than the inhibition of AMPK (Bain et al., 
2007). 
During the course of this investigation, the ULK1 inhibitor, SBI-0206965 was 
described to be a potent inhibitor of AMPK (Dite et al., 2018), in HUVECs 
concentrations greater than 10 µM SBI-0206965 inhibited AMPK. At higher 
concentrations (30 µM) it appeared that SBI-0206965 reduced the proportion of 
cells with 2-4n DNA and may also reduce the proportion of cells with 4n DNA 
content, however more replicates would be necessary before statistical analysis 
could be carried out. Similarly to compound C, SBI-0206965 also reduced HUVEC 
viability and proliferation. As SBI-0206965 was originally described as an 
inhibitor of ULK1 the apparent anti-proliferative effects of SBI-0206965 (and 
potentially compound C) could be mediated through the inhibition of autophagy 
as AMPK and ULK1 are both central regulators of the autophagy pathway (Egan 
et al., 2015). 
During autophagy cellular component such as proteins and organelles are 
digested to generate nutrients and energy to maintain cellular homeostasis. 
When nutrients are available, AMPK is inhibited whereas mTOR is active 
promoting proliferation while also inhibiting autophagy through the 
phosphorylation of ULK1 (Chan, 2009; Egan et al., 2011). However, when the 
energy state of the cell is low, AMPK is activated which phosphorylates and 
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activates ULK1 thereby promoting autophagy (Egan et al., 2011). Furthermore, 
AMPK inhibits mTOR to relieve the inhibitory phosphorylation of ULK1 (Inoki et 
al., 2003; Egan et al., 2011). Interestingly, autophagy has recently been 
implicated to play a role in mitosis and cell cycle progression. During mitosis 
autophagy is inhibited in part through the phosphorylation of Vps34 by CDK1 
(Eskelinen et al., 2002; Furuya et al., 2010). Mitotic inhibition of autophagy is 
thought to protect DNA from degradation following nuclear envelope breakdown 
and Golgi dispersion. Autophagy then recommences at the end of telophase and 
in G1 when DNA is no longer vulnerable in the cytoplasm (Eskelinen et al., 2002). 
Vps34, a phosphatidylinositol-3-phosphate (PtdIns3P) kinase class III (PI(3)K-III) 
and has a role in both autophagy and cytokinesis. Vps34 produces the 
phospholipid PtdIns3P at the midbody (at a time coinciding with increased 
autophagy), which recruits the centrosomal proteins FYVE-CENT and TTC19 
which in turn recruit the ESCRT-III component CHMP4 to mediate abscission 
(Sagona et al., 2010, 2011; You et al., 2016). Downregulation of the PI(3)K-III 
machinery cause cells to arrest during cytokinesis resulting in binucleation 
(Sagona et al., 2010). Thus, the inhibition of AMPK/ULK1 by compound C/SBI-
0206965 may arrest the cell cycle or cause defective cytokines by altering 
autophagy.  
As compound C is poorly-selective and SBI-0206965 inhibits both ULK1 and AMPK 
a genetic means of downregulating AMPK activity was employed (Egan et al., 
2015; Dite et al., 2018). To this end, HUVECs were infected with adenoviruses 
which expressed a dominant negative form of AMPKα1 (Ad.AMPKα1-DN) (Woods 
et al., 2000). The dominant negative AMPKα1 (α1DN) contained a D157A 
mutation rendering it catalytically inactive. α1DN is said to function in a 
dominant negative manner by competing with endogenous α subunits to bind 
with the regulatory β and γ subunits (Woods et al., 2000). However, due to the 
presence of endogenous AMPKα subunits, expression of α1DN does not 
completely abolish AMPK activity (Woods et al., 2000). Expression of α1DN in 
proliferating HUVECs caused a reduction in the proportion of binucleated cells 
compared to Ad.GFP infected cells but did not reach statistical significance 
(p=0.11). Cells infected with Ad.GFP appeared to have increased instances of 
binucleation, where approximate 30% of infected HUVECs were binucleated in 
contrast to ~10% binucleated HUVECs when incubated with DMSO. Ideally an 
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Ad.Null control would have been carried out to discern if the increase in 
binucleation was due to viral infection or the overexpression of viral 
proteins/GFP. Previously HeLa cells infected with Ad.Null viruses have not been 
reported to have increased instance of binucleation so it is unlikely that 
adenovirus infection is always associated with binucleation (Neto et al., 2013). 
As HUVECs are a primary cell line, they may be more sensitive viral infection and 
the hijacking of the transcription/translation machinery which may in turn cause 
mitotic failure.  
Although infection of cells with Ad.AMPK-DN downregulated AMPK activity, there 
was overexpression of α1DN which may influence signalling pathways mediated 
through protein-protein interactions. Therefore, AMPKα subunits were 
downregulated by incubation of HUVECs with targeted siRNA. AMPKα1 protein 
expression was reduced by 46.4 ± 12% and AMPKα2 by 65.3 ± 24.5% relative to 
cells incubated with Sc siRNA. Unexpectedly, downregulation of AMPKα1 caused 
an increase in AMPKα2 expression by 110% ± 64% (Figure 3-19). This is a novel 
observation and may reflect an adaptive mechanism of HUVECs to compensate 
for the loss of AMPKα1, the predominant α-subunit in these cells.  
Assessment of siRNA treated cells by flow cytometry indicated that there was a 
sub-population of cells which had a small size and fit into the 2n DNA population 
gate, termed “microcells”. As microcells were produced following incubation 
with Sc siRNA but not pharmacological tools, it is likely that they formed as a 
consequence of the transfection protocol. When cells were assessed by 
immunofluorescence, no unusual cell morphology was apparent (data not 
shown). To determine if the cells were apoptotic, co-staining for annexin could 
be carried out.  
Downregulation of AMPKα1 caused a decrease in the proportion of cells with 4n 
DNA whereas knockdown of AMPKα2 did not alter the DNA content of HUVECs. 
However, accurate gating of cell populations was difficult due to the unusual 
spread of cell populations, therefore the quantification may be skewed by the 
gating applied. Examination of the histogram overlay of Sc siRNA versus AMPKα1 
siRNA-treated cells showed that the number of cells at approximately 50K PE-A 
appeared identical in both cases. This region correlated to 4n DNA so it is likely 
that AMPKα1 knockdown does not influence HUVEC DNA content. This is 
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consistent with a previous report in U2OS cells where expression of shRNA to 
both AMPKα1 and AMPKα2 did not increase in the proportion of multinucleated 
cells (Banko et al., 2011).  
To investigate how AMPK inhibition by compound C may influence mitosis, 
HUVECs were synchronised to S-phase using a double thymidine block. When 
cells were released from the block they were incubated with either compound C 
or DMSO vehicle control. Cells which were incubated with DMSO entered 
telophase 8 h post release whereas compound C appeared to delay mitotic 
entry/progress, cells were observed to undergo metaphase 12 h after the block. 
Ideally this preliminary work would be replicated a number of times and 
evaluation of DNA content by flow cytometry following synchronisation and 
incubation with compound C treatment.  
As both the AMPKα subunits are genetically deleted in the AMPK -/- MEFs, they 
are a model where there was complete downregulation of AMPK. As such AMPK 
must not be essential for the cell cycle otherwise the cell line would not be 
viable. Assessment of the MEFs by flow cytometry revealed no difference in the 
proportion of cells with 2n, 2-4n, 4n or <4n DNA content between the two 
genotypes. In AMPK -/- MEFs the mitotic role of AMPK could instead be carried 
out by an AMPK-related kinase (ARK) enabling the cells to divide normally. 
Alternatively AMPK may play a more subtle role in MEF mitosis which does not 
severely influence the cell cycle when AMPK is absent.  
3.3.3.2 Up regulation of AMPK activity  
As HeLa cells and HUVECs have low basal AMPK activity, down regulation of 
AMPK may have limited effects. Therefore, upregulation of AMPK activity may be 
more informative to determine how AMPK can regulate the cell cycle. Incubation 
of HeLa cells with A769662 did not alter binucleation, DNA content or cell 
viability but reduced proliferation. As A769662 reduced proliferation, it was 
surprising there was not an associated reduction of cells with 2-4n DNA. 
Conversely, synchronised U2OS cells have been reported to exhibit a significant 
increase in multinucleated cells following incubation with A769662 (Banko et al., 
2011). This may be due to the cells being synchronised at metaphase prior to 
acute incubation with A769662. It is possible that during metaphase over 
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activation of AMPK may cause mitotic failure, whereas chronic incubation (18-24 
h) of unsynchronised cells may not produce the same effect.  
In HUVECs A769662 did not alter the DNA content of cells or proliferation 
although a reduction in viability was apparent. Additionally in MEFs, A769662 did 
not alter the DNA content in cells of either genotype. A769662 reduced both wild 
type and AMPK -/- MEF proliferation to a comparable extent, indicating that the 
reduction in MEF proliferation was AMPK-independent. A769662 also likely has 
cell-type specific effects, reducing proliferation in HeLa cells and MEFs without 
altering HUVEC proliferation. Conversely A769662 did not lower the viability of 
HeLa cells or MEFs but reduced HUVEC viability/mitochondrial activity. These 
cells likely have different metabolisms; HeLa cells (like most cancer cells) 
exhibit Warburg metabolism where cells generate the majority of their ATP by 
glycolysis (Warburg, 1925; Amemiya et al., 2017). Thus, HeLa cells are less 
dependent on mitochondrial respiration so the results obtained from MTS assays 
may not be the same observed in primary cells.  
When assessed by flow cytometry, A769662 caused a substantive right-shift 
(towards higher PI staining) in AMPK -/- MEFs, whereas wild type MEFs and 
HUVECs were unaffected. This right shift aligned the histogram of AMPK -/- cells 
with that of wild type cells. When cells were manually gated, the percentage of 
cells in each population was comparable with both AMPK -/- cells incubated with 
DMSO and wild type MEFs incubated with A769662. This could indicate that 
functionally A769662 did not affect the cell cycle but altered how cells respond 
to PI staining rather than causing a partial increase in the DNA complement.  
MetSal drastically altered AMPK -/- MEF DNA content, whereby there was a large 
left shift compared to DMSO control MEFs. This shift was not observed in wild 
type MEFs. A left shift/a population of cells with <2n DNA could potentially 
represent cells undergoing apoptosis/necrosis or “microcell” formation. 
Metformin is a mild mitochondrial toxin causing an increase in intracellular AMP 
(Zhou et al., 2001). It is possible that AMPK -/- MEF were unable to withstand 
the metabolic stress induced by metformin and became apoptotic. However, 
canagliflozin activates AMPK in a similar manner as metformin, and left shift was 
not observed (Zhou et al., 2001; Hawley et al., 2016). Furthermore, neither 
canagliflozin nor MetSal affected cell viability/mitochondrial activity of MEFs 
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when assessed by MTS assay. Apoptosis was not apparent when HUVECs when 
assessed by microscopy, so this may be a facet of AMPK -/- MEFs.  
Consistent with observations made in HUVECs, canagliflozin has previously been 
reported to reduce cell viability but not proliferation (Mancini et al., 2018). 
AICAR (2 mM) and A79662(10 µM) has also been reported to reduce HAEC viability 
(Reihill et al., 2011). The present study showed that both compounds reduced 
HUVEC proliferation albeit at different concentrations (1 mM AICAR and 50 µM 
A769662). AICAR has also been shown to inhibit HUVEC proliferation between 50-
500 µM (Peyton et al., 2012). Additionally, A769662 (300 µM) and metformin (2 
mM) were reported to reduce HUVEC proliferation and DNA synthesis arresting 
cells in G0/G1 by increasing expression of the CDKIs p21 and p27, and increasing 
p53 protein levels and its phosphorylation while decreasing cyclin A and Rb 
phosphorylation (Peyton et al., 2012). In the present study, neither AICAR (1 
mM) nor A769662 (50 µM) reduced HUVEC proliferation, however, different 
concentrations of each drug was used in the present study. It is unlikely that the 
differences in concentration would make a substantial difference as the higher 
AICAR concentration used in the current study would still be expected to 
activate AMPK and the lower concentration of A76962 (50 µM) used in this study 
was sufficient to increase AMPK activity.  
HUVECs were infected with adenoviruses containing a gene for a constitutively 
active form of AMPK (Ad.AMPK-CA), which is composed of the first 312 amino 
acids of AMPKα1 with a T172D mutation and an N-terminal myc tag (Woods et 
al., 2000). Expression of constitutively active AMPK caused a significant 
reduction in the proportion of binucleated cells compared to Ad.GFP infected 
cells. Ad.AMPK-CA infection reduced binucleation to approximately 10%, in line 
with basal HUVEC binucleation rates. Thus constitutively active AMPK was able 
to prevent adenovirus induced binucleation demonstrating a role of AMPK to 
control the fidelity of cytokinesis.  
3.3.4 Summary  
While there is evidence supporting AMPKα subunit localization during mitosis, 
there are caveats that require resolution. MTOC/midbody localisation has been 
observed using anti-AMPKα1, anti-AMPKα2 and two different anti-phospho-T172 
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AMPK in HeLa cells and HUVECs. However midbody immunoreactivity of phospho-
T172 AMPK was observed in AMPK -/- MEFs suggesting that the anti-phospho-
T172 AMPK antibody lacks specificity. Collectively, the experiments outlined in 
this Chapter suggest that AMPK activity is important for the timing of the cell 
cycle and mitosis. Alterations in AMPK activity affected cell cycle progression 
and the fidelity of cytokinesis. Interestingly, the subcellular localisation of AMPK 
shows a considerable overlap with a number of mitotic proteins including PLK1 
(Vazquez-Martin et al., 2011). Additionally, the PLK1 inhibitor GW843682X, 
abolishes AMPK recruitment to the MTOC and midbody and causes binucleation in 
A431 cells (Vazquez-Martin et al., 2011).The signalling pathways AMPK may 
regulate during mitosis remain unclear and in the following Chapters the 
interaction between AMPK and well-established mitotic regulators will be 
investigated. 
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4 Chapter 4-Using fission yeast to investigate the 
role of AMPK in mitosis 
4.1 Introduction 
S. pombe is a popular model organism in the study the cell cycle due to the high 
degree of conservation between S. pombe and humans as well as the relative 
ease of study of this organism in the lab. Importantly, the genome of S. pombe 
has been sequenced making it a useful model for genetic screens such as the one 
outlined in this Chapter (Wood et al., 2002). A number of proteins are known to 
have crucial roles in regulating mitosis and cytokinesis in all eukaryotic 
organisms, these include the aurora kinase family (Ark1p in S pombe), anillin 
(Mid1p), polo-like kinase (Plo1p), and the ESCRT proteins (Bähler et al., 1998; 
Wu et al., 2003; Musab S Bhutta et al., 2014). Human and S. pombe orthologues 
are summarised in Table 4-1, an outline of ESCRT orthologues can be found in 
Table-4-3. 
Human protein S. pombe protein 
AMPKα Ssp2p 
AMPKβ Amk2p 
AMPKγ Cbs2p 
Aurora kinase Ark1p 
Anillin Mid1p 
Polo-like kinase Plo1p 
Table 4-1. Comparison of mammalian and S. pombe orthologues.  
 
Accumulating evidence has indicated a role for AMPK during the cell cycle, such 
as the alterations in polyploidy in response to AMPK activity modulation and the 
localisation of AMPK in mitosis (detailed in Chapter 3). However, the mechanism 
by which AMPK signalling regulates mitosis is unknown. To address this, a yeast 
genetic approach was used to identify novel interactions between AMPK and a 
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number of key regulators of mitosis and cytokinesis. Fission yeast with 
chromosomal deletions of either the AMPK subunits; ssp2 (α subunit orthologue), 
amk2 (β subunit), cbs2 (γ subunit) or ssp1 (CaMKK orthologue), were individually 
crossed with yeast strains containing mutations in genes encoding proteins 
known to have significant roles in the cell cycle, namely ark1, plo1, mid1 and 
various ESCRT genes. Double mutant strains were isolated by tetrad analysis or 
random spore analysis and examined for the presence of so-called “synthetic 
phenotypes”. Such synthetic phenotypes are apparent in double mutant strains, 
but absent in single mutant strains. The appearance of a synthetic phenotype 
provides evidence of a genetic interaction between the two genes, suggesting a 
functional interaction between the encoded proteins. Thus this genetic approach 
was used to identify novel interactions between AMPK and other proteins 
required for cytokinesis.   
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Results 
4.1.1 AMPK has a role in cytokinesis in S. pombe 
To examine how AMPK may influence S. pombe cytokinesis, septation was 
assessed using Calcofluor-White staining in ssp1Δ, ssp2Δ, amk2Δ and cbs2Δ 
strains (Rezig et al., 2019). The relative frequency of previously described 
“septation phenotypes” were classified as follows (Class A-F as described in 
Bhutta et al., 2014, Class G noted in this study): 
 Class A-centrally positioned septa 
 Class B-non-central septa 
 Class C-misaligned septa 
 Class D-multiple septa 
 Class E-absent septa 
 Class F-delayed separation after septation 
 Class G-ectopic deposition of septa material 
Wild type cells predominantly displayed the Class A phenotype (~80% of cells), 
the next most frequent phenotype was Class F (~20% cells) with very few cells 
having any other septation phenotypes (Figure 4-1). Wild type cells had a Class 
A:F ratio of 4.61 (Figure 4-1). In contrast, chromosomal deletion of ssp2, cbs2, or 
ssp1 caused a significant increase in the proportion of cells with the Class F 
phenotype coinciding with a reduction in the proportion with the Class A 
phenotype (Figure 4-1). Although alterations in the septation phenotype of 
amk2Δ cells did not achieve statistical significance, there was a trend to 
increased Class F phenotype (p=0.16) and reduced Class A phenotype 
respectively (p=0.17), as well as a shift in the ratio of Class A:F phenotype 
(Figure 4-1). Overall, these observations demonstrate that AMPK is involved in 
efficient septation and thus cytokinesis in S. pombe.   
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Figure 4-1. Chromosomal deletions of genes encoding AMPK subunits or ssp1 alter 
septation in S. pombe. 
(A) Representation of the different septation phenotypes, showing either Calcofluor-White staining 
(upper) or illustration (lower). (B) Wild type (GG1278), ssp2Δ (GG3033), amk2Δ (GG2981), cbs2Δ 
(GG2981) and ssp1Δ (GG3080) strains were cultured in liquid YE media at 30oC for 18 h. Division 
septa were visualised using Calcofluor-White staining followed by fluorescence microscopy where 
the frequency of each phenotype was recorded. At least 300 cells were counted over three 
technical replicates which was performed on three independent occasions for each genotype. (C) 
Quantification of Class A:F phenotypes ± SEM. (D) Representative images of Calcofluor-White 
stained cells. Scale bar represents 20 μm. * p< 0.05, ** p< 0.01 relative to wild type (Students t 
test).  
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4.1.2 Generation of double mutant strains 
To identify novel interaction between AMPK and proteins involved in mitosis, a 
synthetic phenotype screen was undertaken. Yeast strains with individual 
chromosomal deletions of either ssp2, amk2, cbs2 or ssp1 were crossed with 
strains containing mutations in genes with established roles in cytokinesis. Such 
strains included: temperature sensitive mutation in the aurora kinase ark1 (ark1-
T8 (Koch et al., 2011)); a temperature sensitive mutations in polo-like kinase 
plk1 (either the plo1-ts18 or plo1-ts35 allele (Anderson et al., 2002)); 
chromosomal deletion of the anillin mid1 (mid1Δ (Sohrmann et al., 1996)); or 
chromosomal deletion of selected ESCRT proteins (sst4Δ, sst6Δ, vps28Δ, vps36Δ, 
vps35Δ, vps20Δ, vps32Δ, vps2Δ or vps4Δ (Iwaki et al., 2007)). Double mutant 
strains were either generated by tetrad analysis or random spore analysis 
(detailed in Section 2.25). 
During tetrad analysis, two yeast strains of opposite mating type were mixed and 
incubated on solid ME media to induce mating and tetrad formation (Rezig et 
al., 2019). Mating mixture was transferred to solid YE media and tetrads isolated 
using a micro-manipulator. Ascus wall breakdown was induced by incubation at 
37oC and individual spores were separated. Cells were incubated until colonies 
formed and genotype interrogated by replica-plating onto selection media. 
Representative tetrad crosses are shown in Figure 4-2. Once double mutants 
were identified, they were allocated a “Glasgow” (GG) number and stored in the 
laboratory collection at -80oC. Table 4-2 outlines the double mutant strains 
generated through the course of this investigation. A full list of strain list can be 
found in Appendix 1.  
As the chromosomal deletion of ssp2, amk2, cbs2 and ssp1 have been reported to 
reduce S. pombe mating efficiency (Valbuena and Moreno, 2012), random spore 
analysis was utilised as a way to generate double mutant cells more efficiently. 
In random spore analysis, the mating mixture is incubated with β-glucuronidase 
to digest vegetative cells and the ascus membrane without affecting ascospores. 
Ascospores were incubated until colonies formed, isolated and the genotype 
analysed by replica plating to identify double mutant cells (Figure 4-3). 
However, if both parental strains were tagged with the same auxotrophic 
marker/antibiotic resistance cassette, tetrad analysis was necessary.   
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Figure 4-2. Representative examples of S. pombe double mutant isolation by tetrad analysis  
(A) Cells containing a chromosomal deletion of cbs2Δ tagged with a kanamycin resistance cassette 
(cbs2::KanMX4, GG2980) were crossed with cells containing a deletion of the ESCRT gene 
vps20Δ tagged with an auxotrophic uracil marker (vps20::ura4+, GG1619). Resulting tetrads were 
isolated and incubated until colonies formed. Plates were replica-plated onto selective media; solid 
YE media containing the antibiotic G418 or minimal media (EMM) lacking uracil. Double mutant 
cells could then be identified and were allocated the “Glasgow” reference numbers (GG3015 or 
GG3016). (B) Tetrad analysis of a cross between strains amk2::KanMX4 (GG2981) and 
vps25::ura4+ (GG1618). A double mutant strain is indicated with a red circle and allocated the 
reference GG3044.  
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Figure 4-3. Representative example S. pombe double mutant isolation by random spore 
analysis 
A strain containing a chromosomal deletion of amk2 tagged with a kanamycin resistance cassette 
(amk2::KanMX4, GG2979) was crossed with a strain containing a chromosomal deletion of the 
ESCRT protein vps36 tagged with an auxotrophic uracil marker (vps36::ura4+, GG1617). The 
mating mixture was incubated with β-glucuronidase to digest ascus membranes and vegetative 
cells. The resulting mixture was incubated on solid YE media until colonies formed. Colonies were 
transferred to solid YE media followed by replica-plating onto selective media in order to identify 
double mutant strains, indicated with red circles.  
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Genotype ssp2Δ amk2Δ cbs2Δ ssp1Δ 
sst4Δ  GG2995 
GG2996 
GG2997 
GG3012 
GG3013 
GG3014 
GG3128 
GG3129 
GG3130 
sst6Δ  GG3006 
GG3007 
GG3075 
GG3108 
GG3109 
GG3110 
GG3090 
GG3121 
GG3122 
vps28Δ  GG3008 
GG3055 
GG3076 
GG3084 
GG3085 
GG3086 
GG3087 
GG3088 
GG3089 
vps36Δ  GG3175 
GG3176 
GG3177 
GG3029 
GG3030 
GG3031 
GG3137 
GG3138 
GG3139 
vps25Δ GG3064 
GG3065 
GG3044 
GG3045 
GG3046 
GG3068 
GG3069 
GG3083 
 
vps20Δ  GG2998 
GG2999 
GG3000 
GG3015 
GG3016 
GG3017 
GG3116 
GG3123 
GG3124 
vps32Δ  GG3009 
GG3010 
GG3058 
 GG3131 
GG3132 
GG3133 
vps2Δ  GG3002 
GG3003 
GG3004 
GG3052 
GG3053 
GG3054 
GG3117 
GG3163 
GG3164 
vps4Δ  GG3050 
GG3051 
GG3071 
GG3056 
GG3131 
GG3135 
GG3125 
GG3126 
GG3127 
plo1-ts35 GG3092  
GG3093 
  GG2987 
GG2988 
GG2993 
plo1-ts18 GG3169 
GG3170 
GG3144 
GG3145 
GG1346 
GG3148 
GG3149 
GG3150 
GG3152 
GG3153 
GG3154 
ark1-T8 GG3057 
GG3073 
GG3074 
GG3081 
GG3082 
GG3077 
GG3078 
GG2983 
GG2989 
GG2990 
midΔ GG3099 
GG3160 
GG3161 
GG3097 
GG3098 
GG3113 
GG3094 
GG3095 
GG3096 
GG3166 
GG3167 
GG3168 
Table 4-2. Double mutant S. pombe strains generated in this study. 
Double mutant strains were allocated a Glasgow “GG” collection number and stored at -80oC in 
30% (v/v) glycerol. A full list of genotypes is shown in Appendix 1.  
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4.1.3 Attempted generation of ssp2::KanMX6 strain 
As the ssp2Δ strain in the lab collection (GG3033, original sourced from Dr. 
Petersen, Flinders University, Australia (Davie et al., 2015)) was tagged with a 
uracil auxotrophic marker (ssp2::ura4+), random spore analysis was not feasible 
to generate double mutant strains with many of the ESCRT deletion strains as 
most of the strains were also tagged with uracil auxotrophic markers. Therefore, 
attempts were made to generate a ssp2 chromosomal deletion strain tagged with 
a kanamycin resistance cassette (ssp2::kanMX6) based on a homologous 
recombination method (Bähler et al., 1998). 
Transforming DNA was generated by PCR using a plasmid encoding the kanMX6 
cassette and 100mer primers containing 20 bases homologous to the kanMX6 
module and 80 bases homologous to either the 5’ UTR (forward primer) or 3’ 
UTR (reverse primer) of the ssp2 gene (schematically shown in Figure 2-1, 
Section 2.22). Transforming DNA was generated using different combinations of 
forward and reverse primers each with different regions of homology to the 5’ or 
3’ UTR (Figure 4-4A). The combination of FW2 and RV2 did not generate a PCR 
product (data not shown).  
Transformation reactions were carried out as described (Section 2.22) and cells 
grown on solid YE media containing G418 until colonies formed. G418-resistant 
colonies were isolated and cultured in liquid YE media overnight at 30oC with 
shaking. Genomic DNA was isolated and PCR performed to determine if the 
correct recombination event occurred. PCR was performed using the “ssp2Δ 
primers” consisting of a forward primer that would recognise a sequences 5’ of 
the initial deletion primer and a reverse primer homologous to an area in the 
kanMX6 sequence (Figure 4.4B). To ensure that isolated DNA was of good quality, 
a PCR was carried out simultaneously using primers for the fkh2 gene that would 
generate a product similar in size to the ssp2Δ primers. A number of 
transformation reactions were performed and unfortunately it was not possible 
to generate the ssp2::KanMX6 strain (Figure 4-4B).  
  
 128 
 
 
Figure 4-4. Attempted generation of ssp2::KanMX6 S. pombe strain based on the 
homologous recombination method 
(A) Generation of linear transforming DNA by PCR using the kanMX6 plasmid backbone and a 
combination of different forward (FW) and reverse (RV) primers. A 1.6 kbp product was generated 
as expected. (B) PCR of genomic DNA from G418 resistant colonies (numbered 1-4) revealed no 
PCR product from the ssp2Δ checking primers. fkh2+ primers successfully produced a product of 
approximately 200 bp.  
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4.1.4 ark1 interacts genetically with ssp1, ssp2 and amk2 
Double mutant S. pombe strains were generated to contain a chromosomal 
deletion of either the ssp1, ssp2, amk2 or cbs2 gene and a temperature sensitive 
mutation in ark1 (ark1-T8). Double mutant strains were investigated for 
synthetic growth phenotypes by serial dilution onto solid YE media and 
incubation at different temperatures. ssp1Δ ark1-T8 double mutant strains 
showed less growth at 28oC and 30oC than either parental strain (Figure 4.5). 
This synthetic phenotype is indicative of a genetic interaction between the ssp1+ 
and ark1+ genes.  
To further analyse the synthetic phenotype of the ssp1Δ ark1-T8 cells, septation 
was analysed using Calcofluor-White staining. Double mutant cells showed a 
significant reduction in cells with the Class A phenotype compared to both 
parental strains (Figure 4-6). The double mutant cells also had a significant 
increase in the Class E (absent septa) phenotype compared to the parental 
strains. A significant increase in Class B, D and G phenotypes was found 
compared to ssp1Δ but were at a comparable frequency to that of ark1-T8 
(Figure 4-6). Interestingly, ssp1Δ ark1-T8 cells had similar levels of the Class F 
(reduced separation after septation) phenotype as wild type and ark1-T8 cells 
but approximately 20% less than ssp1Δ cells (Figure 4-6). 
 
Figure 4-5. Growth defects in ssp1Δ ark1-T8 double mutant cells. 
Wild type (GG1278), ssp1Δ (GG3080), ark1-T8 (GG2426) and three separate isolates of ssp1Δ 
ark1-T8 (GG2983, GG2989, GG2990) strains were suspended at 1.5x106 cell/ml and subjected to 
10-fold serial dilution. Cell suspension was pipetted onto solid YE media and incubated at the 
indicated temperatures for 3 days.  
  
 130 
 
 
Figure 4-6. Septation defects in ssp1Δ ark1T8 double mutant cells. 
Wild type (GG1278), ark1-T8 (GG2426), ssp1Δ (GG3080) and three separate isolates of ssp1Δ 
ark1-T8 (GG2983, GG2989, GG2990) strains were grown in liquid YE media for 18 h. Division 
septa were visualised using Calcofluor-White, examined by fluorescence microscopy and the 
frequency of each phenotype recorded. 300 cells in total were counted over three technical 
replicates, performed on three independent occasions for each genotype. (B) Quantification of 
Class A:F phenotypes ± SEM. (C) Representative images of Calcofluor-White stained cells. Scale 
bar represents 20 μm. * p< 0.05 relative to ssp1Δ, # p< 0.05 relative to ark1-T8, (Students t test).  
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Potential genetic interactions were next examined between ark1 and the AMPK 
subunit orthologues. ssp2Δ ark1-T8 cells exhibited increased growth compared to 
ark1-T8 cells at 25oC and 28oC, indicating a partial rescue of the ark1-T8 
phenotype, however, the cells had reduced growth compared to ssp2Δ cells 
(Figure 4.7A). amk2Δ ark1-T8 cells had reduced growth rates compared to the 
parental strains thereby demonstrating a synthetic phenotype (Figure 4-7B). In 
contrast, cbs2Δ ark1-T8 double mutant strains did not exhibit any apparent 
synthetic growth phenotypes and had a similar growth rate to ark1-T8 cells 
(Figure 4-7C). A table collating these results will be presented in the Discussion 
section (Table 4-3)  
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Figure 4-7. Growth defects in ssp2Δ ark1-T8, amk2Δ ark1-T8, and cbs2Δ ark1-T8 double 
mutant cells. 
(A) Wild type (GG1278), ark1-T8 (GG2426), ssp2Δ (GG3033) and three separate isolates of ssp2Δ 
ark1-T8 (GG3057, GG3073, GG3074). (B) Wild type (GG1278), ark1-T8 (GG2426), amk2Δ 
(GG2979) and two separate isolates of amk2Δ ark1-T8 (GG3081, GG3082). (C) Wild type 
(GG1278), ark1-T8 (GG2426), cbs2Δ (GG2981) and two separate isolates of cbs2Δ ark1-T8 
(GG3077, GG3078). Strains were suspended at 1.5x106 cell/ml and subjected to 10-fold serial 
dilution. Cell suspension was pipetted onto solid YE media and incubated at the indicated 
temperatures for 3 days.  
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4.1.5 plo1 interacts genetically with ssp1, amk2 and cbs2 
To investigate if the ssp1 and plo1 genes interacted, double mutant strains were 
generated containing a chromosomal deletion of ssp1 and a temperature 
sensitive mutation in plo1, either the plo1-ts35 or plo1-ts18 allele. ssp1Δ plo1-
ts35 cells displayed a synthetic growth phenotype where double mutant strains 
were more heat tolerant than plo1-ts35 cells, yet were not able to grow to the 
same extent as ssp1Δ cells (Figure 4-8A). A synthetic phenotype was also 
apparent in ssp1Δ plo1-ts18 cells; at 25oC ssp1Δ plo1-ts18 cells exhibited 
increased growth compared to both ssp1Δ cells and plo1-ts18 cells (Figure 4-8B). 
Double mutant cell growth appeared to be faster than that of plo1-ts18 but less 
than ssp1Δ at 35oC (Figure 4-8B).  
As ssp1Δ plo1-ts35 cells showed growth intermediate of the parental strains, the 
growth rate was analysed further in liquid media. Cells were seeded at 5 x105 
cells/ml in liquid YE media and cell number assessed over a 36 h period. This 
confirmed that ssp1Δ plo1-ts35 cells grew faster than plo1-ts35 cells but slower 
than ssp1Δ cells (Figure 4-9). Septation analysis of ssp1Δ plo1-ts mutants did not 
reveal any synthetic phenotypes (Figure 4-10). Notably, plo1-ts35 and ssp1Δ 
plo1-ts35 strains only exhibited Class G phenotype, with ectopic deposition of 
new cell wall.  
A synthetic growth phenotype was also apparent in amk2Δ plo1-ts18 and cbs2Δ 
plo1-ts18 strains (Figure 4-11). These double mutants showed increased growth 
at 25oC compared to the respective parental strains. However, ssp2Δ plo1-ts18 
strains had comparable growth to ssp2Δ parental strain (Figure 4-11). Calcofluor-
White staining and analysis of septation of amk2Δ plo1-ts18 cells did not reveal 
any obvious synthetic phenotype, instead these cells closely resembled the plo1-
ts18 parental strain (Figure 4-12A). Similarly, cbs2Δ plo1-ts18 cells showed a 
closer resemblance to plo1-ts18 cells than cbs2Δ cells (Figure 4-12B).   
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Figure 4-8. Synthetic growth defects in ssp1Δ plo1-ts double mutant cells. 
(A) Wild type (GG1278), plo1-ts35 (GG1167), ssp1Δ (GG2966) and three separate isolates of 
ssp1Δ plo1-ts35 (GG2989, GG2988, GG2993) (B) Wild type (GG1278), plo1-ts18 (GG380), ssp1Δ 
(GG3080) and three separate isolates of ssp1Δ plo1-ts18 (GG3152, GG3153, GG3154). Strains 
were suspended at 1.5x106 cell/ml and subjected to 10-fold serial dilution. Cell suspension was 
pipetted onto solid YE media and incubated at the indicated temperatures for 3 days. 
 
Figure 4-9. Growth defects in ssp1Δ plo1-ts35 cells grown in liquid YE media. 
Wild type (GG1278), plo1-ts35 (GG1167), ssp1Δ (GG2966) and three separate isolates of ssp1Δ 
plo1-ts35 (GG2989, GG2988, GG2993) were culture in liquid YE media in a shacking water bath at 
28oC for 36 h. Cell number was analysed using a Coulter Z2 cell counter.  
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Figure 4-10. Synthetic septation defects in ssp1Δ plo1-ts double mutant cells. 
(A) Wild type (GG1278), plo1-ts18 (GG380), plo1-ts35 (GG1167), ssp1Δ (GG2966 and GG3080), 
three separate isolates of ssp1Δ plo1-ts18 (GG3152, GG3153, GG3154) and three separate 
isolates of ssp1Δ plo1-ts35 (GG2989, GG2988, GG2993). Strains were cultured in liquid YE media 
at 30oC for 18 h. Division septa were visualised using Calcofluor-White, examined by fluorescence 
microscopy and the frequency of each phenotype recorded. 300 cells in total were counted over 
three technical replicates, performed on three independent occasions for each genotype. (B) 
Quantification of Class A:F phenotypes ± SEM. (C) Representative images of Calcofluor-White 
stained cells. Scale bar represents 20 μm. * p< 0.05 when comparing ssp1Δ to ssp1Δ plo1-ts18, 
### p< 0.005 when comparing ssp1Δ to ssp1Δ plo1-ts35 (Students t test). 
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Figure 4-11. Analysis of synthetic growth defects in ssp2Δ plo1-ts18, amk2Δ-plo1-ts18 and 
cbs2Δ-plo1-ts18 mutant strains. 
(A) Wild type (GG1278), ssp2Δ (GG3033), plo1-ts18 (GG380) and two separate isolates of ssp2Δ 
plo1-ts18 (GG3169, GG3170). (B) Wild type (GG1278), amk2Δ (GG2979), plo1-ts18 (GG380) and 
three separate isolates of amk2Δ plo1-ts18 (GG3144, GG3145, GG3146). (C) Wild type (GG1278), 
cbs2Δ (GG2981), plo1-ts18 (GG380) and three separate isolates of cbs2Δ plo1-ts18 (GG3148, 
GG3149, GG3150). Strains were suspended at 1.5x106 cell/ml and subjected to 10-fold serial 
dilution. Cell suspension was pipetted onto solid YE media and incubated at the indicated 
temperatures for 3 days. 
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Figure 4-12. Synthetic septation defects in amk2Δ plo1-ts18 and cbs2Δ plo1-ts18 double 
mutant cells. 
Division septa were visualised using Calcofluor-White, examined by fluorescence microscopy and 
the frequency of each phenotype recorded. 300 cells in total were counted over three technical 
replicates, performed on three independent occasions for each genotype. (A) Wild type (GG1278), 
plo1-ts18 (GG380), amk2Δ (GG2979) and three separate isolates of amk2Δ plo1-ts18 (GG3144, 
GG3145, GG3146) (B) Wild type (GG1278), plo1-ts18 (GG380), cbs2Δ (GG2981) and three 
separate isolates of cbs2Δ plo1-ts18 (GG3148, GG3149, GG3150). Strains were cultured in liquid 
YE media at 30oC for 18 h. (C) Quantification of Class A:F phenotypes ± SEM. (D) Representative 
images of Calcofluor-White stained cells. Scale bar represents 20 μm. * p< 0.05 comparing amk2Δ 
to amk2Δ plo1-ts18, # p< 0.05 comparing plo1-ts18Δ to ssp1Δ plo1-ts18, $ p< 0.05 comparing 
cbs2Δ to cbs2Δ plo1-ts18 (Students t test).  
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To further understand the genetic interactions noted between the AMPK 
pathway and ark1/plo1, ark1-GFP and plo1-GFP strains were acquired from the 
Japanese National BioResource Project. These stains which expressed GFP-fusion 
proteins were acquired with the aim of studying the subcellular localisation of 
Ark1p/Plo1p and to examine if localisation was altered upon the chromosomal 
deletion of AMPK subunits/ssp1. Strains were lysed and resolved by SDS-PAGE to 
determine the presence of a GFP-fusion protein by immunoblotting. No GFP or 
GFP-fusion proteins was detected from plo1-GFP cells at the expected molecular 
weight (27 kDa for GFP and ~110 kDa for Plo1p) (Figure 4-13). An 
immunoreactivite band was detected at ~75 kDa from ark1-GFP cells, 
corresponding to the expected molecular weight of the fusion protein (Figure 4-
13). Unfortunately, GFP fluorescence from ark1-GFP cells was very faint and 
could not be detected by confocal microscopy (data not shown). 
 
Figure 4-13. Plo1-GFP cells did not express GFP fusion protein. 
Wild type (GG1278), plo1-GFP (GG3226) and ark1-GFP (GG3227) strains were cultured overnight 
in liquid YE media at 30oC with shaking. Cells were lysed by incubation with 1% (v/v) Triton X-100 
solution containing phosphatase inhibitors followed by vortex mixing with HCl-washed glass beads. 
Resulting lysates were resolved by SDS-PAGE and immunoblotted with anti-GFP antibodies. In 
parallel, cell lysates prepared from HEK 293 cells transfected with a plasmid encoding kinase dead 
(KD)-PLK1-YFP was assessed as a positive control (anti-GFP antibodies also recognise YFP 
isoforms). Total protein was stained with Ponceau S. GFP-fusion protein bands are indicated with a 
white arrow. 
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4.1.6 mid1 interacts genetically with ssp1, ssp2, amk2 and cbs2  
Mid1+is important for S. pombe cytokinesis as its chromosomal deletion results in 
random positioning of the contractile ring and division septa (Sohrmann et al., 
1996b; Wu et al., 2006). Additionally Mid1p is also a downstream target of Plo1p 
(Almonacid et al., 2011). Therefore, it was investigated if the mid1 gene 
interacted with ssp1 or the AMPK subunits. Serial dilution of such double mutant 
strains on solid YE media indicated that synthetic phenotypes were present for 
each of the double mutant strains. In all cases the double mutant was more heat 
tolerant than mid1Δ cells but less tolerant that the associated deletion of ssp1, 
ssp2, amk2 or cbs2 at both 30oC and 35oC (Figure 4-14).  
 
Figure 4-14. Growth defects in mid1Δ and ssp1Δ/ssp2Δ/amk2Δ/cbs2Δ double mutant cells. 
(A) Wild type (GG1278), mid1Δ (GG1554), ssp2Δ (GG3033) and three separate isolates of ssp2Δ 
mid1Δ (GG3099, GG3160, GG3161). (B) Wild type (GG1278), mid1Δ (GG1125), amk2Δ (GG2979) 
and three separate isolates of amk2Δ mid1Δ (GG3097, GG3098, GG3113). (C) Wild type 
(GG1278), mid1Δ (GG1125), cbs2Δ (GG2981) and three separate isolates of cbs2Δ mid1Δ 
(GG3094, GG3095, GG3096). (D) Wild type (GG1278), mid1Δ (GG1554), ssp1Δ (GG2966) and 
three separate isolates of ssp1Δ mid1Δ (GG3166, GG3167, GG3168) Strains were suspended at 
1.5x106 cell/ml and subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE 
media and incubated at the indicated temperatures for 3 days. 
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4.1.7 ssp1 interacts genetically with components of the ESCRT 
pathway 
The ESCRT proteins form a series of multi-protein complexes divided into four 
functional classes; ESCRT-0, ESCRT-I, ESCRT-II and ESCRT-III which function with 
many accessory proteins such as Vps4p (Wollert and Hurley, 2010). The ESCRT 
machinery facilitate the curving of the cell membrane and abscission during 
cytokinesis, and are important regulators of cell separation and cytokinesis in S. 
pombe (Bhutta et al., 2014). In the present study, a number of S. pombe strains 
containing single chromosomal deletions of ESCRT genes were used, namely; 
sst4Δ, sst6Δ, vps28Δ, vps36Δ, vps35Δ, vps20Δ, vps32Δ, vps2Δ and vps4Δ (Table 4-
2).  
GG number Genotype Human 
orthologue 
ESCRT Class  
GG1623 sst4Δ HRS ESCRT-0 
GG1615 sst6Δ TSG101 ESCRT-I 
GG1616 vps28Δ Vps28 ESCRT-I 
GG1617 vps36Δ EAP45 ESCRT-II 
GG1618 vps25Δ EAP20 ESCRT-II 
GG1619 vps20Δ CHMP6 ESCRT-III 
GG2540 vps32Δ CHMP4 ESCRT-III 
GG1621 vps2Δ CHMP2A/B ESCRT-III 
GG1622 vps4Δ VPS4A/B Accessory protein 
Table 4-3. Summary of ESCRT deletion strains used in the present study. 
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A striking genetic interactions was apparent between vps2Δ and ssp1Δ. The 
double mutant strain had dramatically reduced growth at both 30oC and 35oC 
compared to the parental strains (Figure 4-15). Although a synthetic septation 
phenotype was not apparent in ssp1Δ vps2Δ cells, a significant increase in the 
proportion of Class F phenotype compared to vps2Δ was detected (Figure 4-16). 
Additionally, ssp1Δvps2Δ cells had a decrease in the Class A:F ratio compared to 
the parental strains (Figure 4-16). Single mutant parental strains both had very 
similar septation phenotypes, approximately 55% Class A and 45% Class F (Figure 
4-16).  
 
Figure 4-15. Analysis of synthetic growth defects in ssp1Δ vps2Δ double mutant ells. 
Wild type (GG1278), vps2Δ (GG1621), ssp1Δ (GG3080) and three separate isolates of ssp1Δ 
vps2Δ (GG3117, GG3163, GG3164). Strains were suspended at 1.5x106 cell/ml and subjected to 
10-fold serial dilution. Cell suspension was pipetted onto solid YE media and incubated at the 
indicated temperatures for 3 days. 
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Figure 4-16. Analysis of synthetic septation defects in ssp1Δ vps2Δ double mutant cells. 
Wild type (GG1278), vps2Δ (GG1621), ssp1Δ (GG3080) and three separate isolates of ssp1Δ 
vps2Δ (GG3117, GG3163, GG3164). Division septa were visualised using Calcofluor-White, 
examined by fluorescence microscopy and the frequency of each phenotype recorded. 300 cells in 
total were counted over three technical replicates, performed on three independent occasions for 
each genotype. (B) Quantification of Class A:F phenotypes ± SEM. (C) Representative images of 
Calcofluor-White stained cells. Scale bar represents 20 μm. # p< 0.05 comparing vps2Δ to ssp1Δ 
vps2Δ (Students t test). 
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A genetic interaction was also detected between ssp1 and vps4. The ssp1Δ vps4Δ 
cells were more temperature sensitive than parental strains at 35oC (Figure 4-
17). Analysis of the septation phenotype of ssp1Δ vps4 cells revealed a 
significant increase in the proportion of Class F cells relative to vps4Δ cells, 
however there was no significant alteration compared to ssp1Δ cells (Figure 4-
18).  
Analysis of growth by serial dilution of other combinations of AMPK/ESCRT 
deletion strains did not reveal any synthetic phenotypes and are displayed in 
Appendix 2.  
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Figure 4-17. Analysis of synthetic growth defects in ssp1 vps4 double mutant cells. 
Wild type (GG1278), vps4Δ (GG1622), ssp1Δ (GG3080) and three separate isolates of ssp1Δ 
vps4Δ (GG3125, GG3126, GG3127). Strains were suspended at 1.5x106 cell/ml and subjected to 
10-fold serial dilution. Cell suspension was pipetted onto solid YE media and incubated at the 
indicated temperatures for 3 days. 
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Figure 4-18. Analysis of synthetic septation defects in ssp1Δ vps4Δ double mutant cells. 
(A) Wild type (GG1278), vps4Δ (GG1622), ssp1Δ (GG3080) and three separate isolates of ssp1Δ 
vps4Δ (GG3125, GG3126, GG3127). Division septa were visualised using Calcofluor-White, 
examined by fluorescence microscopy and the frequency of each phenotype recorded. 300 cells in 
total were counted over three technical replicates, performed on three independent occasions for 
each genotype. (B) Quantification of Class A:F phenotypes ± SEM. (C) Representative images of 
Calcofluor-White stained cells. Scale bar represents 20 μm. # p< 0.05 comparing vps4Δ to ssp1Δ 
vps4Δ (Students t test). 
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4.2 Discussion 
4.2.1 Principal findings 
 S. pombe AMPK has a role in the efficient septation/cytokinesis of 
daughter cells 
 The genes encoding components of the AMPK heterotrimer/ssp1 were 
described to interact with ark1-T8, mid1 and plo1-ts18/plo1-ts35 
 ssp2 interacted with components of the ESCRT machinery; vps2 and vps4 
4.2.2 AMPK has a role in controlling S. pombe cytokinesis 
The data presented in this Chapter demonstrated that the AMPK pathway has a 
role in mitosis and specifically cytokinesis in S. pombe. Chromosomal deletion of 
each of ssp2, cbs2 or ssp1 caused an alteration in the septation phenotype of 
dividing cells. Class F phenotypes (delayed separation after septation) were 
increased by approximately 20% compared to wild type strains. Such increased 
frequency of Class F phenotype could reflect delayed cytokinesis, mis-timed 
cytokinesis or defective septum degradation. In future, real time fluorescence 
microscopy could be employed to examine the length of time taken to resolve 
the septa in these mutants.  
Previously, the septation phenotype of wild type cells was described as 
approximately 90% Class A and 10% Class F (inferred A:F ratio of 9) (Bhutta et 
al., 2014). In this study, wild type cells were described as 80% class A and 20% 
Class F (A:F of 4.61). The over representation of Class F in this study may reflect 
different culturing methods of yeast strains. Alternatively, as phenotype 
classification is a subjective process, how an individual records either Class A or 
Class F may differ. Importantly, in this study yeast strains were cultured in the 
same manner prior to Calcofluor-White staining; 18 h in liquid YE media at 30oC 
with shaking. Secondly, elements of the experiments were double blinded; in 
doing so the genotype was not known when septation phenotype was assessed. 
Blinded and non-blinded experiments produced comparable results.  
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4.2.3 The AMPK pathway genetically interacts with a number of 
mitotic regulators in S. pombe 
Synthetic phenotypes were observed in a number of double mutant S. pombe 
strains generated in this study (Table 4-3). The nature of the synthetic 
phenotypes varied; a number of double mutant strains were less viable than the 
parental strains whereas some strains had a phenotype intermediate of the 
parental strains or finally a synthetic phenotype that was “fitter” than parental 
strains. Genetic interactions studied in this Chapter are shown in Table 4-3. 
 ssp2Δ amk2Δ cbs2Δ ssp1Δ 
ark1-T8 # - X - 
plo1-ts18 X + + + 
plo1-ts35    # 
midΔ # # # # 
sst4Δ  X X X 
sst6Δ  X X X 
vps28Δ  X X X 
vps36Δ  X X X 
vps25Δ X X X  
vps20Δ  X X X 
vps32Δ  X  X 
vps2Δ  X X - 
vps4Δ  X X - 
Table 4-4. Summary of the genetic interactions detected in S. pombe 
Double mutant strains where genetic interactions were detected are shaded green. Combinations 
which resulted in a synthetic phenotype which grew less that the respective parents are denoted by 
“-”. In cases where double mutant strains had a phenotype between the parental strains are noted 
by “#”. Where double mutant stains displayed a phenotype “fitter” than parental strains are noted by 
“+”. Lack of a synthetic phenotype is noted by “X”. Grey boxes represent combinations where 
double mutant strains were not generated.  
4.2.3.1 ark1 double mutants 
Intriguingly, the nature of synthetic growth phenotypes varied depending on the 
associated deletion of AMPK genes; ssp1Δ ark1-T8 and amk2Δ ark1-T8 strains had 
reduced growth compared to both parental strains, whereas ssp2Δ ark1-T8 cells 
had a partial rescue of ark1-T8 temperature sensitivity and grew at an 
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intermediate rate between the respective parental strains. From this growth 
phenotype, it can be inferred that ssp2 is epistatic to ark1, suggesting that 
Ssp2p likely acts downstream of Ark1p.  
Analysis of the septation phenotype of ssp1Δ ark1-T8 revealed an overall similar 
pattern to that of ark1-T8 cells, with both genotypes having similar proportions 
of Class B, D and G phenotypes although double mutants had elevated instances 
of Class E relative to both parental strains. Previously the ark1-T8 septation 
phenotype was characterised as approximately 50% Class A, 5% Class C, 15% Class 
E and 30% Class F (Bhutta et al., 2014) bearing a similarity to the phenotype 
described in this Chapter. The most notable difference was the description of a 
new septation phenotype in this study representing ectopic deposition of the 
septa material (Class G phenotype). Due to differences in culturing techniques 
(25oC opposed to 30oC, or shaking speed of the incubator) ectopic deposition 
may not have been observed in the previous study. Alternatively, Class G cells 
may have been discounted from the analysis. Surprisingly, 20% of ssp1Δ ark1-T8 
cells displayed the Class F phenotype, the same proportion as wild type and 
ark1-T8 cells, compared to 35-40% in ssp1Δ cells. This “rescue” of double mutant 
cells from the ssp1Δ/delayed separation phenotype may indicate a functional 
relationship between the encoded proteins and is further evidence of an 
interaction between Ssp1p and Ark1p.  
Despite evidence of a genetic interaction between ark1 and ssp1, ssp2 or amk2, 
there was no interaction between ark1 and cbs2. This may indicate that the 
interaction between S. pombe AMPK and Ark1p is independent of AMP or the 
Cbs2p subunit. Structural analysis of the S. pombe AMPK heterotrimer (Ssp1p-
Amk2p-Cbs2p) indicated that the interactions between Amk2p and Cbs2p are 
mediated through hydrogen bonding and ionic interactions (Townley and 
Shapiro, 2007). This led the authors to suggest that the Amk2p-Cbs2p interaction 
may not be obligatory for Ssp2p function (Townley and Shapiro, 2007). If the 
interaction between aurora kinase and AMPK was conserved in human cells, it is 
likely that the redundancy of the regulatory subunits would not be conserved as 
canonically it is believed that AMPK is only active as a heterotrimer.  
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4.2.3.2 plo1 double mutants 
Two different temperature sensitive mutant alleles of plo1 were utilised in this 
investigation, plo1-ts18 and plo1-ts35 (Anderson et al., 2002). These mutant 
alleles produced drastically different phenotypes; plo1-ts35 cells grew 
efficiently between 28-30oC, although not to the same extent as wild type cells, 
and showed reduced growth at 32oC. In contrast, plo1-ts18 cells had limited 
growth between 25-30oC but had considerable growth at 35oC although at a 
lower rate than wild type cells. Septation also occurs differently between the 
mutation types; 100% of plo1-ts35 cells had the Class G phenotype whereas plo1-
ts18 had a spread of septation phenotypes (approximately 60% Class A, 10% Class 
C, 10% Class D, 10% Class F and 10% Class G). Septation of plo1-ts35 was 
previously quantified as approximately; 45% Class A, 5% Class C, 5% Class D, 20% 
Class E and 15% Class F (Bhutta et al., 2014). Unusually, the results of Bhutta et 
al. do not align with the results presented in this Chapter. In previous studies, 
plo1-ts35 was cultured at 25oC (30oC in this investigation) therefore the observed 
shift of plo1-ts35 cells to a Class G phenotype may reflect strains being cultured 
at or beyond the restrictive temperature of the particulate mutation. plo1-ts18, 
has a single mutation in the kinase domain causing a arginine to glycine at 
position 216 (MacIver et al., 2003). plo1-ts35 also has a mutation in the kinase 
domain but the exact identity is not known (C. McInerny, personal 
communications). Identifying the precise plo1-ts35 mutation may help 
understand the synthetic phenotypes observed between the AMPK pathway.  
ssp1Δ plo1-ts35 strains had a partial rescue of plo1-ts35 temperature sensitivity 
at 32oC but had reduced growth rate compared to ssp1Δ. Consistently, when 
ssp1Δ plo1-ts35 strains were grown in liquid culture at 28oC, double mutant cells 
were able to grow more than plo1-ts35 cells but less than ssp1Δ cells. Double 
mutant cells growth plateaued at a lower cell concentration than both ssp1Δ and 
plo1-ts35 cells. In contrast, the synthetic growth phenotype of ssp1Δ plo1-ts18 
cells presented as increased growth at 25oC than both parental strains. At 35oC 
ssp1Δ plo1-ts18 cells had increased growth compared to plo1-ts18 cells but 
slower growth compared to ssp1Δ cells (Figure 4-8B).  
Analysis of septation in ssp1Δ plo1-ts18 cells also indicated synthetic 
phenotypes. As discussed, plo1-ts18 cells displayed an array of septation 
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phenotypes (approximately 62% Class A, 6% Class C, 7% Class D, 12% Class F and 
12% Class G). However, the combination of ssp1Δ and plo1-ts18 masked the plo1-
ts18 phenotype; double mutant cells had approximately 50% Class A, 3% class C, 
35% Class F and 10% Class G bearing a closer resemblance to ssp1Δ cells (55% 
Class A and 45% Class F). This combined evidence indicates a genetic interaction 
between the ssp1 and plo1 genes, however epistasis and the order of interaction 
remains difficult to discern at this point.  
A synthetic phenotype was not present in ssp2Δ plo1-ts18 cells as double mutant 
cells grew at a comparable rate to ssp2Δ cells at all tested temperatures. 
However, ssp2 may be a negative regulator of plo1, chromosomal deletion of 
ssp2 in plo1-ts18 mutant cells negated the plo1-ts18 phenotype of limited 
growth at 25oC. The deletion of amk2 or cbs2 in plo1-ts18 cells caused an 
interesting synthetic phenotype where double mutant cells exhibited increased 
growth at 25oC in comparison to the respective parental strains. Interestingly, a 
second AMPKα orthologue has been described in S. pombe, termed ppk9 (Hanyu 
et al., 2009; Matsusaka et al., 1995). As interactions were present between plo1 
and amk2 and cbs2, it is possible that Plo1p interacts with S. pombe AMPK but 
only in the context of the Ppk9p-Amk2p-Cbs2p heterotrimer and not the Ssp1p-
Amk2p-Cbs2p complex. 
4.2.3.3 mid1 double mutants 
Genetic interactions were detected between mid1 and ssp1, ssp2, amk2 and 
cbs2; in each case double mutant strains showed a partial recovery of the mid1Δ 
temperature sensitivity between 30-35oC, whereby double mutant cells were 
able to grow faster than mid1Δ cells but not as well as the respective ssp1Δ or 
AMPK deletion parental strain (Figure 4-14). Although the synthetic phenotypes 
appeared subtle, as mid1 was described to interact with ssp1, ssp2, amk2 and 
cbs2, it is likely that the genetic interactions reflect a functional interaction 
between the encoded proteins.  
Ssp1p has been shown to regulate mitotic entry by phosphorylating Cdr2p (Deng 
et al., 2014). Cdr2p localises to the cortical nodes with a number of proteins 
including Mid1p, with which Cdr2p co-immunoprecipitates (Moseley et al., 2009). 
Cdr2p is the S. pombe orthologue of human brain-specific kinase 1/2 (BRSK1/2), 
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an AMPK-related kinase (ARK). ARKs are characterised by sequence similarity 
around T172 of AMPKα and require T172 (or orthologous residue) to be 
phosphorylated for activation. (Lizcano et al., 2004). In human cells LKB1 can 
phosphorylate all 12 ARKs (Lizcano et al., 2004). Therefore the observed genetic 
interaction between ssp1 and mid1 may indicate a number of outcomes which 
are not mutually exclusive; a direct interaction between Ssp1p and Mid1p (A in 
Figure 4-19); Ssp1p may influence Mid1p through the Ssp2p heterotrimer (B in 
Figure 4-19); Ssp1p may influence Midp1 through the ARK Cdr2p as previously 
indicated (C in Figure 4-19) (Moseley et al., 2009); Ssp1p may influence Mid1p by 
an unidentified pathway (D in Figure 4-19). As a genetic interaction was noted 
between each of the genes encoding the AMPK subunits with mid1, it would be 
expected that the Ssp2p heterotrimer would have a role in the regulation of 
Mid1p along with Ssp1p.  
 
Figure 4-19. Ssp1p may regulate Mid1p in a number of ways 
Ssp1p may interact with Mid1p directly (scenario A). Ssp1p may influence Mid1p by activating the 
Ssp2p heterotrimer, scenario B. Ssp1p may regulate Mid1p through activation of Cdr2p, scenario 
C. Alternatively, Ssp1p may influence Mid1p by an unidentified mechanism, scenario D. These 
scenarios are not mutually exclusive.  
4.2.3.4 ESCRT double mutants 
A number of double mutant strains were generated utilising chromosomal 
deletions of selected components of the ESCRT pathway and either ssp1Δ, ssp2Δ, 
amk2Δ or cbs2Δ. The majority of these double mutant strains did not display any 
synthetic growth phenotypes when assessed by serial dilution (Appendix 2). 
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However, synthetic phenotypes were detected in ssp1Δ vps2Δ and ssp1Δ vps4Δ 
strains. Interestingly, ssp1Δ, vps2Δ and vps4Δ all had similar septation defects, 
with a comparable reduction in Class A phenotypes and increased prevalence of 
Class F phenotype. As genetic interactions were observed between vps2/vps4 
and ssp1 but not amk2 or cbs2, this may indicate that Ssp1p regulation of the 
ESCRT-III pathways is mediated by an AMPK-independent pathway although ssp2Δ 
vps2Δ and ssp2Δ vps4Δ strains were not generated so a role for AMPK should not 
be ruled out. Both vps2 and vps4 encode proteins which function at the end of 
the ESCRT cascade and are involved in catalysing abscission. This could indicate 
that ssp1 may function in regulating the final stages of ESCRT recruitment to the 
midbody or by regulating Vps4p ATPase activity, rather than having a role earlier 
in the ESCRT pathway. 
4.2.4 Summary 
The results presented in this Chapter are the first to link the AMPK pathway to 
ark1, plo1, mid1 and the ESCRT pathways in S. pombe. This further supports the 
hypothesis that the AMPK pathway has a role in mitosis and cytokinesis. In the 
following Chapter, the yeast genetic interactions will be investigated further in 
a mammalian system. In vitro protein phosphorylation assays will be utilised to 
demonstrate a functional link between the interacting proteins. 
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5 Chapter 5–Phosphorylation of mammalian 
mitotic proteins by AMPK and CaMKKβ 
5.1 Introduction 
In Chapter 3 a role for AMPK was described in the control and fidelity of the cell 
cycle in mammalian cells. Additionally, in Chapter 4 the fission yeast AMPK 
pathway was suggested to interact genetically with a number of key mitotic 
proteins as follows; 
 ssp2, amk2 and ssp1 interacted with ark1 
 amk2, cbs2 and ssp1 interacted with plo1 
 ssp2, amk2, cbs2 and ssp1 interacted with mid1 
 ssp1 interacted with vps2 
 ssp1 interacted with vps4 
The AMPK heterotrimer is well conserved between humans and S. pombe with 
the fission yeast AMPK being composed of Ssp2p (AMPKα subunit), Amk2p (β) and 
Cbs2p (γ) (Hanyu et al., 2009). S. pombe ssp1 is orthologous to CaMKKβ but 
functionally is more similar to LKB1 (Hanyu et al., 2009). The human orthologues 
of the mitotic proteins are also well conserved from fission yeast, Ark1p is 
orthologous to the aurora kinase family in human cells which have diverged to 
form 3 paralogues termed aurora A-C which have distinct functions (Bischoff et 
al., 1998; Giet and Prigent, 1999). Plo1p has also been conserved as the PLK 
family in human cells, PLK1 is more conserved in terms of sequence and function 
to plo1 whereas PLK2-5 have diverged further (Kothe et al., 2007). Mid1p is 
orthologous to human anillin which acts as a scaffold protein and is an integral 
component of the actomyosin ring which mediates early stages of cytokinesis 
(Piekny and Glotzer, 2008). Vps2p and Vps4p function as part of the ESCRT 
machinery; Vps2p (CHMP2A/B in mammalian cells) forms part of the ESCRT-III 
machinery involved in abscission and Vps4p (also Vps4 in human cells) is an AAA-
ATPase crucial to the recycling of ESCRT subunits and abscission (Carlton and 
Martin-Serrano, 2007; Su et al., 2017).  
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In this Chapter, many of the genetic interactions identified in Chapter 4 were 
investigated further in a mammalian system. First, a functional link between 
LKB1 and aurora A, aurora B and PLK1 was assessed in transgenic HeLa cells. 
Secondly, a series of in vitro phosphorylation assays were performed using 
mammalian proteins.   
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5.2 Results 
5.2.1 LKB1 function does not influence mitosis in HeLa cells 
HeLa cells do not express LKB1 (LKB1 -/-), so genetically modified HeLa cells 
were utilised to examine how LKB1 expression/activity could influence the cell 
cycle. These cells either expressed FLAG-tagged wild type-LKB1 (WT-LKB1) or 
kinase dead-LKB1 (KD-LKB1) under the control of a tetracycline inducible 
promoter (Sapkota et al.,2002). Both constructs could be induced by the 
incubation with tetracycline although expression of KD-LKB1 was lower than that 
of WT-LKB1 (Figure 5-1). As anticipated in LKB1 -/- HeLa cells, AICAR (1 mM, 1 h) 
caused an increase in phospho-S79 ACC but did not alter phospho-T172 AMPK 
indicating the allosteric effect of AICAR/ZMP on AMPK activity (Figure 5-1). 
Similarly, in KD-LKB1 expressing cells, AICAR stimulated phosphorylation of ACC 
but not AMPK (Figure 5-1). WT-LKB1 HeLa cells had higher basal and AICAR-
stimulated phosphorylation of ACC, an increase in phospho-T172 AMPK was also 
apparent following stimulation with AICAR as expected (Figure 5-1).  
Next the subcellular localisation of LKB1 in these cells was investigated by 
immunofluorescence microscopy. Staining of LKB1 -/- HeLa cells with anti-LKB1 
antibodies produced low levels of non-specific immunoreactivity (Figure 5-1). 
Higher levels of LKB1 immunoreactivity were detectable in both LKB1-WT and 
LKB1-KD HeLa cells, which localised to the cytoplasm and nucleus (Figure 5-1). 
LKB1 also localised to the intracellular bridge but not to the midbody.  
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Figure 5-1. Subcellular localisation of LKB1 during telophase 
(A) KD-LKB1 or WT-LKB1 HeLa cells were incubated in the presence or absence of tetracycline (1 
μg/ml) for 24 h to induce expression of FLAG-tagged mutant LKB1. KD-LKB1, WT-LKB1 and LKB1 
-/- HeLa cells were subsequently incubated in the presence or absence of AICAR (1 mM, 1 h) and 
lysates prepared. Lysates were resolved by SDS-PAGE and subjected to immunoblotting with the 
antibodies indicated, a HUVEC lysate was included as a positive control. N=1. (B) Quantification of 
tetracycline-induced LKB1 expression relative to GAPDH. Presented as %WT-LKB1 expression. 
N=4. (C-E) KD-LKB or WT-LKB1 HeLa cells were incubated with tetracycline (1 μg/ml) for 24 h. 
LKB1 -/-, KD-LKB1 or WT-LKB1 HeLa cells were fixed with 4% (w/v) PFA and stained with anti-
tubulin (Abcam, ab6160) and anti-LKB1 (New England Biolabs, #3050) antibodies. DNA was 
stained with RedDot2. Scale bar=10 μm. Representative images are shown from three 
independent experiments in each case. 
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As a genetic interactions were described between the AMPK kinase ssp1 and both 
ark1 and plo1 in Chapter 4, the localisation of their mammalian orthologues 
(aurora A/aurora B and PLK1) was assessed in WT-LKB1, KD-LKB1 HeLa cells, 
LKB1 -/- Hela cells and HUVECs. Aurora A immunoreactivity was observed in the 
cytoplasm and nuclei of all tested cell lines (Figure 5-2). Midbody localisation of 
aurora A was only observed in HUVECs (Figure 5-2). In HeLa cells, there was 
enrichment of aurora A at the intracellular bridge but not at the midbody proper 
(Figure 5-2). Similarly, aurora B immunoreactivity was detected in the cytoplasm 
and nuclei of LKB1 -/- HeLa cells, LKB1-KD HeLa cells, LKB1-WT HeLa cells and 
HUVECs (Figure 5-3). Midbody localisation of aurora B was only observed in 
HUVECs (Figure 5-3). Finally, PLK1 immunoreactivity was detected in the 
cytoplasm and nuclei of all tested cells and at the midbody in HUVECs (Figure 5-
4).  
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Figure 5-2. Subcellular localisation of aurora A during telophase 
(A) LKB1 -/- HeLa cells, (B) KD-LKB1 HeLa cells, (C) WT-LKB1 HeLa cells and (D) HUVECs were 
fixed with 4% (w/v) PFA. Cells were stained with anti-tubulin (Abcam, ab6160) and anti-aurora A 
(Abcam, ab1287) antibodies. DNA was stained with RedDot2. KD-LKB1 and WT-LKB1 HeLa cells 
were pre-treated with tetracycline (1 μg/ml) for 24 h. Scale bar=10 μm. Representative images are 
shown from three independent experiments in each case. 
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Figure 5-3. Subcellular localisation of aurora B during telophase 
(A) LKB1 -/- HeLa cells, (B) KD-LKB1 HeLa cells, (C) WT-LKB1 HeLa cells and (D) HUVECs were 
fixed with 4% (w/v) PFA. Cells were stained with anti-tubulin (Abcam, ab6160) and anti-aurora B 
(Abcam, ab2254) antibodies. DNA was stained with RedDot2. KD-LKB1 and WT-LKB1 HeLa cells 
were pre-treated with tetracycline (1 μg/ml) for 24 h. Scale bar 10=μm. Representative images are 
shown from three independent experiments in each case. 
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Figure 5-4. Subcellular localisation of PLK1 during telophase 
(A) LKB1 -/- HeLa cells, (B) KD-LKB1 HeLa cells, (C) WT-LKB1 HeLa cells and (D) HUVECs were 
fixed with 4% (w/v) PFA. Cells were stained with anti-tubulin (Abcam, ab6160) and anti-PLK1 
(Novus Biologicals, NB-100-547) antibodies. DNA was stained with RedDot2. KD-LKB1 and WT-
LKB1 HeLa cells were pre-treated with tetracycline (1 μg/ml) for 24 h. Scale bar 10=μm. 
Representative images are shown from three independent experiments in each case. 
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Next, the expression of WT-LKB1 or KD-LKB1 on HeLa cell polyploidy was 
assessed. Cells were incubated with AMPK activators or inhibitors for 18 h prior 
to staining with PI and assessment of DNA content by flow cytometry. Expression 
of either WT-LKB1 or KD-LKB1 did not influence HeLa cell DNA content (Figure 5-
5). Compound C (10 µM) caused a significant reduction in the proportion of KD-
LKB1 cells with 2n DNA coinciding with an increase in the proportion of cells with 
4n DNA (Figure 5-5). In contrast, compound C did not significantly alter DNA 
content of WT-LKB1 HeLa cells (Figure 5-5). Incubation with STO-609, A769662, 
AICAR or canagliflozin did not alter the DNA content of either KD-LKB1 or WT-
LKB1 HeLa cells.  
HeLa cells which expressed KD-LKB1 had low basal levels of phospho-S79 ACC 
which did not increase in response to either AICAR, A769662 or canagliflozin 
(Figure 5-5I). A769662 and AICAR significantly increased phospho-S79 ACC in WT-
LKB1 HeLa cells, however, canagliflozin did not stimulate AMPK activity. Neither 
STO-609 nor compound C reduced basal phospho-S79 ACC levels in either cell 
type (Figure 5-5I). Expression of LKB1 was markedly lower in KD-LKB1 expressing 
cells. Surprisingly, both compound C and AICAR significantly increased levels of 
WT-LKB1 relative to GAPDH (Figure 5-6). AICAR stimulated an increase in 
phospho-T172 AMPK in WT-LKB1 HeLa cells but not in KD-LKB1 HeLa cells, no 
other treatments altered phospho-T172 AMPK (Figure 5-6).  
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Figure 5-5. The effect of modulating AMPK activity on the DNA content of WT- and KD-LKB1 
expressing HeLa cells 
KD-LKB1 and WT-LKB1 inducible HeLa cells were pre-treated with tetracycline (1 μg/ml) for 24 h. 
HeLa cells were then seeded into 6-well plate and incubated for 4 h until cells adhered. Cells were 
subsequently treated as indicated for 18 h with tetracycline (1 μg/ml). (A) Representative scatter 
plots and histogram overlays comparing DMSO (blue) with activator/inhibitor treated cells (pink) of 
WT-LKB1 HeLa cells. (B) Representative scatter plots and histogram overlays comparing DMSO 
(blue) with activator/inhibitor treated cells (pink) of KD-LKB1 HeLa cells. (C) Comparison of WT-
LKB1 (green) and KD-LKB1 (blue) HeLa histograms. (D-G) Analysis of the proportion of cells with 
2n, 2-4n, 4n or >4n DNA content presented as % cells ± SEM from 3 independent experiments. (H) 
HeLa cells were treated with the indicated compounds for 18 h and lysates prepared. Lysates were 
resolved by SDS-PAGE and immunoblotted using the antibodies indicated. Representative images 
are shown. (I) Quantification of phospho-S79 ACC relative to total ACC, presented as % DMSO of 
WT-LKB1 ± SEM. (J) Quantification of LKB1 relative to GAPDH, presented as % DMSO of WT-
LKB1. (K) Quantification of phospho-T172 AMPK relative to total AMPK, presented as % DMSO of 
WT-LKB1. * p<0.05, **p<0.01 relative to cells incubated with DMSO and # p<0.05 as indicated 
(two-way ANOVA). N=3.  
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5.2.2 Development of in vitro phosphorylation assays 
To examine the genetic interactions outlined in Chapter 4 further, in vitro 
phosphorylation assays were undertaken using mammalian protein orthologues. 
As many of the described genetic interactions were between kinases, “kinase 
dead” (KD) mutant proteins were utilised as substrates to limit 
autophosphorylation and to ensure in vitro phosphorylation occurred only from 
the active kinase in question to the substrate and not the reverse. A number of 
experiments were first undertaken to optimise the in vitro phosphorylation 
assays and generation of substrate proteins, which will be outlined in this 
Section.  
HEK 293 cells were transfected with plasmids encoding genes for substrates (KD-
aurora A-mCherry, KD-aurora B-GFP, KD-PLK1-YFP, CHMP2A-GFP, CHMP2B-GFP, 
GFP or mCherry) and harvested after 48 h. Lysates were resolved by SDS-PAGE 
and interrogated by immunoblotting. Successful expression of KD-aurora A-
mCherry was confirmed by probing with anti-aurora A and anti-mCherry 
antibodies (Figure 5-6A). KD-aurora A-mCherry appeared as a two distinct 
species when probed with either of the antibodies (Figure 5-6A). The higher 
molecular mass species represented the molecular mass expected for the fusion 
protein (~72 kDa). Expression of KD-PLK1-YFP was confirmed by probing with 
anti-PLK1 and anti-GFP (which also recognises YFP isoforms) antibodies (Figure 
5-6B/E). mCherry expression was confirmed by probing with anti-mCherry 
antibodies (Figure 5-6D). Finally the expression of GFP, CHMP2A-GFP and KD-
aurora B-GFP was confirmed by probing with anti-GFP antibodies (Figure 5-
6C/E). No obvious GFP immunoreactivity was observed in HEK 293 cells 
transfected with plasmids encoding CHMP2B-GFP.  
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Figure 5-6. Expression of substrates for in vitro phosphorylation assays in HEK 293 cells  
HEK 293 cells were transfected with the indicated plasmids and incubated for 48 h and lysates 
prepared. Lysates were resolved by SDS-PAGE and immunoblotted with the antibodies indicated. 
HEK 293 cells were transfected with (A) A plasmid expressing KD-aurora A-mCherry. (B) A 
plasmid expressing KD-PLK1-YFP. (C) A plasmid expressing GFP. (D) A plasmid expressing 
mCherry. (E) Plasmids expressing either KD-PLK1, CHMP2A-GFP, KD-aurora B-GFP or 
CHMP2B-GFP. Note that anti-GFP antibodies also bind YFP isoforms. Arrows indicate the proteins 
at the expected molecular masses. * Endogenous aurora A or PLK1.  
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To generate a kinase dead AMPK, HEK 293 cells were infected with adenoviruses 
encoding a dominant negative AMPKα1 mutant (Ad.AMPKα1-DN). This mutant 
AMPK contained a myc tag and a D157A mutation to render it inactive (KD-
AMPKα1-myc) (Woods et al., 2000). Cells were lysed after 24 h and KD-AMPKα1 
immunoprecipitated with anti-myc nanobodies conjugated to magnetic beads. 
The resultant immunoprecipitate (IP) and immunodepleted lysate (ID) were 
subjected to immunoblotting for AMPK subunits and myc. AMPKα1 and AMPKβ1 
were successfully detected in the immunoprecipitate (Figure 5-7).  
 
Figure 5-7. Immunoprecipitation of KD-AMPKα1-myc from adenovirus infected HEK 293 
cells 
HEK 293 cells were infected with Ad.AMPKα1-DN for 24 h. Lysates were prepared and incubated 
with anti-myc conjugated magnetic beads for 1 h with rotation at 4oC. Supernatant was removed 
and retained as the immunodeplete (ID). Samples were resolved by SDS-PAGE and subjected to 
immunoblotting with the indicated antibodies. N=1.  
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The final substrate for in vitro phosphorylation assays to be generated was KD-
LKB1 which was immunoprecipitated from KD-LKB1 HeLa cells using anti-FLAG 
antibodies (Sapkota et al., 2002). KD-LKB1 was successfully immunoprecipitated 
and 5 μl of the IP was sufficient to provide a detectable signal when probed with 
anti-LKB1 antibodies (Figure 5-8).  
 
Figure 5-8. Immunoprecipitation of KD-LKB1-FLAG from transgenic HeLa cells 
KD-LKB1 HeLa cells were incubated with tetracycline (1 μg/ml) for 24 h to induce expression of 
FLAG-tagged KD-LKB1 and lysates prepared. Anti-FLAG antibodies were bound to magnetic 
beads and incubated with lysates overnight with rotation at 4oC. Supernatant was removed and 
retained as the immunodeplete (ID). Beads were resuspended in 20 μl LSB. Samples were 
resolved by SDS-PAGE and subjected to immunoblotting with the antibodies indicated. * LKB1-
FLAG, # IgG heavy chain. N=1.  
  
 169 
 
To reduce any endogenous phosphorylation of immunoprecipitated proteins, 
dephosphorylation assays were performed. To track dephosphorylation, AMPK 
T172 was examined due to the ease of immunoprecipitation and phospho-
antibody availability. AMPK was immunoprecipitated from a 2-6.5% PEG isolate 
of rat liver and incubated with λ-phosphatase as described in Section 2.16.2. IP 
pellet was resolved by SDS-PAGE and immunoblotted for phospho-T172 AMPK. 
Incubation with 400 U λ-phosphatase substantially dephosphorylated AMPK T172 
(Figure 5-9).  
 
Figure 5-9. Dephosphorylation of rat liver AMPK by lambda phosphatase 
(A) AMPK was immunoprecipitated from a 2-6.5% PEG precipitate of rat liver. Beads (5 μl/ 
reaction) were incubated with lambda phosphatase at 30oC for 1 h on a shaking platform. Beads 
were washed and resuspended in 2x LSB. Reactions were resolved by SDS-PAGE and 
immunoblotted with anti-phospho-T172 AMPK antibodies and IgG examined as a loading control. 
(B) Densitometric analysis of phospho-T172 AMPK relative to IgG. N=1.  
  
 170 
 
The activity of the recombinant protein kinases used to phosphorylate substrate 
proteins (aurora A-GST, aurora B-GST, PLK1-His, CaMKKβ-GST, AMPKα1β1γ1 or 
AMPKα2β2γ1) were assayed using myelin basic protein (MBP) as a substrate. In 
vitro phosphorylation was performed as detailed in Section 2.16.3 and samples 
resolved by SDS-PAGE and phosphorylation of MBP was determined by 
phosphorimaging. All recombinant kinases phosphorylated MBP, demonstrating 
kinase activity (Figure 5-10).  
 
Figure 5-10. In vitro phosphorylation of MBP by recombinant proteins 
(A) In vitro phosphorylation of MBP (5 μg) by aurora A-GST, aurora B-GST, PLK1-His or CaMKKβ-
GST (50 ng each). (B) In vitro phosphorylation of MBP by either AMPKα1β1γ1 or AMPKα2β2γ1 
(units of activity indicated, where 1 U is 1 nmol 32P incorporated/min into SAMS peptide). Reactions 
were terminated by the addition of 2x LSB and resolved by SDS-PAGE. Gels were stained with 
Coomassie and dried. 32P incorporation was assessed by phosphorimaging.  
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5.2.3 Analysis of In vitro phosphorylation  
5.2.3.1 Aurora A phosphorylates KD-LKB1-FLAG but not DN-AMPK or 
CaMKKβ-GST in vitro 
KD-LKB1-FLAG was immunoprecipitated from transgenic KD-LKB1 HeLa cells 
using anti-FLAG antibodies as described in Figure 5-8. As a suitable control, an 
anti-FLAG immunoprecipitation was carried out in parallel on HeLa cell lysates 
(which lack LKB1). Alternatively, kinase dead AMPK (KD-AMPKα1-myc) was 
immunoprecipitated from HEK 293 cells infected with Ad.AMPKα1-DN using anti-
myc conjugated beads as described in Figure 5-7. Additionally, an 
immunoprecipitation using anti-myc conjugated beads was performed on lysates 
prepared from Ad.Null infected HEK 293 cells. Immunoprecipitation products 
were incubated with active aurora A (Aurora A-GST, 50 ng) in the presence of [γ-
32P]ATP. Reactions were also performed using MBP (5 μg) as a positive control to 
demonstrate kinase activity. Products were resolved by SDS-PAGE and 32P 
incorporation assessed using a phosphorimager.  
KD-LKB1 was phosphorylated to an extent when aurora A was omitted from the 
reaction (figure 5-11). This could indicate the construct was not entirely kinase 
dead or the anti-FLAG immunoprecipitation pulled down additional kinases. 
Densitometric analysis of two independent experiments indicated that KD-LKB1 
band intensity increased approximately 40% ± 8% when KD-LKB1 was incubated 
with aurora A (Figure 5-11). No incorporation of [γ-32P]ATP was observed in anti-
FLAG immunoprecipitates from LKB1 -/- HeLa cell lysates (Figure 5-11). No 
bands of the correct molecular mass could be attributed to AMPK subunits in KD-
AMPKα1-myc immunoprecipitates when visualised on a phosphorimager (Figure 
5-11). Anti-myc immunoprecipitation of Ad.Null infected HEK 293 cell lysates, 
had an identical phosphorylation pattern to immunoprecipitation of Ad.AMPKα1-
DN infected HEK 293 lysates demonstrating that anti-myc immunoprecipitation 
lacked specificity and that aurora A did not phosphorylate KD-AMPKα1 (Figure 5-
11). 
Next, to determine if aurora A could phosphorylate CaMKKβ-GST in vitro, 
CaMKKβ-GST or GST were denatured by heating at 95oC for 5 min to abolish 
kinase activity. Aurora A did not phosphorylate denatured CaMKKβ-GST or GST 
(Figure 5-12).  
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Figure 5-11. Analysis of in vitro phosphorylation of KD-LKB1 and DN-AMPK-myc by aurora 
A 
KD-LKB1-FLAG was immunoprecipitated from KD-LKB1 HeLa cells stimulated with tetracycline (1 
μg/ml, 24 h) using anti-FLAG antibodies. In parallel, an IP was performed on cell lysates prepared 
from LKB1 -/- HeLa cells. KD-AMPKα1-myc was immunoprecipitated from Ad.AMPKα1-DN 
infected HEK 293 cell lysates using anti-myc conjugated beads. Simultaneously an IP was 
performed using anti-myc conjugated beads on cell lysates from Ad.Null infected HEK 293 cells. 
MBP (5 μg) was also used as a substrate for aurora A. Substrate were incubated in the presence 
or absence of 50 ng aurora A-GST and [γ-32P]ATP for 30 min at 30oC. Reactions were terminated 
by the removal of the supernatant and addition of 2x LSB. Alternatively, Alternatively 4x LSB was 
added to reactions using MBP as a substrate or reactions when substrate was omitted. Reactions 
were resolved by SDS-PAGE and resulting gels stained with Coomassie, dried and 32P 
incorporation assessed using a phosphorimager (A) Representative phosphorimage and 
coomassie stained gel. (B) Densitometric analysis of KD-LKB1-FLAG phosphorylation by aurora A. 
Data shown as ± SEM. N=2. 
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Figure 5-12. Analysis of in vitro phosphorylation of CaMKKβ-GST by aurora A 
CaMKKβ-GST or GST (500 ng) were heated at 95oC for 5 min. In vitro phosphorylation reactions 
were carried out using aurora A (50 ng). Reactions were incubated with [γ-32P]ATP for 30 min at 
30oC. Boiled CaMKKβ-GST and aurora A were also incubated with MBP (5 μg). In vitro 
phosphorylation reactions were terminated by the addition of 4x LSB. Reactions were resolved by 
SDS-PAGE and resulting gel stained with Coomassie, dried and 32P incorporation assessed using 
a phosphorimager. N=1. 
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5.2.3.2 Aurora B may phosphorylate KD-LKB1-FLAG but not DN-AMPK or 
CaMKKβ-GST in vitro 
As described in Section 5.2.3.1, KD-LKB1 and DN-AMPK were immunoprecipitated 
from cell lysates with the appropriate controls. Immunoprecipitation products 
were incubated with aurora B-GST and [γ-32P]ATP to assess in vitro 
phosphorylation. Phosphorylation of KD-LKB1 by aurora B was inconsistent, 
densitometric analysis of KD-LKB1 phosphorylation from two independent 
experiments had considerable variability (Figure 5-13B). A strong 32P-labelled 
band was observed in the KD-AMPKα1-myc immunoprecipitates at approximately 
50 kDa, which may represent AMPKγ3 (which has a predicted mass of 
approximately 54 kDa). Band intensity was not altered by aurora B (Figure 5-13). 
Furthermore, aurora B did not phosphorylate denatured CaMKKβ-GST or GST 
(Figure 5-14). 
5.2.3.3 PLK1 may phosphorylate CaMKKβ but not KD-LKB1-FLAG or DN-
AMPK in vitro 
PLK1 did not phosphorylate KD-LKB1 in vitro (Figure 5-15). Incubation of DN-
AMPK with PLK1 did not alter band intensity (Figure 5-15). Heat denatured 
CaMKKβ-GST (~82 kDa) and GST (~27 kDa) could both be phosphorylated by PLK1 
to a similar extent (Figure 5-16).  
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Figure 5-13. Analysis of in vitro phosphorylation of KD-LKB1 and DN-AMPK-myc by aurora 
B 
KD-LKB1-FLAG was immunoprecipitated from KD-LKB1 HeLa cells stimulated with tetracycline (1 
μg/ml, 24 h) using anti-FLAG antibodies. In parallel, an IP was performed on cell lysates prepared 
from LKB1 -/- HeLa cells. KD-AMPKα1-myc was immunoprecipitated from Ad.AMPKα1-DN 
infected HEK 293 cell lysates using anti-myc conjugated beads. Simultaneously an IP was 
performed using anti-myc conjugated beads on cell lysates from Ad.Null infected HEK 293 cells. 
MBP (5 μg) was also used as a substrate for aurora B. Substrate were incubated in the presence 
or absence of 50 ng aurora A-GST and [γ-32P]ATP for 30 min at 30oC. Reactions were terminated 
by the removal of the supernatant and addition of 2x LSB. Alternatively 4x LSB was added to 
reactions where substrate was omitted. Reactions were resolved by SDS-PAGE and resulting gels 
dried and 32P incorporation assessed using a phosphorimager (A) Representative phosphorimage 
and coomassie stained gel. (B) Densitometric analysis of KD-LKB1-FLAG phosphorylation by 
aurora A. Data shown as ± SEM. N=2. 
  
 176 
 
 
Figure 5-14. Analysis of in vitro phosphorylation of CaMKKβ-GST by aurora B 
CaMKKβ-GST or GST (500 ng) were heated at 95oC for 5 min. In vitro phosphorylation reactions 
were carried out using aurora B (50 ng). Reactions were incubated with [γ-32P]ATP for 30 min at 
30oC. Boiled CaMKKβ-GST and aurora A were also incubated with MBP (5 μg). In vitro 
phosphorylation reactions were terminated by the addition of 4x LSB. Reactions were resolved by 
SDS-PAGE and resulting gel stained with Coomassie, dried and 32P incorporation assessed using 
a phosphorimager. N=1. 
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Figure 5-15. Analysis of in vitro phosphorylation of KD-LKB1 and DN-AMPK-myc by PLK1 
KD-LKB1-FLAG was immunoprecipitated from KD-LKB1 HeLa cells stimulated with tetracycline (1 
μg/ml, 24 h) using anti-FLAG antibodies. In parallel, an IP was performed on cell lysates prepared 
from LKB1 -/- HeLa cells. KD-AMPKα1-myc was immunoprecipitated from Ad.AMPKα1-DN 
infected HEK 293 cell lysates using anti-myc conjugated beads. Simultaneously an IP was 
performed using anti-myc conjugated beads on cell lysates from Ad.Null infected HEK 293 cells. 
MBP (5 μg) was also used as a substrate for PLK1. Substrate were incubated in the presence or 
absence of 50 ng aurora A-GST and [γ-32P]ATP for 30 min at 30oC. Reactions were terminated by 
the removal of the supernatant and addition of 2x LSB. Alternatively 4x LSB was added to 
reactions where substrate was omitted. Reactions were resolved by SDS-PAGE and resulting gels 
stained with Coomassie, dried and 32P incorporation assessed using a phosphorimager (A) 
Representative phosphorimage and coomassie stained gel. (B) Densitometric analysis of KD-
LKB1-FLAG phosphorylation by aurora A. Data shown as ± SEM. N=2. 
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Figure 5-16. Analysis of in vitro phosphorylation of CaMKKβ-GST by PLK1 
CaMKKβ-GST or GST (500 ng) were heated at 95oC for 5 min. In vitro phosphorylation reactions 
were carried out using aurora A (50 ng). Reactions were incubated with [γ-32P]ATP for 30 min at 
30oC. Boiled CaMKKβ-GST and PLK1 were also incubated with MBP (5 μg). In vitro 
phosphorylation reactions were terminated by the addition of 4x LSB. Reactions were resolved by 
SDS-PAGE and resulting gel stained with Coomassie, dried and 32P incorporation assessed using 
a phosphorimager. N=1. 
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5.2.3.4 CaMKKβ phosphorylates KD-Aurora A-mCherry, KD-Aurora B-GFP 
and may phosphorylate KD-PLK1-YFP in vitro 
HEK 293 cells were transfected with plasmids encoding either; KD-Aurora A-
mCherry, KD-Aurora B-GFP, KD-PLK1-YFP, CHMP2A, GFP or mCherry and 
incubated for 48 h. Cells were lysed and immunoprecipitated using either anti-
mCherry or anti-GFP nanobodies (which recognise YFP isoforms) conjugated to 
magnetic beads as appropriate. Substrate-bound beads were incubated with 
CaMKKβ-GST in the presence of [γ-32P]ATP. Reactions were resolved by SDS-PAGE 
and examined using a phosphorimager.  
Bands were visible on the coomassie stained gel for KD-Aurora A-mCherry (~72 
kDa and ~60 kDa), KD-Aurora B-GFP (~66 kDa), KD-PLK1-YFP (~95 kDa), GFP (~27 
kDa) and mCherry (~24 kDa) at the expected molecular mass (Figure 5-17). No 
band could be attributed to CHMP2A-GFP (expected molecular weight of~50 kDa) 
(Figure 5-17).  
Incubation of KD-Aurora A-mCherry with CaMKKβ-GST produced two bands on the 
phosphorimage at the appropriate molecular masses for the fusion protein 
(Figure 5-17). Bands were not apparent when CaMKKβ was omitted from the 
reaction, indicating in vitro phosphorylation by CaMKKβ (Figure 5-17). In vitro 
phosphorylation of KD-aurora B-GFP was also evident as band intensity was 
reduced or absent when CaMKKβ was omitted from the reaction (Figure 5-17). 
CaMKKβ-mediated phosphorylation of KD-PLK1-YFP was inconsistent between 
replicates (Figure 5-17). A faint band was produced when GFP was incubated 
with CaMKKβ (Figure 5-17). No phosphorylation of mCherry was observed (Figure 
5-17).  
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Figure 5-17. Analysis of in vitro phosphorylation of DN-Aurora A-mCherry, DN-Aurora B-
GFP, DN-PLK1-YFP and CHMP2A-GFP by CaMKKβ 
HEK 293 cells were transfected with plasmids encoding DN-Aurora A-mCherry, DN-Aurora B-GFP, 
DN-PLK1-YFP or CHMP2A-GFP. Cells were lysed and immunoprecipitated with either anti-
mCherry or anti-GFP (recognised YFP isoforms) conjugated magnetic beads as appropriate. 
Substrate bound beads or MBP (5 μg) were incubated with CaMKKβ-GST with 250 µM CaCl2 and 
2 μM calmodulin and [γ-32P]ATP for 30 min at 30oC. In vitro phosphorylation reactions were 
terminated by the removal of the supernatant and addition of 2x LSB. Alternatively 4x LSB was 
added to reactions using MBP as a substrate or reactions when substrate was omitted. Reactions 
were resolved by SDS-PAGE and resulting gels stained with Coomassie, dried and 32P 
incorporation assessed using a phosphorimager Representative phosphorimage and coomassie 
stained gel. (B) Densitometric analysis of CaMKKβ mediated phosphorylation of substrates. Data 
shown as ± SEM. N=2.  
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5.2.3.5 AMPKα1β1γ1 phosphorylates KD-Aurora A-mCherry, KD-Aurora B-
GFP and KD-PLK1-YFP in vitro 
Substrates were prepared as described previously, and incubated with active 
recombinant AMPKα1β1γ1 (a kind gift from Dr. S. Hawley, University of Dundee, 
UK). Incubation of KD-aurora A-mCherry or KD-aurora B-GFP with AMPKα1β1γ1 
caused a significant increase in band intensity (Figure 5-18). AMPKα1β1γ1 also 
phosphorylated KD-PLK1-YFP, however, statistical analysis could not be 
undertake due to lack of replicates. Omission of AMP from the assay buffer 
reduced AMPKα1β1γ1-mediated phosphorylation of both KD-aurora A-mCherry 
and KD-aurora B-GFP (Figure 5-19). AMPKα1β1γ1 could phosphorylate GFP to an 
extent (Figure 5-18).  
5.2.3.6 AMPKα2 does not phosphorylate KD-PLK1-YFP or KD-Aurora B-GFP 
but may phosphorylate KD-Aurora A-mCherry in vitro 
To determine whether the AMPK heterotrimer composition altered 
phosphorylation, substrates were prepared as described previously, and 
incubated with active recombinant AMPKα2β2γ1 (a kind gift from Dr. S. Hawley, 
University of Dundee, UK). Incubation of KD-aurora A-mCherry with AMPKα2β2γ1 
produced a band correlating to the higher molecular mass (~72 kDa) species. The 
lower molecular mass (~58 kDa) species was not further phosphorylated by 
AMPKα2β2γ1 (Figure 5-20). AMPKα2β2γ1 did not phosphorylated KD-PLK1-YFP or 
KD-Aurora B-GFP (Figure 3-20). GFP was not efficiently pulled down to examine 
phosphorylation by AMPKα2β2γ1 (Figure 5-20). There was no phosphorylation of 
mCherry by AMPKα2β2γ1 (Figure 5-20).  
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Figure 5-18. Analysis of in vitro phosphorylation of DN-Aurora A-mCherry, DN-Aurora B-
GFP, DN-PLK1-YFP and CHMP2A-GFP by AMPKα1β1γ1 
HEK 293 cells were transfected with plasmids encoding DN-Aurora A-mCherry, DN-Aurora B-GFP, 
DN-PLK1-YFP or CHMP2A-GFP. Cells were lysed and immunoprecipitated with either anti-
mCherry or anti-GFP (recognised YFP isoforms) conjugated magnetic beads as appropriate. 
Substrate bound beads or MBP (5 μg) were incubated with 0.5 U AMPKα1β1γ1 (where 1 U is 1 
nmol 32P incorporated/min into SAMS peptide), 0.2 mM AMP and [γ-32P]ATP for 30 min at 30oC. In 
vitro phosphorylation reactions were terminated by the removal of the supernatant and addition of 
2x LSB. Alternatively 4x LSB was added to reactions using MBP as a substrate or reactions when 
substrate was omitted. Reactions were resolved by SDS-PAGE and resulting gels stained with 
Coomassie, dried and 32P incorporation assessed using a phosphorimager Representative 
phosphorimage and coomassie stained gel. (B) Densitometric analysis of AMPKα1β1γ1 mediated 
phosphorylation of substrates. Data shown as ± SEM. N=3 phosphorylation of KD-aurora A-
mCherry and KD-aurora B-GFP. N=2 phosphorylation of KD-PLK1-YFP, GFP and mCherry. * 
p<0.05 **** p<0.001 two-way ANOVA.  
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Figure 5-19. Analysis of AMP-dependence of the in vitro phosphorylation of DN-Aurora A-
mCherry, DN-Aurora B-GFP or DN-PLK1-YFP by AMPKα2β2γ1 
HEK 293 cells were transfected with plasmids encoding DN-Aurora A-mCherry, DN-Aurora B-GFP 
or DN-PLK1-YFP. Cells were lysed and immunoprecipitated with either anti-mCherry or anti-GFP 
(recognises YFP isoforms) conjugated magnetic beads as appropriate. Substrate-bound beads or 
MBP (5 μg) were incubated with 0.5 U AMPKα1β1γ1 (where 1 U is 1 nmol 32P incorporated/min 
into SAMS peptide) and [γ-32P]ATP with or without 0.2 mM AMP for 30 min at 30oC. In vitro 
phosphorylation reactions were terminated by the removal of the supernatant and addition of 2x 
LSB. Alternatively 4x LSB was added to reactions using MBP as a substrate. Reactions were 
resolved by SDS-PAGE and the resulting gels stained with Coomassie, dried and 32P incorporation 
assessed using a phosphorimager. N=1.  
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Figure 5-20. Analysis of in vitro phosphorylation of DN-Aurora A-mCherry, DN-Aurora B-
GFP, DN-PLK1-YFP and CHMP2A-GFP by AMPKα2β2γ1 
HEK 293 cells were transfected with plasmids encoding DN-Aurora A-mCherry, DN-Aurora B-GFP, 
DN-PLK1-YFP or CHMP2A-GFP. Cells were lysed and immunoprecipitated with either anti-
mCherry or anti-GFP (recognised YFP isoforms) conjugated magnetic beads as appropriate. 
Substrate bound beads or MBP (5 μg) were incubated with 0.5 U AMPKα2β2γ1 (where 1 U is 1 
nmol 32P incorporated/min into SAMS peptide), 0.2 mM AMP and [γ-32P]ATP for 30 min at 30oC. In 
vitro phosphorylation reactions were terminated by the removal of the supernatant and addition of 
2x LSB. Alternatively 4x LSB was added to reactions using MBP as a substrate or reactions when 
substrate was omitted. Reactions were resolved by SDS-PAGE and resulting gels stained with 
Coomassie, dried and 32P incorporation assessed using a phosphorimager. (B) Densitometric 
analysis of AMPKα2β2γ1 mediated phosphorylation of substrates. N=1.  
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5.3 Discussion 
5.3.1 Principal findings 
 LKB1 expression or function does not influence binucleation in transgenic 
HeLa cells 
 LKB1 activity prevents compound C induced polyploidy in transgenic HeLa 
cells 
 CaMKKβ phosphorylates aurora A, aurora B and potentially PLK1 in vitro 
 AMPKα1β1γ1 phosphorylates aurora A, aurora B and PLK1 in vitro 
5.3.2 LKB1 activity may influence HeLa cell mitosis 
LKB1 was found to localise to the cytoplasm, nuclei and the intracellular bridge 
but not the midbody in transgenic HeLa cells. Localisation was consistent for 
both WT- and KD-LKB1. The specificity of anti-LKB1 antibodies were also 
demonstrated due to the lack of immunoreactivity observed in LKB1 -/- HeLa 
cells. Consistent with the subcellular localisation described in this work, in the 
human osteosarcoma epithelial cell line U2OS cells, LKB1 has been described to 
localise to the cytoplasm and nucleus but also the MTOC (Werle et al., 2014). In 
U2OS cells LKB1 regulates the centrosome function and depletion of LKB1 causes 
an increase in the number of centrosomes in an AMPK-independent manner 
which is potentially mediated by altered regulation of PLK1 (Werle et al., 2014). 
Transgenic HeLa cells undergoing early phases of mitosis weakly adhered to 
coverslips meaning that LKB1 localisation could not be assessed during 
metaphases.  
During telophase, aurora A has been described to localise to the MTOC and to 
the intracellular bridge in HeLa cells without an enrichment at the midbody 
(Marumoto et al., 2003). Consistently, in this study, aurora A was detected at 
the intracellular bridge and in the cytoplasm and nuclei. Localisation of aurora A 
was not influenced upon the expression of WT-LKB1 or KD-LKB1. In HUVECs 
(which have intact LKB1) aurora A was detected at the midbody, cytoplasm and 
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nucleus. Aurora A subcellular localisation during mitosis in HUVECs has not been 
described before.  
Similarly, aurora B and PLK1 were detected in the nucleus, cytoplasm and the 
intracellular bridge but not the midbody of HeLa cells. In contrast, previous 
studies have reported aurora B localisation to the midbody as well as the nucleus 
and cytoplasm of HeLa cells in telophase (Crosio et al., 2002; He et al., 2013; 
Capalbo et al., 2019). Additionally, PLK1 has also been described at the midbody 
and in the cytoplasm of HeLa cells (Pal et al., 2010; He et al., 2013; An et al., 
2018). Therefore, there was a clear discrepancy between the localisation of 
PLK1 and aurora B described in this Chapter and previous studies. These 
differences could be a result of different staining protocols, different antibodies 
or the source of HeLa cells. There has been a growing concern on the variation 
of HeLa cell stocks between different research institutes. HeLa cells collected 
from a number of different research institutes had genetic heterogeneity and 
phenotypic variation. Furthermore, these differences were amplified after 
successive passaging (Liu et al., 2019). Regardless, replacing LKB1 
expression/function did not influence aurora A, aurora B or PLK1 Localisation in 
HeLa cells.  
Expression of either WT- or KD-LKB1 also did not influence the DNA content of 
HeLa cells. However, it was previously reported that expression of WT but not 
KD-LKB1 in LKB1-null squamous cell carcinoma (SSC) cells induced senescence 
and binucleation (Gurumurthy et al., 2008). This effect was not due to 
AMPK/mTOR pathways so the downstream target(s) of LKB1 are unknown but 
likely would be an AMPK-related kinase (ARK). 
Compound C caused a significant decrease in the proportion of cells with 2n DNA 
in KD-LKB1 HeLa cells and increased the proportion of cells with 4n DNA. 
Whereas the DNA content of WT-LKB1 HeLa cells was not significantly altered by 
compound C. This suggests that LKB1 activity can prevent compound C-induced 
cell cycle arrest/binucleation. As flow cytometry cannot differentiate between 
cells in G2/M-phase prior to karyokinesis or cells which contained two nuclei, is 
not possible to determine if compound C caused an increase in binucleation or 
caused cells to accumulate at the G2/M phase boundary. However, as STO-609 
did not influence the DNA content of KD-LKB1 HeLa cells, it is likely that the 
 187 
 
effects of compound C was mediated by an AMPK-independent mechanism. 
Alternatively, overexpression of WT-LKB1 may overcome the capacity of 
compound C to inhibition of AMPK.  
5.3.3 A network of phosphorylation exists between AMPK, 
CaMKKβ, LKB1 and mitotic proteins 
During the course of this investigation, a number of phosphorylation events were 
described in vitro (Figure 5-21). These phosphorylation events have largely not 
been described before and are summarised as follows; 
 CaMKKβ phosphorylated aurora A, aurora B and may phosphorylate PLK1. 
 AMPKα1β1γ1 phosphorylated aurora A, aurora B and PLK1. 
 AMPKα2β2γ1 phosphorylated aurora A and PLK1. 
 Aurora A phosphorylated LKB1, also described by Zheng et al., 2018. 
 Aurora B may phosphorylate LKB1. 
 PLK1 may phosphorylate CaMKKβ. 
 
 
Figure 5-21. A number of phosphorylation events link the AMPK pathway to aurora A, aurora 
B and PLK1 
In vitro phosphorylation events discovered in this Chapter are indicated with a black arrow. In vitro 
phosphorylation of LKB1 by aurora B and phosphorylation of CaMKKβ by PLK1 were unclear 
(dashed arrows). CaMKKβ and LKB1 have well established roles in the phosphorylation of AMPK 
(red arrows).  
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Expression of a plasmid encoding KD-aurora A-mCherry in HEK 293 cells produced 
two distinct bands when assessed by SDS-PAGE and immunoblotting with anti-
mCherry or anti-aurora A antibodies. The aurora A fusion protein contained I57V 
and K162R mutations to render it kinase dead and an N-terminal mCherry tag. 
The higher molecular mass species (~72 kDa) represented the expected 
molecular mass of the fusion protein whereas the lower molecular mass species 
was approximately 60 kDa. As both species were detected with anti-mCherry 
antibodies, it is most likely that a C-terminal truncation occurred. Expression of 
KD-aurora B-GFP and KF-PLK1-YFP generated products of the expected molecular 
mass, ~65 kDa and ~90 kDa respectively.  
CaMKKβ and AMPK heterotrimers phosphorylated aurora A in vitro. AMPKα1β1γ1 
mediated-phosphorylated of aurora A was reduced when AMP was omitted from 
the assay, demonstrating that phosphorylation was likely AMPK-dependent rather 
than due to contamination with a different protein kinase. AMPKα2β2γ1-
mediated phosphorylation of aurora A occurred exclusively to the higher 
molecular mass species. The low molecular mass species was phosphorylated to 
a similar extent as when AMPK was omitted from the reaction. Potentially, the 
site which was phosphorylated by AMPKα2β2γ1 may not be present in the lower 
molecular mass species due to a C-terminal truncation. However, AMPKα2β2γ-
mediated phosphorylation of aurora A was only assessed once, thus more 
replicates would be necessary.  
AMPKα1β1γ1 also phosphorylated KD-aurora B-GFP in an AMP-dependent manner 
whereas AMPKα2β2γ1 did not phosphorylate aurora B. The AMPKα subunit 
isoforms have been described to have a subtly different substrate specificity in 
vitro, with different preferences for the bulky hydrophobic residues and basic 
residues that form the consensus sequence either side of the phosphorylated S/T 
(Woods et al., 1996). Therefore it is possible that aurora B contained a sequence 
which fits the phosphorylation motif of AMPKα1 but not that of AMPKα2. Both 
AMPKα1β1γ1 and AMPKα2β2γ could phosphorylate KD-PLK1-YFP, however the 
AMP-dependence could not be determined.  
The AMPK phosphorylation consensus has been well characterised as β-Ø-β-X-X-
X-S/T-X-X-X-Ø, where β represents basic amino acids and Ø represents 
hydrophobic residues (Figure 5-22) (Hardie, 2011; Marin et al., 2015). As such 
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S342 of aurora A may be a potential site for AMPK-mediated phosphorylation. 
Prior to S342 there is enrichment of basic residues and hydrophobic residues 
downstream of this site (Figure 5-22). The orthologous site in Xenopus (S349) is 
phosphorylated in M-phase although the kinase which phosphorylates this site is 
not known (Littlepage et al., 2002). Phosphorylation of this site does not 
influence aurora A activity but is thought to regulate the protein structure or its 
regulation (Littlepage et al., 2002). If this site was confirmed to be 
phosphorylated by AMPK (or perhaps CaMKKβ) it could help inform how the 
protein structure of aurora A influences function in mitosis.  
 
Figure 5-22. Sequence analysis of aurora A and PLK1 indicated the presence of an AMPK 
phosphorylation motif  
The amino acids around S341 or aurora A and S137 of PLK1 aligned with the phosphorylation 
motif of AMPK. AMPK can phosphorylate both serine and threonine residues, but for clarity only 
serine is shown in the phosphorylation motif.  
S137 of PLK1 could also fit the AMPK phosphorylation consensus (Figure 5-22). 
S137 is phosphorylated by PLK2 to promote cell survival during mitochondrial 
dysfunction (Matsumoto et al., 2009). Additionally S137 is phosphorylated late in 
mitosis and its phosphorylation is integral to the proper timing of mitosis (van de 
Weerdt et al., 2005). If these sites were validated to be phosphorylated by 
AMPK, it could indicate the role in which AMPK played in the timing of mitosis. 
Incubation of KD-LKB1 with active aurora A-GST increased band intensity by 40% 
± 8% when assessed by phosphorimaging, demonstrating that aurora A 
phosphorylated KD-LKB1 in vitro. This is consistent with a previous study in 
which aurora A phosphorylated LKB1 on S299 in non-small cell lung cancers 
(NSCLC). Aurora A mediated phosphorylation of LKB1 inhibited the interaction 
between LKB1 and AMPK thereby reducing AMPK phosphorylation and activity 
(Zheng et al., 2018).  
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Immunoprecipitation and in vitro phosphorylation of KD-AMPKα1-myc produced a 
number of bands on the phosphorimage demonstrating a degree of non-
specificity. This may have been expected due to immunoprecipitation of 
endogenous myc and potential interacting proteins. In some instances, a band of 
approximately 54 kDa was apparent which may represent AMPKγ3. Band intensity 
was not influenced by incubation with any of the kinases tested. If this band did 
represent AMPKγ3, it may be the first indication that this subunit is 
phosphorylated.  
As a kinase dead form of CaMKKβ could not be acquired, so to remove kinase 
activity commercial CaMKKβ-GST was heated at 95oC for 5 minutes to cause 
denaturation. Heat denatured CaMKKβ could not phosphorylate MBP. Neither 
aurora A nor aurora B phosphorylated denatured CaMKKβ. PLK1 may 
phosphorylate CaMKKβ-GST in vitro as a band of the appropriate molecular mass 
(~80 kDa) was detected, however, PLK1 phosphorylated GST to a comparable 
extent. Therefore it is more likely that PLK1 phosphorylated the GST tag rather 
than CaMKKβ, although more replicates would be necessary before ruling our 
PLK1 mediated phosphorylation of CaMKKβ. Conversely, CaMKKβ appeared to 
phosphorylate KD-PLK1-YFP but results were inconsistent between replicates. 
Therefore, it is possible that PLK1 and CaMKKβ may cross-regulate their function 
in a reciprocal manner, however, this would need to be assessed further.  
As discussed, AMPK was demonstrated to phosphorylate PLK1 in vitro. 
Demonstrating a link between PLK1 and the AMPK pathway which could 
represent a novel regulatory pathway as previous reports have indicated a role 
for LKB1 in the regulation of PLK1 independent of AMPK. LKB1 activates the ARK 
NUAK1 which inhibits myosin phosphatase targeting-1 (MYPT1), a subunit of 
protein phosphatase 1β (PP1β) (Zagorska et al., 2010; Werle et al., 2014). 
Inactivation of PP1β promotes accumulation of active phospho-T210 PLK1 (Werle 
et al., 2014). Furthermore, NUAK1 is phosphorylated by PLK1 on S476 and S480 
to promote polyubiquitination and degradation (Banerjee et al., 2014). 
Consistent with this, when PLK1 activity is low in S-phase, NUAK1 levels are 
elevated, and when PLK1 activity is high in G2/M-phase NUAK1 levels are low 
(Banerjee et al., 2014). Additionally, A431 cells treated with the PLK1 inhibitor 
GW843682X have no mitotic accumulation of phospho-T172 AMPK and have an 
increased rated of binucleation (Vazquez-Martin et al., 2011). GW843682X was 
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also reported to prevent phospho-S79 ACC localisation at the MTOC but not the 
midbody (Vazquez-Martin et al., 2013). However, it should be noted that 
GW843682X can inhibit AMPK in vitro; 10 µM GW843682X reduced AMPK activity 
by over 50% (Protein Phosphorylation and Ubiquitination unit, University of 
Dundee, MRC, n.d.). Thus the identification of PLK1 as a substrate for both AMPK 
and CaMKK in vitro could have interesting implications on how PLK1 regulates 
mitosis and cytokinesis.  
A limitation of the current study was that AMPKα1β1γ1 and CaMKKβ both 
phosphorylated GFP to an extent. As GFP was used as a tag for aurora B and a 
GFP isoform (YFP) used to tag PLK1, there was concern these results may 
represent AMPKα1β1γ1 or CaMKKβ phosphorylating the associated tag rather 
than aurora B/PLK1 directly. Phosphorylation of GFP was considerably less than 
that of AMPKα1β1γ1/CaMKKβ mediated-phosphorylation of KD-aurora B-GFP or 
KD-PLK1-YFP. Therefore it is proposed that AMPKα1β1γ1 and CaMKKβ could 
phosphorylate aurora B and PLK1 in vitro and to a considerably lesser extent also 
phosphorylated GFP. There was insufficient pull down of GFP for AMPKα2β2γ1-
mediated phosphorylation to be assessed. There was no phosphorylation of 
mCherry in vitro so there is not the same concern for AMPK and CaMKKβ 
mediated phosphorylation of KD-aurora A.  
5.3.4 Future work 
5.3.4.1 CHMP2 isoforms as a substrate for phosphorylation 
As a genetic interaction was described between ssp1 and vps2 in S. pombe, the 
human orthologues (CHMP2A and CHMP2B) were investigated as a substrate of 
AMPK/CaMKKβ. Initially, transfection of HEK 293 cells with a plasmid containing 
a gene for CHMP2A-GFP produced a product of the expected molecular mass 
(~50 kDa). However, when transfections were repeated to generate substrates 
for in vitro phosphorylation reactions, there was no product viable on Coomassie 
stained gels. This could indicate that CHMP2A-GFP was not produced in HEK 293 
cells or that the immunoprecipitation with anti-GFP conjugated beads was not 
sufficient in this instance. Transfection of HEK 293 cells with a plasmid encoding 
CHMP2B-GFP did not successfully generate a product.  
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Interestingly, the amino acid sequence surrounding T10 of CHMP2A and T9 of 
CHMP2B closely resemble the AMPK phosphorylation consensus (Figure 5-23). In 
both CHMP2 isoforms there is enrichment of basic residues prior to a threonine, 
and hydrophobic residues in the +4 and +5 positions relative to a threonine. 
While the sequences are not an exact match for the AMPK phosphorylation 
motif, it may indicate that CHMP2A and CHMP2B could be AMPK substrates and 
merits further research. Sequence alignment of Vps2 and CHMP2a indicates a 
serine residue at position 13 (aligns with T10 of CHMP2A) this may suggest that 
phosphorylation of the N-terminus is a conserved regulatory mechanism of ESCRT 
function between mammalian cells and fission yeast. 
 
Figure 5-23. Sequence analysis of CHMP2A and CHMP2B indicated the presence of an 
AMPK phosphorylation motif  
The first 20 amino acids of CHMP2A and CHMP2B aligned with the phosphorylation motif of 
AMPK. AMPK can phosphorylate both serine and threonine residues, but for clarity only threonine 
is shown in the phosphorylation motif. 
5.3.4.2 Anillin and Vps4 as substrates for phosphorylation 
While many of the genetic interactions identified in Chapter 4 were explored 
further in this Chapter, some of the interactions were not examined. This 
includes the interaction between ssp1/ssp2/amk2/cbs2 with mid1 or the 
interaction between ssp1 and vps4. Unfortunately, due to time constraints it was 
not possible to examine if either anillin (mammalian orthologue of S. pombe 
Mid1p) or Vps4 were substrates for AMPK, CaMKKβ or LKB1 but could be 
interesting to examine further.  
5.3.4.3 Investigation into LKB1 ability to phosphorylate mitotic proteins 
In Chapter 4, a number of genetic interactions were noted between the AMPK 
T172 kinase ssp1 and mitotic proteins. In this Chapter, LKB1 was only examined 
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as a substrate for in vitro phosphorylation rather than as the active kinase. 
Therefor it would be interesting to examine if LKB1 could phosphorylate mitotic 
proteins. This could be achieved by immunoprecipitation of WT-LKB1 from 
inducible HeLa cells using an anti-FLAG antibody in a similar manner to how KD-
LKB1 was isolated. It is unknown if an in vitro phosphorylation reaction would 
occur efficiently if both the substrate and the active kinase were bound to 
beads, therefore it would be suggested that WT-LKB1 be immunoprecipitated 
and incubated with heat denatured recombinant aurora A-GST, aurora B-GST or 
PLK1-His.  
5.3.4.4 Investigating the significance of in vitro phosphorylation 
To confirm phosphorylation in vivo, kinases could be mutated to utilise ATP 
analogues such as ATPγS as demonstrated by Hertz et al., 2010. 
Thiophphorylated substrates could then be isolated and identified by mass 
spectrometry. This technique could also identify the residue which is 
phosphorylated. Next, the biological importance of the phosphorylation could be 
assessed in a number of way; plasmids could be generated containing 
phosphomimetic (Ser/Thr mutated to Asp) or phosphonull (Ser/Thr to Ala) 
mutations. Plasmids could be transfected into cells and the functional effects 
assessed by measuring binucleation, proliferation, cell morphology or how these 
mutations influenced kinase activity.  
5.3.5 Summary 
A number of phosphorylation events between the AMPK pathway and aurora A, 
aurora B and PLK1 were identified. Most of these phosphorylation events are 
novel with the only phosphorylation event that had been described previously 
being the phosphorylation of LKB1 by aurora A. While there have previously been 
links reported between LKB1and PLK1 in a number of studies, this is the first 
account of direct phosphorylation. Unfortunately due to time constraints the 
functional effects of the phosphorylation could not be examined but could 
represent a novel aspect of AMPK function.  
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6 Chapter 6–Discussion 
6.1 Background 
At the start of these studies, a number of publication had suggested a role for 
AMPK in the regulation of mitosis but the precise role AMPK plays was not fully 
understood. The AMPKα2 subunit had been described to localise to the midbody 
during telophase (Pinter et al., 2012). Additionally phospho-T172 AMPK and 
phospho-S79 ACC were both reported to localise to the MTOC and to the 
midbody (Vazquez-Martin et al., 2009; Vazquez-Martin et al., 2013). These data 
indicated that AMPK localised to key compartments concerned with mitosis and 
cytokinesis. Furthermore, in a chemical genetic screen PPP1R12C and PAK2 were 
identified as substrates of AMPKα2 which implicated AMPK in the regulation of 
MRLC in mitosis (Banko et al., 2011).  
6.2 Final discussion 
6.2.1 AMPK localisation in mitosis 
The data described in this Thesis builds on these previous observations, 
demonstrating that in HUVECs and HeLa cells AMPKα1 localised to the MTOC 
(Figure 3-1 and 3-2). Additionally, previously described midbody localisation of 
AMPKα2 was confirmed in HUVECs (Pinter et al., 2012) and also shown to occur 
in HeLa cells(Figure 3-1 and 3-2), suggesting AMPKα subunit localisation during 
mitosis is conserved within human cells. Localisation to these mitotic structures 
was mutually exclusive; AMPKα1 was never observed at the midbody and AMPKα2 
was never detected at the MTOCs. This suggests that the AMPK heterotrimers 
have independent targeting mechanisms and most likely independent functions 
in mitosis. At the midbody, AMPK has been described in the context of a 
AMPKα2β2γ2 heterotrimer in HUVECs (Pinter et al., 2012) but given the 
differential expression of AMPK subunit isoforms, it is unclear if the regulatory 
subunits play a role in AMPK function at the midbody. The regulatory subunits 
which associate with AMPKα1 at the MTOC remain unknown.  
Active phospho-T172 AMPK has been reported to localise to the MTOC and 
midbody in a number of cancer cell lines and in primary marsupial cells 
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(Vazquez-Martin et al., 2009; Thaiparambil et al., 2012). This localisation was 
replicated in HeLa cells and demonstrated in HUVECs for the first time (figure 3-
4 and 3-5). Anti-phospho-T172 AMPK antibodies recognised both phospho-
AMPKα1 and phospho-AMPKα2 and is therefore consistent with the reported 
localisation of the individual subunit isoforms. However, the data presented here 
questions the specificity of phospho-T172 AMPK antibodies as immunoreactivity 
was detected in AMPK -/- MEFs with one commercial antibody (Figure 3-6).  
It remains unclear if AMPK is phosphorylated at the MTOC/midbody or if 
phospho-T172 AMPK is recruited to these sites. In transgenic HeLa cells, LKB1 
was found to localise to the cytoplasm, nuclei, the intracellular bridge but not 
the midbody when cells were in telophase. Interestingly, in U2OS cells, LKB1 has 
been reported to localise to the MTOC (Werle et al., 2014). Therefore, it is 
possible that LKB1 is recruited to the MTOC where it phosphorylates AMPK. As 
LKB1 is also enriched in the intracellular bridge, LKB1 may phosphorylate AMPK 
as it is recruited to the midbody. Unfortunately, due to poor antibody 
selectivity, it was not possible to examine CaMKKβ subcellular localisation.  
The MTOC acts as a site for the non-dynamic end of microtubules to anchor to 
and nucleate from, thereby enabling chromatid separation. The MTOC also acts 
as a scaffolding site to integrate multiple signalling pathways central to the 
regulation of mitosis, including CDK1/cyclin B, aurora A and PLK1 (Jackman et 
al., 2003). The localisation of AMPKα1 to the MTOC could therefore suggest a 
function for AMPK in the maturation of centrioles, microtubule nucleation, 
chromatid separation or in the regulation of aurora kinases or PLK1. AMPKα2 
localisation to the midbody could suggest a role in vesicle transport or the 
regulation of ESCRT subunits.  
6.2.2 AMPK activity during mitosis 
AMPK activity is not absolutely required for mitotic progression as 
AMPKα1/AMPKα2 double homozygous knockout cell lines are viable. However, 
evidence suggests that AMPK activity may be important for the fidelity or timing 
of cytokinesis in mammalian cells and fission yeast.  
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In fission yeast, after contraction of the actomyosin ring the division septum is 
deposited between the newly formed daughter cells. Enzymatic digestion of the 
division septa then enables the daughter cells to separate (Sipiczki and Bozsik, 
2000; Dekker et al., 2004). Staining of the division septa with Calcofluor-White 
allowed for the classification of yeast septation phenotype to determine how 
genetic alterations influenced septation. Deletion of ssp2, cbs2 or ssp1 caused a 
significant increase in the frequency of the Class F septation phenotype, 
representing delayed separation after septation compared to wild type cells 
(Figure 4-1). This suggests that AMPK has a role in the timely coordination of 
fission yeast cytokinesis, however the precise mechanism by which 
downregulation of AMPK delayed separation is unknown. A similar phenotype was 
also observed in vps2Δ and vps4Δ strains (Figure 4-16 and 4-18) which may 
indicate a link between the AMPK pathway and the ESCRT machinery during 
fission yeast cytokinesis.  
AMPK has well characterised anti-proliferative effects in mammalian cells, which 
is in part mediated by inducing cell cycle arrest at the G1/S-phase boundary 
though the stabilisation of p53 (Jones et al., 2005). Pharmacological stimulation 
of AMPK activity was demonstrated to reduced cell proliferation although an 
effect on cytokinesis was not observed as activation of AMPK with small 
molecule activators did not influence polyploidy. However, the expression of 
constitutively active AMPK prevented binucleation of HUVECs (Figure 3-17).  
Compound C caused HUVECs to arrest prior to S-phase (Figure 3-12). 
Furthermore, compound C reduced BrdU incorporation into DNA (Figure 3-14), 
demonstrating reduced proliferation. However, the anti-proliferative effect of 
compound C is likely AMPK-independent as both wild type and AMPK -/- MEFs 
had similarly reduced BrdU incorporation. In both LKB1 -/- HeLa cells and in KD-
LKB1 HeLa cells compound C caused a significant increase in the proportion of 
cells with 4n DNA (Figure 5-5). Interestingly, the expression of WT-LKB1 
prevented the accumulation of polyploid cells in response to compound C. 
However, in other cells, such as HUVECs and MEFs compound C did not cause an 
increase in the proportion of cells with 4n DNA. Therefore, this may represent a 
cell type specific effect of compound C in HeLa cells. As, STO-609 did not 
influence polyploidy in HeLa cells it is believed that compound C induced 
polyploidy by an AMPK-independent manner which may be regulated by LKB1.  
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6.2.3 Signalling pathways AMPK may regulate in mitosis 
To understand which signalling pathways AMPK may regulate during mitosis, a 
genetic screen was undertaken in S. pombe. In doing so, novel genetic 
interactions were identified between the genes for AMPK subunits/ssp1 and 
ark1, plo1 and mid1. Additionally, ssp1 but not amk2 or cbs2 was found to 
interact with the ESCRT components vps2 and vps4 (Table 4-4). Many of these 
interactions were then further characterised by in vitro phosphorylation assays 
using the mammalian protein orthologues.  
Aurora A and PLK1 have been described to localise to the MTOC where they 
regulate centrosome function and maturation in the early stages of mitosis 
(Arnaud et al., 1998; Sugimoto et al., 2002). It has also been reported that AMPK 
has a role in spindle orientation through MRLC and that pharmacological 
inhibition of PLK1 suppressed recruitment of phospho-T172 AMPK to the MTOC 
(Vazquez-Martin et al., 2011; Thaiparambil, et al., 2012). In this study, AMPK 
was found to phosphorylate both PLK1 and aurora A in vitro (Figure 5-18). 
Additionally CaMKKβ phosphorylated aurora A and may phosphorylate PLK1  
(Figure 5-17) which may indicate that a feedback loop exists between aurora 
A/PLK1 and CaMKKβ/AMPK. Aurora A phosphorylated LKB1, consistent with 
previous publications (Zheng et al., 2018). Together this could indicate a novel 
role for AMPK in the regulation of centrosomes. The integration of the AMPK 
pathway with aurora A and PLK1 at the MTOC during the early stages of mitosis 
may be a mechanism for cells to perform an energetic check point to ensure 
there was sufficient ATP for the timely completion of mitosis. 
Aurora B has been described to localise to the midbody in a number of cell types 
(Crosio et al., 2002; Fuller et al., 2008; He et al., 2013; Capalbo et al., 2019) 
and was detected at the midbody of HUVECs in this study. In vitro both AMPKα1 
and AMPKα2 phosphorylated KD-aurora A-GFP whereas only AMPKα1 
phosphorylated aurora B. Although AMPKα1 was excluded from the midbody, it 
may phosphorylate aurora B in the cytoplasm/intracellular bridge where the two 
proteins were both detected. Additionally, AMPK may phosphorylate the aurora 
kinases/PLK1 during interphase to regulate their function.  
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Both vps2 and vps4 were described to interact with ssp1 which may indicate that 
either LKB1 or CaMKKβ could regulated ESCRT function in human cells. Vps2p 
(CHMP2A/CHMP2B human orthologue), an ESCRT-III component which 
oligomerize to deform the cell membrane to catalyse abscission (Elia et al., 
2012). Vps4p (also Vps4 in human cells) is an AAA-ATPase which remodels ESCRT-
III polymers to regulate oligomerization, abscission and recycling of ESCRT 
subunits (Elia et al., 2012). Interestingly, An AMPK consensus sequence is 
apparent at the N-terminus of both CHMP2 isoforms (T10 of CHMP2A and T9 of 
CHMP2B). Neither sites have been described to be phosphorylated previously and 
therefore could represent a novel means of regulation of the ESCRT pathway. 
Unfortunately, ssp2Δ vps2Δ and ssp2Δ vps4Δ strains were not generated in this 
study so a genetic interaction could not be assessed with the AMPKα subunit in S. 
pombe. Therefore the genetic interaction observed between ssp1 and vps2/vps4 
may in fact represent a physical interaction with AMPK rather than CaMKKβ or 
LKB1 directly, this will be discussed further in Section 6.6.  
6.3 Proposed model for AMPK in mitosis 
During the early phases of mitosis AMPKα1 localises to the MTOC where it may be 
phosphorylated by LKB1. AMPK regulates spindle orientation and MRLC through 
PPP1R12C and PAK2 (Banko et al., 2011; Thaiparambil et al., 2012). The AMPK 
pathway may also regulate centrosome function/maturation through the 
phosphorylation of aurora A or PLK1. Mitotic activation of AMPK may be 
negatively regulated by aurora A which phosphorylates LKB1 to limit T172 
phosphorylation (Figure 6-1). AMPK activity may therefore be tightly regulated 
by antagonising signals which may explain why clear results were not obtained 
following pharmacological over activation or inhibition of AMPK.  
As mitosis progresses AMPK may regulate the formation or contraction of the 
actomyosin ring through interactions with anillin, although this has not been 
fully characterised. During telophase AMPKα2 localises to the midbody and 
AMPKα1 is localised to the cytoplasm/ intracellular bridge. AMPK may then 
phosphorylate aurora B to enable cytokinesis to occur in a timely fashion (Figure 
6-1). AMPK may also phosphorylate CHMP2 to regulate ESCRT-III polymerisation 
or transport to the midbody. AMPK may then phosphorylate Vps4 to regulate its 
ATPase activity enabling abscission or ESCRT recycling.  
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Figure 6-1. Proposed role for AMPK in mitosis and cytokinesis. 
AMPK may regulate S. pombe septation, cell cycle progression and binucleation of mammalian 
cells. Both AMPK and CaMKKβ phosphorylated aurora A, aurora B and PLK1. Aurora A was 
described to phosphorylate LKB1, which has previously been described to inhibit the interaction 
between LKB1 and AMPK. Genetic interactions were described between the AMPK pathway and 
anillin (mid1), CHMP2 (vps2) and Vps4 (vps4) but in vitro phosphorylation was not assessed.  
6.4 Summary  
AMPK has a well-documented anti-proliferative effect to limit ATP consumption 
when nutrients are limiting. This is achieved through the regulation of a number 
of pathways including the stabilisation of p53 to cause cell cycle arrest (Jones et 
al., 2005). Additionally AMPK downregulates mTOR to limit proliferation, protein 
synthesis and lipid synthesis (Inoki et al., 2002; Gwinn et al., 2008). With the 
localisation of AMPK to mitotic structures, the numerous genetic interactions 
described in S. pombe and network of cross-phosphorylation events detected in 
vitro, it is highly likely that AMPK plays a role in the regulation of mitosis. The 
precise role AMPK plays remains difficult to discern but it is most likely exerting 
an anti-proliferative cytostatic effect.  
6.5 Limitations of the present study 
The use of cancer cell lines which have undergone a number of genetic 
alterations should be considered as this could cause unforeseen effects on the 
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cell cycle. As HeLa cells lack LKB1, they are a useful tool in the study of how 
altered LKB1 signalling may affect AMPK and in particular the effects on 
proliferation. However, due to altered AMPK phosphorylation, the cell line may 
not be the best model to study the role of AMPK in physiological circumstances. 
This was addressed by the use of HUVECs to represent human primary cells but 
other cell types could also be assessed such as human fibroblasts. Another 
important consideration is the specificity of the pharmacological compounds 
used to investigate the influence of AMPK activity modulation on polyploidy. 
Many of the compound used have well documented AMPK-independent affects, 
such as compound C which can inhibit a number of kinases (Bain et al., 2007).  
A number of the key results of this work were generated by in vitro 
phosphorylation assays. These in vitro assays represent a simple experimental 
design to investigate protein phosphorylation but the results obtained in vitro 
may not be mirrored in vivo. Therefore, it would be important to confirm these 
results with observations in vivo.  
6.6 Future work 
The current study presents a number of avenues which warrant further 
investigation; 
 What are the real-time spatio-temporal dynamics of AMPK and the 
upstream kinases during mitosis? And what functions does AMPK play at 
these locations? 
Transfection of cells with plasmids encoding AMPK-GFP fusion proteins was 
attempted in HeLa cells to examine AMPK localisation without the need for 
antibodies. However, this proved to be unsuccessful for a number of reasons; 
low transfection rate; senescence of transfected cells; GFP localisation to the 
midbody. It would therefore be beneficial to optimise the transfection protocol 
and use alterative fluorophores. This approach would also enable real time 
visualisation of how pharmacological manipulation of AMPK activity influenced 
mitotic dynamics.  
 How is septation altered in mutant S. pombe cells? 
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Deletion of AMPK subunits or ssp1 caused in increase in the Class F septation 
phenotype but it is not known how abrogation of S. pombe AMPK altered 
septation. A number of possibilities may underlie this, including altered 
septum/membrane composition as a result of abrogated carbohydrate/lipid 
metabolism. Alternatively, there may be ineffective septum degradation due to 
altered expression or post-translational modification of hydrolytic enzymes. 
Altered septation may also be a result of delayed contraction of the actomyosin 
ring.  
Real time analysis of septation using Calcofluor-White staining could help 
determine at which point septation is delayed. Additionally, the composition and 
dynamics of the actomyosin ring could be examined. Metabolomic analysis could 
also determine if AMPK subunit deletion influenced whole cell carbohydrate and 
lipid metabolism. Finally, expression/PTM of hydrolytic enzymes could be 
assessed.  
 Do the genetic interactions between AMPK and mitotic proteins reflect 
physical interactions in vivo? 
In this study when genetic interactions were identified in vitro phosphorylation 
assays were undertaken to determine if the gene products could phosphorylate 
each other. However a number of other genetic and biochemical approaches 
could be employed to examine protein interactions which would further validate 
the results. This could include carrying out yeast two-hybrid experiments in S. 
pombe where a transcription factor is split into two fragments, each of which is 
fused to theorised interacting proteins. If the proteins interacted in vivo, the 
transcription factor would be reconstituted and mediate the production of a 
measurable reported gene. This is an ideal technique to be carried out in S. 
pombe due to the relative ease of genetic manipulation. Further analysis could 
be carried out in mammalian cells by assessing co-immunoprecipitation or 
fluorescent in situ-hybridisation. Binding sequences could also be characterised 
using peptide arrays and alanine screens to determine the binding sequence.  
 How are other cell cycle modulators influenced by AMPK? 
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It would also be interesting to evaluate how AMPK interacted with other cell 
cycle regulators such as MRLC, cyclins, CDK, CKIs or the anaphase-promoting 
complex. Genetic interactions could be assessed using S. pombe followed by 
performing in vitro phosphorylation assays. 
 On which residues are the identified proteins phosphorylated? And what 
are the functional implications of phosphorylation?  
The most striking results in this study was the discovery of a network of cross-
phosphorylation which existed between AMPK/LKB1/CaMKKβ and aurora 
A/aurora B/PLK1. After confirming in vitro phosphorylation of proteins, mass 
spectrometry could be undertaken to identify which residues were 
phosphorylated. This could be followed by the generation of phosphomimetic or 
phosphonull mutants. Then the activity of mutant proteins could be assessed to 
determine how phosphorylation influenced activity. Importantly the 
stoichiometry of the phosphorylation could also be assessed. 
 
 
 
203 
 
7 Appendix 1-S. pombe strain list 
The following is the full genotype of S. pombe strains used and generated during 
the course of this investigation.  
Lab 
number 
Genotype Source 
GG380 
h+ plo1-ts18::ura4+ ura4-D18 his2 leu1-32 ade6-
M210 
(MacIver, Glover 
and Hagan, 2003) 
GG400 h- ade6-216 leu1-31 ura4-D18 Laboratory stock 
GG1125 h- mid1::ura4+ ura4-D18 leu1-32 ade6-M210 
A kind gift from 
A Paoletti, 
Centre de 
recherché de 
l’Institut Curie. 
(AP245). 
(Sohrmann et al., 
1996) 
GG1167 h+ plo1-ts35 ura4-D18 leu1-32 
(Anderson et al., 
2002) 
GG1554 h+ dmf1::kanMX4 ura4-D18 leu1-32 ade6-216 
A kind gift from 
A Paoletti, 
Centre de 
recherché de 
l’Institut Curie. 
(AP245). 
(Sohrmann et al., 
1996) 
GG1615 h90 sst6::ura4+ ura4-D18 leu1-32 ade6-6-M210 
(Iwaki et al., 
2007) 
GG1616 h90 vps28::ura4+ ura4-D18 leu1-32 ade6-M210 
(Iwaki et al., 
2007) 
GG1617 h- vps36::ura4+ ura4-D18 leu1-32 ade6-M210 
(Iwaki et al., 
2007) 
GG1618 h- vps25::ura4+ ura4-D18 leu1-32 
(Iwaki et al., 
2007) 
GG1619 h90 vps20::ura4+ ura4-D18 leu1-32 ade6-M210 
(Iwaki et al., 
2007) 
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GG1621 h- vps2::LEU2 ura4-C190T leu1-32 
(Iwaki et al., 
2007) 
GG1622 h- vps4::ura4+ ura4-D18 leu1-32 
(Iwaki et al., 
2007) 
GG2426 
h+ ark1-T8-GFP-flag-His<<kanR ura4-D18 leu1-
32 ade6-210 
(Koch et al., 
2011) 
GG2540 h90 vps32::ura4+ leu1-31 ura4-D18 ade6-M210 
(Iwaki et al., 
2007) 
GG2979 h+ amk2::KanMX4 ade- leu- ura- 
(Valbuena and 
Moreno, 2012) 
GG2981 h+ cbs2::KanMX4 ade- leu- ura- 
(Valbuena and 
Moreno, 2012) 
GG2966 h- ssp1::ura4+ ura4-D18 
(Valbuena and 
Moreno, 2012) 
GG2986 
h? ssp1::ura4+ ark1-T8-GFP-flag<<kanR ura4-
D18 
This study 
GG2987 h? ssp1::ura4+ plo1-ts35 ura4-D18 This study 
GG2988 h? ssp1::ura4+ plo1-ts35 ura4-D18 leu1-32 This study 
GG2989 
h? ssp1::ura4+ ark1-T8-GFP-flag-His<<kanR 
ura4-D18 leu1-31 
This study 
GG2990 
h? ssp1::ura4+ ark1-T8-GFP-flag-His<<kanR 
ura4-D18 leu1-31 ade6-210 
This study 
GG2991 
h? ssp1::ura4+ ark1-T8-GFP-flag-His<<kanR 
ura4-D18 leu1-31 ade6-210 
This study 
GG2992 
h? ssp1::ura4+ ark1-T8-GFP-flag-His<<kanR 
ura4-D18 leu1-31 ade6-210 
This study 
GG2993 h? ssp1::ura4+ plo-ts35 ura4-D18leu1-31 This study 
GG2995 h? amk2::kanMX4 sst4::ura4+ ura- leu- This study 
GG2996 h? amk2::kanMX4 sst4::ura4+ ura- leu-ade- This study 
GG2997 h? amk2::kanMX4 sst4::ura4+ ura- leu- This study 
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GG2998 h? amk2::kanMX4 vps20::ura4+ ura- leu-ade- This study 
GG2999 h? amk2::kanMX4 vps20::ura4+ ura- leu-ade- This study 
GG3000 h? amk2::kanMX4 vps20::ura4+ ura- leu-ade- This study 
GG3001 h? amk2::kanMX4 vps20::ura4+ ura- leu-ade- This study 
GG3002 h? amk2::kanMX4 vps2::LEU2 ura- leu- ade- This study 
GG3003 h? amk2::kanMX4 vps2::LEU2 ura- leu- ade- This study 
GG3004 h? amk2::kanMX4 vps2::LEU2 ura- leu- ade- This study 
GG3005 h? amk2::kanMX4 vps2::LEU2 ura- leu This study 
GG3006 h? amk2::kanMX4 sst6::ura4+ ura- leu- ade- This study 
GG3007 h? amk2::kanMX4 sst6::ura4+ ura- leu- ade- This study 
GG3008 h? amk2::kanMX4 vps28::ura4+ ura- leu- ade- This study 
GG3009 h? amk2::kanMX4 vps32::ura4+ ura- leu- ade- This study 
GG3010 h? amk2::kanMX4 vps32::ura4+ ura- leu- ade- This study 
GG3012 h? cbs2::kanMX4 sst4::ura4+ ura- leu- This study 
GG3013 h? cbs2::kanMX4 sst4::ura4+ ura- leu- This study 
GG3014 h? cbs2::kanMX4 sst4::ura4+ ura- leu-ade- This study 
GG3015 h? cbs2::kanMX4 vps20::ura4+ ura- leu- ade- This study 
GG3016 h? cbs2::kanMX4 vps20::ura4+ ura- leu- ade- This study 
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GG3017 h? cbs2::kanMX4 vps20::ura4+ ura- leu- ade- This study 
GG3029 h? cbs2::kanMX4 vps36::ura4+ ura- leu- ade- This study 
GG3030 h? cbs2::kanMX4 vps36::ura4+ ura- leu- This study 
GG3031 h? cbs2::kanMX4 vps36::ura4+ ura- leu- This study 
GG3032 h? cbs2::kanMX4 vps36::ura4+ ura- leu- ade- This study 
GG3033 h- ssp2::ura4+ ura4-D18 leu1-32 
(Davie et al., 
2015) 
GG3041 h? ssp1::kanMX4 
(Davie et al., 
2015) 
GG3044 h? amk2::kanMX4 vps25::ura4+ ura- leu- ade- This study 
GG3045 h? amk2::kanMX4 vps25::ura4+ ura- leu- ade- This study 
GG3046 h? amk2::kanMX4 vps25::ura4+ ura- leu- ade- This study 
GG3047 h? amk2::kanMX4 vps36::ura4+ ura- leu- ade- This study 
GG3048 h? amk2::kanMX4 vps36::ura4+ ura- leu- ade- This study 
GG3049 h? cbs2::kanMX4 vps32::ura4+ ura- leu- ade- This study 
GG3050 h? amk2::kanMX4 vps4::ura4+ ura- leu- ade- This study 
GG3051 h? amk2::kanMX4 vps4::ura4+ ura- leu- ade- This study 
GG3052 h? cbs2::kanMX4 vps2::LEU2 ura- leu- ade- This study 
GG3053 h? cbs2::kanMX4 vps2::LEU2 ura- leu- ade- This study 
GG3054 h? cbs2::kanMX4 vps2::LEU2 ura- leu- ade- This study 
 207 
 
GG3055 h? amk2::kanMX4 vps28::ura4+ ura- leu- This study 
GG3056 h? cbs2::kanMX4 vps4::ura4+ ura- leu- This study 
GG3057 
h? ssp2::ura4+ ark1-T8-GFP-flag-His<<kanR 
ura4-D18 leu1-32 ade6-210 
This study 
GG3058 h? amk2::kanMX4 vps32::ura4+ ura- leu- ade- This study 
GG3059 h? amk2::kanMX4 vps32::ura4+ ura- leu- ade- This study 
GG3060 h? amk2::kanMX4 vps32::ura4+ ura- leu- ade- This study 
GG3061 h+ ssp2::ura4+ leu1-32 ura4-D18 This study 
GG3062 h- amk2::kanMX4+ ade- leu- ura- This study 
GG3063 h- cbs22::kanMX4+ ade- leu- ura- This study 
GG3064 
h? ssp2::ura4+ vps25::ura4+ leu1-32 ura4-D18 
ade- 
This study 
GG3065 
h? ssp2::ura4+ vps25::ura4+ leu1-32 ura4-D18 
ade- 
This study 
GG3066 h+ ssp2::ura4+ leu1-32 ura4-D18 This study 
GG3067 h? amk2::kanMX4 vps32::ura4+ ura- leu- ade This study 
GG3068 h? cbs2::kanMX4 vps25::ura4+ ura- leu- ade This study 
GG3069 h? cbs2::kanMX4 vps25::ura4+ ura- leu- This study 
GG3070 h? cbs2::kanMX4 vps36::ura4+ ura- leu- ade This study 
GG3071 h? amk2::kanMX4+ vps4::ura4+ ura- leu- This study 
GG3072 h? amk2::kanMX4+ vps4::ura4+ ura- leu- ade- This study 
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GG3073 
h? ssp2::ura4+ ark1-T8-GFP-flag-His<<KanR ura- 
leu- 
This study 
GG3074 
h? ssp2::ura4+ ark1-T8-GFP-flag-His<<KanR ura- 
leu- 
This study 
GG3075 h? amk2::kanMX4 sst6::ura6+ ura- leu- ade- This study 
GG3076 h? amk2::kanMX4 vps28::ura6+ ura- leu- ade- This study 
GG3077 
h? cbs2::kanMX4 ark1-T8-GFP-flag-His<<KanR 
ura- leu- ade- 
This study 
GG3078 
h? cbs2::kanMX4 ark1-T8-GFP-flag-His<<KanR 
ura- leu- ade- 
This study 
GG3079 h- ssp1::kanMX4 ura- leu- This study 
GG3080 h+ ssp1::kanMX4 ura- leu- This study 
GG3081 
h? cbs2::kanMX4 ark1-T8-GFP-flag-His<<KanR 
ura- leu- ade- 
This study 
GG3082 
h? cbs2::kanMX4 ark1-T8-GFP-flag-His<<KanR 
ura- leu- ade- 
This study 
GG3083 h? cbs2::kanMX4 vps25::ura4+ ura- leu- ade- This study 
GG3084 h? cbs2::kanMX4 vps28::ura4+ ura- leu- ade- This study 
GG3085 h? cbs2::kanMX4 vps25::ura4+ ura- leu- ade- This study 
GG3086 h? cbs2::kanMX4 vps25::ura4+ ura- leu- ade- This study 
GG3087 h? ssp1::kanMX4 vps28::ura4+ ura- leu- ade- This study 
GG3088 h? ssp1::kanMX4 vps28::ura4+ ura- leu- ade- This study 
GG3088 h? ssp1::kanMX4 vps28::ura4+ ura- leu- ade- This study 
GG3090 h? ssp1::kanMX4+ sst6::ura4+ ura- leu- ade- This study 
 209 
 
GG3091 h? cbs2::kanMX4 vps32::ura4+ ura- leu- ade- This study 
GG3092 
h? ssp2::kanMX4 plo1-ts18::ura4+ ura- leu- ade- 
his2- 
This study 
GG3093 
h? ssp2::kanMX4 plo1-ts18::ura4+ ura- leu- ade- 
his2- 
This study 
GG3094 h? cbs2::kanMX4  mid1::ura4+ ura- leu- This study 
GG3095 h? cbs2::kanMX4  mid1::ura4+ ura- leu- This study 
GG3096 h? cbs2::kanMX4  mid1::ura4+ ura- leu- This study 
GG3097 h? amk2::kanMX4  mid1::ura4+ ura- leu- This study 
GG3098 h? amk2::kanMX4  mid1::ura4+ ura- leu- This study 
GG3099 h? ssp2::ura4+  dmf1::kanMX4 ura- leu- ade- This study 
GG3108 h? cbs2::kanMX4  sst6::ura4+ ura- leu-ade- This study 
GG3109 h? cbs2::kanMX4  sst6::ura4+ ura- leu-ade- This study 
GG3110 h? cbs2::kanMX4  sst6::ura4+ ura- leu-ade- This study 
GG3111 h? cbs2::kanMX4  sst6::ura4+ ura- leu-ade- This study 
GG3112 h? amk2::kanMX4  mid1::ura4+ ura- leu-ade- This study 
GG3113 h? amk2::kanMX4  mid1::ura4+ ura- leu-ade- This study 
GG3114 h? amk2::kanMX4  mid1::ura4+ ura- leu-ade- This study 
GG3115 
h? amk2::kanMX4  plo1-ts18::ura4+ ura- leu-
ade- 
This study 
GG3116 h? ssp1::kanMX4  vps20::ura4+ ura- leu-ade- This study 
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GG3117 h? ssp1::kanMX4  vps2::LEU2 ura- leu-ade- This study 
GG3119 
h? cdr2::natMX6 ark1-T8-GFP-flag-His<<kanR 
ura- leu- 
This study 
GG3120 
h? cdr2::natMX6 ark1-T8-GFP-flag-His<<kanR 
ura- leu- 
This study 
GG3121 h? ssp1::kanMX4  sst6::ura4+ ura- leu- ade- This study 
GG3122 h? ssp1::kanMX4  sst6::ura4+ ura- leu- ade- This study 
GG3123 h? ssp1::kanMX4  vps20::ura4+ ura- leu- This study 
GG3124 h? ssp1::kanMX4  vps20::ura4+ ura- leu- This study 
GG3125 h? ssp1::kanMX4  vps4::ura4+ ura- leu- This study 
GG3126 h? ssp1::kanMX4  vps4::ura4+ ura- leu- This study 
GG3127 h? ssp1::kanMX4  vps4::ura4+ ura- leu- This study 
GG3128 h? ssp1::kanMX4  sst4::ura4+ ura- leu- This study 
GG3129 h? ssp1::kanMX4  sst4::ura4+ ura- leu- This study 
GG3130 h? ssp1::kanMX4  sst4::ura4+ ura- leu- This study 
GG3131 h? ssp1::kanMX4  vps32::ura4+ ura- leu- This study 
GG3132 h? ssp1::kanMX4  vps32::ura4+ ura- leu- ade- This study 
GG3233 h? ssp1::kanMX4  vps32::ura4+ ura- leu- This study 
GG3134 h? cbs2::kanMX4  vps4::ura4+ ura- leu- This study 
GG3135 h? cbs2::kanMX4  vps4::ura4+ ura- leu- This study 
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GG3136 h? cbs2::kanMX4  vps32::ura4+ ura- leu- ade- This study 
GG3137 h? ssp1::kanMX4  vps36::ura4+ ura- leu- This study 
GG3138 h? ssp1::kanMX4  vps36::ura4+ ura- leu- This study 
GG3139 h? ssp1::kanMX4  vps32::ura4+ ura- leu- This study 
GG3140 h? ssp1::kanMX4  vps32::ura4+ ura- leu- ade- This study 
GG3141 h? ssp1::kanMX4  vps32::ura4+ ura- leu- ade- This study 
GG3142 h? ssp1::kanMX4  vps32::ura4+ ura- leu- This study 
GG3144 
h? amk2::kanMX4  plo1-ts18::ura4+ ura- leu- 
ade- 
This study 
GG3145 
h? amk2::kanMX4  plo1-ts18::ura4+ ura- leu- 
ade- 
This study 
GG3146 
h? amk2::kanMX4  plo1-ts18::ura4+ ura- leu- 
ade- 
This study 
GG3147 
h? amk2::kanMX4  plo1-ts18::ura4+ ura- leu- 
ade- 
This study 
GG3148 h? cbs2::kanMX4  plo1-ts18::ura4+ ura- leu- ade- This study 
GG3149 
h? amk2::kanMX4  plo1-ts18::ura4+ ura- leu- 
ade- 
This study 
GG3150 
h? amk2::kanMX4  plo1-ts18::ura4+ ura- leu- 
ade- 
This study 
GG3151 
h? amk2::kanMX4  plo1-ts18::ura4+ ura- leu- 
ade- 
This study 
GG3152 h? ssp1::kanMX4  plo1-ts18::ura4+ ura- leu- ade- This study 
GG3153 h? ssp1::kanMX4  plo1-ts18::ura4+ ura- leu- This study 
GG3134 h? ssp1::kanMX4  plo1-ts18::ura4+ ura- leu- This study 
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GG3155 h? ssp1::kanMX4  plo1-ts18::ura4+ ura- leu- This study 
GG3160 h? ssp1::kanMX4  mid1::ura4+ ura- leu-ade- This study 
GG3161 h? ssp1::kanMX4  mid1::ura4+ ura- leu-ade- This study 
GG3162 h? ssp1::kanMX4  mid1::ura4+ ura- leu-ade- This study 
GG3163 h? ssp1::kanMX4  vps2::LEU2 ura- leu- This study 
GG3164 h? ssp1::kanMX4  vps2::LEU2 ura- leu- This study 
GG3165 h? ssp1::kanMX4  vps2::LEU2 ura- leu- This study 
GG3166 h? ssp2::ura4+ dmf1::kanMX4 ura- leu- This study 
GG3167 h? ssp2::ura4+ dmf1::kanMX4 ura- leu- This study 
GG3168 h? ssp2::ura4+ dmf1::kanMX4 ura- leu- This study 
GG3169 h? ssp2::ura4+ plo1-ts18:: ura4+ ura- leu- ade- This study 
GG3170 h? ssp2::ura4+ plo1-ts18:: ura4+ ura- leu- ade- This study 
GG3171 h? ssp2::ura4+ plo1-ts35 ura- leu- This study 
GG3172 h? ssp2::ura4+ plo1-ts35 ura- leu- This study 
GG3173 h? ssp2::ura4+ plo1-ts35 ura- leu- This study 
GG3174 h? ssp2::ura4+ plo1-ts35 ura- leu- This study 
GG3175 h? amk2::ura4+ vps36:: ura4+ ura- leu- ade- This study 
GG3176 h? amk2::ura4+ vps36:: ura4+ ura- leu- ade- This study 
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GG3177 h? amk2::ura4+ vps36:: ura4+ ura- leu- ade- This study 
GG3178 h? cbs2::ura4+ vps32:: ura4+ ura- leu- ade- This study 
GG3179 h? cbs2::ura4+ vps32:: ura4+ ura- leu- ade- This study 
GG3180 h? cbs2::ura4+ vps32:: ura4+ ura- leu- ade- This study 
GG3225 h- plo1::GFP-NatR YGRC, FY20279 
GG3227 h- ark1::GFP-leu1+ leu1-32 
YGRC, FY9431 
(Okazaki and 
Niwa, 2008) 
Table 7-1. S. pombe strain list 
Strains were stored in 30% (v/v) glycerol at -80oC. YGRC represents the Yeast Genetic Resource 
Centre, National BioResource Project, Japan.  
 
 
 
214 
 
8 Appendix 2-Negative genetic interactions 
between AMPK and ESCRT components in S. 
pombe 
8.1 Negative interactions between ssp2 and ESCRT 
components 
 
Figure 8-1. No growth rate defects were observed in ssp2Δ vps25Δ double mutant cells 
Wild type (GG1278), vps25Δ (GG1618), ssp2Δ (GG3080), and two separate isolates of ssp2Δ 
vps25Δ (GG2064, 3065). Strains were suspended at 1.5x106 cell per ml and subjected to 10-fold 
serial dilution. Cell suspension was pipetted onto solid YE media and for 3 days. 
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8.2 Negative interactions between amk2 and ESCRT 
components 
 
Figure 8-2. No growth rate defects were observed in amk2Δ sst4Δ double mutant cells 
Wild type (GG1278), amk2Δ (GG2979), sst4Δ (GG1623) and three separate isolates of ssp2Δ 
sst4Δ (GG2995, GG2996, GG 2997). Strains were suspended at 1.5x106 cell per ml and subjected 
to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 days. 
 
Figure 8-3. No growth rate defects were observed in amk2Δ sst6Δ double mutant cells 
Wild type (GG1278), sst6Δ (GG1615), amk2Δ (GG2979) and three separate isolates of ssp2Δ 
sst6Δ (GG3006, GG3007, GG3075). Strains were suspended at 1.5x106 cell per ml and subjected 
to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 days. 
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Figure 8-4. No growth rate defects were observed in amk2Δ vps28Δ double mutant cells 
Wild type (GG1278), vps28Δ (GG1616), amk2Δ (GG2979) and three separate isolates of ssp2Δ 
vps28Δ (GG3008, GG3055, GG3076). Strains were suspended at 1.5x106 cell per ml and 
subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 
days. 
 
Figure 8-5. No growth rate defects were observed in amk2Δ vps36Δ double mutant cells 
Wild type (GG1278), vps36Δ (GG1617), amk2Δ (GG2979) and three separate isolates of ssp2Δ 
vps36Δ (GG3173, GG3176, GG3177). Strains were suspended at 1.5x106 cell per ml and 
subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 
days. 
 
 
217 
 
 
Figure 8-6. No growth rate defects were observed in amk2Δ vps25Δ double mutant cells 
Wild type (GG1278), vps25Δ (GG1618), amk2Δ (GG2979) and three separate isolates of ssp2Δ 
vps25Δ (GG3044, GG3045, GG3046). Strains were suspended at 1.5x106 cell per ml and 
subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 
days. 
 
Figure 8-7. No growth rate defects were observed in amk2Δ vps20Δ double mutant cells 
Wild type (GG1278), vps20Δ (GG1619), amk2Δ (GG2979) and three separate isolates of ssp2Δ 
vps20Δ (GG2998, GG2999, GG3000). Strains were suspended at 1.5x106 cell per ml and 
subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 
days. 
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Figure 8-8. No growth rate defects were observed in amk2Δ vps32Δ double mutant cells 
Wild type (GG1278), vps32Δ (GG2540), amk2Δ (GG2979) and three separate isolates of ssp2Δ 
vps32Δ (GG3009, GG3010, GG3058). Strains were suspended at 1.5x106 cell per ml and 
subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 
days. 
 
Figure 8-9. No growth rate defects were observed in amk2Δ vps2Δ double mutant cells 
Wild type (GG1278), amk2Δ (GG2979), vps2Δ (GG1621) and three separate isolates of ssp2Δ 
vps2Δ (GG3002, GG3003, GG3004). Strains were suspended at 1.5x106 cell per ml and subjected 
to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 days. 
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Figure 8-10. No growth rate defects were observed in amk2Δ vps4Δ double mutant cells 
Wild type (GG1278), vps4Δ (GG1622), amk2Δ (GG2979) and three separate isolates of ssp2Δ 
vps4Δ (GG3050, GG3051, GG3071). Strains were suspended at 1.5x106 cell per ml and subjected 
to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 days. 
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8.3 Negative interactions between cbs2 and ESCRT 
components 
 
Figure 8-11. No growth rate defects were observed in cbs2Δ sst4Δ double mutant cells 
Wild type (GG1278), cbs2Δ (GG2981), sst4Δ (GG1623) and three separate isolates of cbs2Δ 
sst4Δ (GG3012, GG3013, GG3014). Strains were suspended at 1.5x106 cell per ml and subjected 
to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 days. 
 
Figure 8-12. No growth rate defects were observed in cbs2Δ sst6Δ double mutant cells 
Wild type (GG1278), sst6Δ (GG1615), cbs2Δ (GG2981) and three separate isolates of cbs2Δ 
sst6Δ (GG3108, GG3109, GG3110). Strains were suspended at 1.5x106 cell per ml and subjected 
to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 days. 
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Figure 8-13. No growth rate defects were observed in cbs2Δ vps28Δ double mutant cells 
Wild type (GG1278), vps28Δ (GG1616), cbs2Δ (GG2981) and three separate isolates of cbs2Δ 
vps28Δ (GG3084, GG3085, GG3086). Strains were suspended at 1.5x106 cell per ml and 
subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 
days. 
 
Figure 8-14. No growth rate defects were observed in cbs2Δ vps36Δ double mutant cells 
Wild type (GG1278), vps36Δ (GG1617), cbs2Δ (GG2981) and three separate isolates of cbs2Δ 
vps36Δ (GG3029, GG3030, GG3031). Strains were suspended at 1.5x106 cell per ml and 
subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 
days. 
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Figure 8-15. No growth rate defects were observed in cbs2Δ vps25Δ double mutant cells 
Wild type (GG1278), cbs2Δ (GG2981), vps25Δ (GG1618) and three separate isolates of cbs2Δ 
vps25Δ (GG3068, GG3069, GG3083). Strains were suspended at 1.5x106 cell per ml and 
subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 
days. 
 
Figure 8-16. No growth rate defects were observed in cbs2Δ vps20Δ double mutant cells 
Wild type (GG1278), vps20Δ (GG1619), cbs2Δ (GG2981) and three separate isolates of cbs2Δ 
vps20Δ (GG3015, GG3016, GG3017). Strains were suspended at 1.5x106 cell per ml and 
subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 
days. 
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Figure 8-17. No growth rate defects were observed in cbs2Δ vps2Δ double mutant cells 
Wild type (GG1278), vps2Δ (GG1621), cbs2Δ (GG2981) and three separate isolates of cbs2Δ 
vps2Δ (GG352, GG3053, GG3054). Strains were suspended at 1.5x106 cell per ml and subjected 
to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 days. 
 
Figure 8-18. No growth rate defects were observed in cbs2Δ vps4Δ double mutant 
Wild type (GG1278), vps4Δ (GG1622), cbs2Δ (GG2981) and three separate isolates of cbs2Δ 
vps4Δ (GG2052, GG3131, GG3135). Strains were suspended at 1.5x106 cell per ml and subjected 
to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 days. 
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8.4 Negative interactions between ssp1 and ESCRT 
components 
 
Figure 8-19. No growth rate defects were observed in ssp1Δ sst4Δ double mutant 
Wild type (GG1278), sst4Δ (GG1623), ssp1Δ (GG3080) and three separate isolates of ssp1Δ 
sst4Δ (GG3128, GG3129, GG3130). Strains were suspended at 1.5x106 cell per ml and subjected 
to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 days. 
 
Figure 8-20. No growth rate defects were observed in ssp1Δ sst6Δ double mutant cells 
Wild type (GG1278), sst6Δ (GG1615), ssp1Δ (GG3080) and three separate isolates of ssp1Δ 
sst6Δ (GG3090, GG3121, GG3122). Strains were suspended at 1.5x106 cell per ml and subjected 
to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 days. 
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Figure 8-21. No growth rate defects were observed in ssp1Δ vps28Δ double mutant cells 
Wild type (GG1278), vps28Δ (GG1616), ssp1Δ (GG3080) and three separate isolates of ssp1Δ 
vps28Δ (GG3087, GG3088, GG3089). Strains were suspended at 1.5x106 cell per ml and 
subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 
days. 
 
Figure 8-22. No growth rate defects were observed in ssp1Δ vps36Δ double mutant cells 
Wild type (GG1278), vps36Δ (GG1617), ssp1Δ (GG3080) and three separate isolates of ssp1Δ 
vps36Δ (GG3137, GG3138, GG3139). Strains were suspended at 1.5x106 cell per ml and 
subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 
days. 
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Figure 8-23. No growth rate defects were observed in ssp1Δ vps20Δ double mutant 
Wild type (GG1278), vps20Δ (GG1619), ssp1Δ (GG3080) and three separate isolates of ssp1Δ 
vps20Δ (GG3116, GG3132, GG3124). Strains were suspended at 1.5x106 cell per ml and 
subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 
days. 
 
Figure 8-24. No growth rate defects were observed in ssp1Δ vps32Δ double mutant cells 
Wild type (GG1278), vps32Δ (GG2540), ssp1Δ (GG3080) and three separate isolates of ssp1Δ 
vps32Δ (GG3131, GG3163, GG3133). Strains were suspended at 1.5x106 cell per ml and 
subjected to 10-fold serial dilution. Cell suspension was pipetted onto solid YE media and for 3 
days. 
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